
<html lang="en"     class="pb-page"  data-request-id="3cbe6ae3-c883-4e11-b241-b86e50f49427"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.1c00047;issue:issue:10.1021/jmcmar.2021.64.issue-9;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis" /></meta><meta name="dc.Creator" content="Michael  Thomas" /></meta><meta name="dc.Creator" content="Stephen  Brand" /></meta><meta name="dc.Creator" content="Manu  De Rycker" /></meta><meta name="dc.Creator" content="Fabio  Zuccotto" /></meta><meta name="dc.Creator" content="Iva  Lukac" /></meta><meta name="dc.Creator" content="Peter G.  Dodd" /></meta><meta name="dc.Creator" content="Eun-Jung  Ko" /></meta><meta name="dc.Creator" content="Sujatha  Manthri" /></meta><meta name="dc.Creator" content="Kate  McGonagle" /></meta><meta name="dc.Creator" content="Maria  Osuna-Cabello" /></meta><meta name="dc.Creator" content="Jennifer  Riley" /></meta><meta name="dc.Creator" content="Caterina  Pont" /></meta><meta name="dc.Creator" content="Frederick  Simeons" /></meta><meta name="dc.Creator" content="Laste  Stojanovski" /></meta><meta name="dc.Creator" content="John  Thomas" /></meta><meta name="dc.Creator" content="Stephen  Thompson" /></meta><meta name="dc.Creator" content="Elisabet  Viayna" /></meta><meta name="dc.Creator" content="Jose M.  Fiandor" /></meta><meta name="dc.Creator" content="Julio  Martin" /></meta><meta name="dc.Creator" content="Paul G.  Wyatt" /></meta><meta name="dc.Creator" content="Timothy J.  Miles" /></meta><meta name="dc.Creator" content="Kevin D.  Read" /></meta><meta name="dc.Creator" content="Maria  Marco" /></meta><meta name="dc.Creator" content="Ian H.  Gilbert" /></meta><meta name="dc.Description" content="There is an urgent need for new treatments for visceral leishmaniasis (VL), a parasitic infection which impacts heavily large areas of East Africa, Asia, and South America. We previously reported o..." /></meta><meta name="Description" content="There is an urgent need for new treatments for visceral leishmaniasis (VL), a parasitic infection which impacts heavily large areas of East Africa, Asia, and South America. We previously reported o..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 27, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00047" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 The Authors. Published by American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00047" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00047" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00047" /></link>
        
    
    

<title>Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00047" /></meta><meta property="og:title" content="Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0032.jpeg" /></meta><meta property="og:description" content="There is an urgent need for new treatments for visceral leishmaniasis (VL), a parasitic infection which impacts heavily large areas of East Africa, Asia, and South America. We previously reported on the discovery of GSK3494245/DDD01305143 (1) as a preclinical candidate for VL and, herein, we report on the medicinal chemistry program that led to its identification. A hit from a phenotypic screen was optimized to give a compound with in vivo efficacy, which was hampered by poor solubility and genotoxicity. The work on the original scaffold failed to lead to developable compounds, so an extensive scaffold-hopping exercise involving medicinal chemistry design, in silico profiling, and subsequent synthesis was utilized, leading to the preclinical candidate. The compound was shown to act via proteasome inhibition, and we report on the modeling of different scaffolds into a cryo-EM structure and the impact this has on our understanding of the series’ structure–activity relationships." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00047"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00047">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00047&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00047&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00047&amp;href=/doi/10.1021/acs.jmedchem.1c00047" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 5905-5930</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.1c00046" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.1c00065" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Michael Thomas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Thomas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Thomas">Michael Thomas</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0377-0281" title="Orcid link">http://orcid.org/0000-0003-0377-0281</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stephen Brand</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephen Brand</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Brand">Stephen Brand</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Manu De Rycker</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Manu De Rycker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Manu++De+Rycker">Manu De Rycker</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3171-3519" title="Orcid link">http://orcid.org/0000-0002-3171-3519</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fabio Zuccotto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fabio Zuccotto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fabio++Zuccotto">Fabio Zuccotto</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3888-7423" title="Orcid link">http://orcid.org/0000-0002-3888-7423</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Iva Lukac</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Iva Lukac</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Iva++Lukac">Iva Lukac</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Peter G. Dodd</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Peter G. Dodd</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Peter+G.++Dodd">Peter G. Dodd</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eun-Jung Ko</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eun-Jung Ko</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eun-Jung++Ko">Eun-Jung Ko</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1222-1938" title="Orcid link">http://orcid.org/0000-0003-1222-1938</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sujatha Manthri</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sujatha Manthri</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sujatha++Manthri">Sujatha Manthri</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kate McGonagle</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kate McGonagle</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kate++McGonagle">Kate McGonagle</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8485-7180" title="Orcid link">http://orcid.org/0000-0001-8485-7180</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Maria Osuna-Cabello</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maria Osuna-Cabello</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maria++Osuna-Cabello">Maria Osuna-Cabello</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jennifer Riley</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jennifer Riley</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer++Riley">Jennifer Riley</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Caterina Pont</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Caterina Pont</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Caterina++Pont">Caterina Pont</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Frederick Simeons</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Frederick Simeons</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Frederick++Simeons">Frederick Simeons</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laste Stojanovski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laste Stojanovski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laste++Stojanovski">Laste Stojanovski</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John Thomas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John Thomas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John++Thomas">John Thomas</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stephen Thompson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephen Thompson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Thompson">Stephen Thompson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elisabet Viayna</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elisabet Viayna</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elisabet++Viayna">Elisabet Viayna</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jose M. Fiandor</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jose M. Fiandor</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Tres Cantos 28760, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jose+M.++Fiandor">Jose M. Fiandor</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Julio Martin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Julio Martin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Tres Cantos 28760, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Julio++Martin">Julio Martin</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1887-0859" title="Orcid link">http://orcid.org/0000-0003-1887-0859</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paul G. Wyatt</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul G. Wyatt</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul+G.++Wyatt">Paul G. Wyatt</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0397-245X" title="Orcid link">http://orcid.org/0000-0002-0397-245X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Timothy J. Miles</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Timothy J. Miles</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Tres Cantos 28760, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Timothy+J.++Miles">Timothy J. Miles</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7407-7404" title="Orcid link">http://orcid.org/0000-0001-7407-7404</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kevin D. Read</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kevin D. Read</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+D.++Read">Kevin D. Read</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8536-0130" title="Orcid link">http://orcid.org/0000-0002-8536-0130</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Maria Marco</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maria Marco</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Health R&D, GlaxoSmithKline, Tres Cantos 28760, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#e984889b8088c784c784889b8a86a98e9a82c78a8684"><span class="__cf_email__" data-cfemail="86ebe7f4efe7a8eba8ebe7f4e5e9c6e1f5eda8e5e9eb">[email protected]</span></a>. Phone: +34 650220972.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maria++Marco">Maria Marco</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2442-0021" title="Orcid link">http://orcid.org/0000-0002-2442-0021</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Ian H. Gilbert</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ian H. Gilbert</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#58317630763f31343a3d2a2c183c2d363c3d3d76393b762d33"><span class="__cf_email__" data-cfemail="f39add9bdd949a9f91968187b397869d979696dd9290dd8698">[email protected]</span></a>. Phone: +44 1382 386240.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ian+H.++Gilbert">Ian H. Gilbert</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5238-1314" title="Orcid link">http://orcid.org/0000-0002-5238-1314</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00047&amp;href=/doi/10.1021%2Facs.jmedchem.1c00047" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 5905–5930</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 27, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 January 2021</li><li><span class="item_label"><b>Published</b> online</span>27 April 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 May 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00047" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00047</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 The Authors. Published by American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="https://acsopenscience.org/open-access/licensing-options/"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by"><a href="https://creativecommons.org/licenses/by/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_cc-1612971093887.svg" alt="CC: Creative Commons" /></img><span><strong>CC: </strong>Creative Commons</span></a><a href="https://creativecommons.org/licenses/by/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_by-1612971093257.svg" alt="BY: Credit must be given to the creator" /></img><span><strong>BY: </strong>Credit must be given to the creator</span></a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00047"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5938</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00047" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Thomas&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Brand&quot;},{&quot;first_name&quot;:&quot;Manu&quot;,&quot;last_name&quot;:&quot;De Rycker&quot;},{&quot;first_name&quot;:&quot;Fabio&quot;,&quot;last_name&quot;:&quot;Zuccotto&quot;},{&quot;first_name&quot;:&quot;Iva&quot;,&quot;last_name&quot;:&quot;Lukac&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;G. Dodd&quot;},{&quot;first_name&quot;:&quot;Eun-Jung&quot;,&quot;last_name&quot;:&quot;Ko&quot;},{&quot;first_name&quot;:&quot;Sujatha&quot;,&quot;last_name&quot;:&quot;Manthri&quot;},{&quot;first_name&quot;:&quot;Kate&quot;,&quot;last_name&quot;:&quot;McGonagle&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Osuna-Cabello&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;Riley&quot;},{&quot;first_name&quot;:&quot;Caterina&quot;,&quot;last_name&quot;:&quot;Pont&quot;},{&quot;first_name&quot;:&quot;Frederick&quot;,&quot;last_name&quot;:&quot;Simeons&quot;},{&quot;first_name&quot;:&quot;Laste&quot;,&quot;last_name&quot;:&quot;Stojanovski&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Thomas&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Thompson&quot;},{&quot;first_name&quot;:&quot;Elisabet&quot;,&quot;last_name&quot;:&quot;Viayna&quot;},{&quot;first_name&quot;:&quot;Jose&quot;,&quot;last_name&quot;:&quot;M. Fiandor&quot;},{&quot;first_name&quot;:&quot;Julio&quot;,&quot;last_name&quot;:&quot;Martin&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;G. Wyatt&quot;},{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;J. Miles&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;D. Read&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Marco&quot;},{&quot;first_name&quot;:&quot;Ian&quot;,&quot;last_name&quot;:&quot;H. Gilbert&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;5905-5930&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00047&quot;},&quot;abstract&quot;:&quot;There is an urgent need for new treatments for visceral leishmaniasis (VL), a parasitic infection which impacts heavily large areas of East Africa, Asia, and South America. We previously reported on the discovery of GSK3494245/DDD01305143 (1) as a preclinical candidate for VL and, herein, we report on the medicinal chemistry program that led to its identification. A hit from a phenotypic screen was optimized to give a compound with in vivo efficacy, which was hampered by poor solubility and genotoxicity. The work on the original scaffold failed to lead to developable compounds, so an extensive scaffold-hopping exercise involving medicinal chemistry design, in silico profiling, and subsequent synthesis was utilized, leading to the preclinical candidate. The compound was shown to act via proteasome inhibition, and we report on the modeling of different scaffolds into a cryo-EM structure and the impact this has on our understanding of the series’ structure–activity relationships.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00047&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00047" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00047&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00047" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00047&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00047" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00047&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00047&amp;href=/doi/10.1021/acs.jmedchem.1c00047" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00047" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00047" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00047%26sid%3Dliteratum%253Aachs%26pmid%3D33904304%26genre%3Darticle%26aulast%3DThomas%26date%3D2021%26atitle%3DScaffold-Hopping%2BStrategy%2Bon%2Ba%2BSeries%2Bof%2BProteasome%2BInhibitors%2BLed%2Bto%2Ba%2BPreclinical%2BCandidate%2Bfor%2Bthe%2BTreatment%2Bof%2BVisceral%2BLeishmaniasis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D9%26spage%3D5905%26epage%3D5930%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291241" title="Phenyls">Phenyls</a>,</li><li><a href="/action/doSearch?ConceptID=292201" title="Scaffolds">Scaffolds</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=290865" title="Nitrogen">Nitrogen</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/jmcmar.2021.64.issue-9/20210513/jmcmar.2021.64.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0032.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">There is an urgent need for new treatments for visceral leishmaniasis (VL), a parasitic infection which impacts heavily large areas of East Africa, Asia, and South America. We previously reported on the discovery of GSK3494245/DDD01305143 (<b>1</b>) as a preclinical candidate for VL and, herein, we report on the medicinal chemistry program that led to its identification. A hit from a phenotypic screen was optimized to give a compound with <i>in vivo</i> efficacy, which was hampered by poor solubility and genotoxicity. The work on the original scaffold failed to lead to developable compounds, so an extensive scaffold-hopping exercise involving medicinal chemistry design, <i>in silico</i> profiling, and subsequent synthesis was utilized, leading to the preclinical candidate. The compound was shown to act via proteasome inhibition, and we report on the modeling of different scaffolds into a cryo-EM structure and the impact this has on our understanding of the series’ structure–activity relationships.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67514" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67514" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Bites from infected sandflies are known to transmit <i>Leishmania</i> parasites, a protozoan parasite. There are more than 20 different species of <i>Leishmania,</i> which cause a group of diseases that manifest in three main clinical forms: cutaneous, mucocutaneous, and visceral leishmaniasis (VL, also referred to as kala-azar).<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> There is also the complication of VL, called post kala-azar dermal leishmaniasis. While the other three forms cause major health problems such as nonhealing ulcers and scarring, VL is the most severe and becomes lethal if not treated. Recurrent epidemics of VL in East Africa (Ethiopia, Kenya, South Sudan, and Sudan) have caused high morbidity and mortality in those countries and together with Brazil, India, and Somalia accounted for more than 90% of the new cases reported in 2018.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> VL is usually due to infection with either <i>Leishmania donovani</i> or <i>Leishmania infantum</i>. The infection causes irregular bouts of fever, substantial weight loss, swelling of the spleen and liver, and anemia. Current available treatments are not adequate due to high toxicity, resistance issues, treatment cost and duration, or the need for hospitalization to administer the treatment, a particularly relevant aspect given the settings where the disease is endemic. Indeed, the only effective oral treatment for VL is miltefosine, although it requires 28 days of dosing, and contraception is necessary for women both during and after treatment due to its teratogenicity. For reasons that are poorly understood, clinical outcomes for these drugs seem to vary from region to region of the world, with much reduced cure rates being observed in East Africa and South America. Given these factors, the need for safer, oral, short-course, and low-cost medicines for the treatment of VL is urgent.</div><div class="NLM_p">There is some cause for optimism, as for the first time, there are a number of compounds in late preclinical or early clinical development, as indicated on the Drugs for Neglected Diseases <i>Initiative</i> (DND<i>i</i>) website.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> We recently reported a leishmanial CRK-12 inhibitor as a preclinical candidate;<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> Novartis (LXE408, compound <b>2</b>)<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> and ourselves (GSK3494245/DDD01305143, compound <b>1</b>)<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> have both reported proteasome inhibitors (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>); DND<i>i</i> have other compounds in clinical development, notably an oxaborole and a nitroimidazole, although the mechanism of action (MoA) of these has not been reported.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In all these cases, the optimization was run phenotypically, with the MoA only being elucidated during or after the medicinal chemistry program. It must be noted<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> that there is a lack of validated drug targets for <i>Leishmania</i>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Compounds <b>1</b> (DDD01305143/GSK3494245), <b>2</b> (LXE408), <b>3</b> (initial hit), and <b>4</b> (early lead).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As we reported recently, compound <b>1</b> was the product of a program which started from substituted 2-phenyloxazolo[4,5-<i>b</i>]pyridine <b>3</b> which was identified through phenotypic screening against the related pathogen <i>Trypanosoma cruzi</i>, the causative agent of Chagas’ disease (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Subsequently, compound <b>3</b> was screened against the physiologically relevant intramacrophage form of <i>L. donovani,</i> where it showed weak activity. In parallel to our efforts, <i>N</i>-(4-chloro-3-(oxazolo[4,5-<i>b</i>]pyridin-2-yl)phenyl)furan-2-carboxamide (the 4-chloro phenyl analogue of <b>3</b>) had also been identified by the groups of Buckner, Gelb, Baell, and Guy as a compound with antikinetoplastid activity, with their optimization being subsequently reported.<a onclick="showRef(event, 'ref8 ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref8 ref11 ref12 ref13 ref14 ref15">(8,11−15)</a></div><div class="NLM_p last">As previously described, an initial scaffold hop from <b>3</b> led to a 2-phenylimidazo[1,2-<i>a</i>]pyrimidine and optimization of the 6-position of the bi-cycle led to a 6-morpholino substituent which increased the potency and metabolic stability. Alongside this, the fluorination of the phenyl ring increased potency and replacement of the furanyl amide with a pyrrolidinyl urea improved solubility (similar changes had also been observed on related scaffolds by other groups<a onclick="showRef(event, 'ref13 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref15">(13,15)</a>). This led to compound <b>4</b>, which showed efficacy in a mouse model of VL.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The key to the success of this compound series was a further set of scaffold hops from 2-phenylimidazo[1,2-<i>a</i>]pyrimidine, and this strategy, along with the discussion of the structure–activity relationships (SARs) around the 2-amino group, is described in detail herein. Although the series was developed phenotypically, it was subsequently found to act principally through the inhibition of the β5-subunit of the proteasome, specifically at the “chymotrypsin” site, and the relationship between the antiparasitic SAR and the identified target is also discussed in detail.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84575" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84575" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds were initially screened against <i>L. donovani</i> in an intracellular assay (<i>L. donovani</i> cultured in differentiated THP1 cells, referred to as the “INMAC assay”<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a>), where we targeted pEC<sub>50</sub> values >5.8, alongside stability in mouse liver microsomes of <5.0 mL/min/g (Cl<sub>i</sub>) and kinetic aqueous solubility >100 μM (measured by chemiluminescent nitrogen detection, CLND). We had successfully used these criteria in the hit to lead stage to identify compounds for <i>in vivo</i> proof-of-concept studies in another program, which subsequently led to the identification of preclinical candidate DDD853651/GSK3186899 active against CRK12.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> As reported previously<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, <i>in vitro</i> profiling of <b>4</b> shows that it met these targets, with an INMAC pEC<sub>50</sub> value of 6.2, Cl<sub>i</sub> of <0.5 mL/min/g in mouse liver microsomes, and aqueous solubility of 150 μM, alongside high mouse and human plasma stability (100% compound remaining after 3 h). A pharmacokinetic (PK) study was thus performed, dosed at 10 mg/kg po and 3 mg/kg iv. An oral dose of 10 mg/kg showed <b>4</b> to have blood levels above EC<sub>90</sub> for around 2 h (pEC<sub>90</sub> 5.7, 780 ng/mL), which would translate to coverage above 6 h for a 50 mg/kg dose, assuming a linear dose increase (see <a href="/doi/suppl/10.1021/acs.jmedchem.1c00047/suppl_file/jm1c00047_si_001.pdf" class="ext-link">Supporting Information</a>). With the limited knowledge of the PK/PD drivers for the treatment of VL, we considered this to be a suitable profile for the progression of <b>4</b> into a previously reported mouse efficacy model of VL,<a onclick="showRef(event, 'ref6 ref7 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref17 ref18">(6,7,17,18)</a> where it was dosed twice daily at 50 mg/kg ip in order to further maximize exposure and give the best chance of achieving proof-of-concept.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro and In Vivo Profile of Compound <b>4</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center"><i>in vitro</i> profile</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">INMAC pEC<sub>50</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">6.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">THP-1 cells pEC<sub>50</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><4.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">aqueous solubility (μM)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">150</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FaSSIF solubility (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>i</sub> mL/min/g<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left"><0.5</td></tr></tbody></table><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="3" align="center">i<i>n vivo</i> profile<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv PK (3 mg/kg)</td><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">AUC ng·min/mL</td><td class="colsep0 rowsep0" align="char" char=".">135,000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Clb mL/min/Kg</td><td class="colsep0 rowsep0" align="char" char=".">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po PK (10 mg/kg)</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="char" char=".">1300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">AUC ng·min/mL</td><td class="colsep0 rowsep0" align="char" char=".">258,000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Vdss L/kg</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>F</i> %</td><td class="colsep0 rowsep0" align="char" char=".">57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">% reduction in parasitemia<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="char" char=".">98</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Data reported previously.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">INMAC is the intramacrophage assay carried out in THP-1 cells with <i>L. donovani</i> amastigotes. Data are the result of five independent replicates and standard deviations are ≤0.2.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Aqueous solubility is kinetic solubility measured by CLND.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Cl<sub>i</sub> is the mouse liver microsomal intrinsic clearance.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">Mouse PK studies dosed at 10 mg/kg po and 3 mg/kg iv.</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last">Infected mouse model of VL, dosed at 50 mg/kg ip, b.i.d for 5 days.</p></div></div></div><div class="NLM_p">After dosing twice daily for 5 days, a reduction in parasitemia of 98% was observed (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). This established the proof-of-concept for this series in VL and, in fact, met our criteria for a preclinical development candidate.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Unfortunately, despite reasonable kinetic aqueous solubility, <b>4</b> was poorly soluble in FaSSIF (Fasted State Simulated Intestinal Fluid)<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> media and this, alongside a positive result in the Ames assay,<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21−23)</a> as reported previously,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> which indicated potential genotoxicity issues, precluded further development of this particular compound.</div><div class="NLM_p">Having achieved the <i>in vivo</i> proof-of-concept, the series moved into the lead-optimization phase, with an initial aim to identify a compound with a suitable profile for rodent toxicology studies. As this would require us to achieve an exposure significantly higher than the minimum efficacious dose, we continued to target compounds with pEC<sub>50</sub> values >6 and now aimed for FaSSIF solubilities >100 μM and to maintain Cl<sub>i</sub> < 1 mg/mL/g. We carried out a systematic exploration of the molecule, initially preparing further analogues of <b>4</b> with variations to the pendant substituents of the 2-phenylimidazo[1,2-<i>a</i>]pyrimidine core. However, this failed to identify any better molecules (data not shown).</div><div class="NLM_p">We next focused our attention on the core phenyl-substituted bi-cycle. Initially, we investigated changes to the phenyl ring and, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, modifications to this part of the scaffold led to analogues that maintained stability in mouse liver microsomes and also showed improved solubility in both aqueous (CLND) and FaSSIF media. Unfortunately, these changes, such as moving or removing fluorine (<b>5</b> and <b>6</b>, respectively), introducing alternative substituents (e.g., OMe analogues <b>7</b> and <b>8</b>), or replacing phenyl with six-membered heterocycles (e.g., pyridine <b>9</b>, pyrimidines <b>10</b> and <b>12</b>, pyrazine <b>11</b>, and pyridazine <b>13</b>), all led to a >10-fold loss of potency. We noted that similar findings were also reported by Tatipaka et al.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and Ferrins et al.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> on the related scaffolds. Analogue <b>4</b>, with the fluorine ortho to the bi-cyclic substituent, appeared to be optimal and our subsequent knowledge of the binding mode of these compounds allowed us to rationalize this (seen later). We were interested to note that the changes made did have a big impact on FaSSIF solubility, with methoxy analogue <b>8</b>, pyrazine <b>11</b>, pyridazine <b>13</b>, and pyrimidines <b>10</b> and <b>12</b> all having FaSSIF solubilities well above 100 μM. Also, <b>10–13</b>, all had intrinsic clearances of <0.5 mL/min/g. Encouraged by this, we turned our attention to the core bi-cycle, surmising that changes to the pattern of hydrogen bond acceptors (HBAs) could lead to similar improvements in solubility.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Profile of Analogues <b>4–13</b>, with Substitutions and Nitrogen Insertions on the Central Phenyl Ring</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0023.gif" alt="" id="GRAPHIC-d7e916-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0024.gif" alt="" id="gr22" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">INMAC is the intramacrophage assay carried out in THP-1 cells with <i>L. donovani</i> amastigotes. Data are the result of at least three independent replicates and standard deviations are ≤0.4.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Aqueous solubility is the kinetic solubility measured by CLND.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">FaSSIF solubility is the fasted state simulated intestinal fluid solubility.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Cl<sub>i</sub> is the mouse liver microsomal intrinsic clearance.</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">Data reported previously.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></p></div><div class="footnote" id="t2fn6"><sup><sup>f</sup></sup><p class="last">ND means not determined.</p></div></div><div></div></div><div class="NLM_p">In order to define a set of alternative bi-cycles for synthesis, we first looked at the SAR from our early hit discovery efforts, on scaffolds with no 6-substituent (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). On comparing with initial hit <b>3</b>, we noted that a scaffold which removed the HBA in the 8-position (e.g., <b>14</b>) showed no activity in the INMAC assay. We therefore focused our scaffold-hopping efforts on bi-cycles, which contained a HBA in the 8-position, and then prioritized them based on cChromLogD (ChromLogD<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> is the chromatographically determined log <i>D</i> and cChromLogD is the calculated version of this), cp<i>K</i><sub>a</sub> (calculated using ACD p<i>K</i><sub>a</sub> predictor), calculated aqueous solubility (using Gastroplus v9.7), and synthetic tractability (based on literature precedent and in-house knowledge). Without a robust model for activity in the Ames test, this was not included in the design process, the intention being to profile compounds in the assay when they demonstrated suitable efficacy in the VL mouse model to warrant further study.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Initial Modifications of the Bi-cyclic Core</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0025.gif" alt="" id="gr23" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">INMAC is the intramacrophage assay carried out in THP-1 cells with <i>L. donovani</i> amastigotes. Data are the result of at least three independent replicates and standard deviations are ≤0.4.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Cl<sub>i</sub> is the mouse liver microsomal intrinsic clearance.</p></div></div><div></div></div><div class="NLM_p">A total of 28 alternative scaffolds were evaluated <i>in silico</i>, all maintaining a HBA in the 8-position (for comparison purposes, the numbering for the imidazo[1,2-<i>a</i>]pyrimidine scaffold in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> is used in this section), plus the correct orientation of the morpholinyl and phenyl substituents. We explored HBDs and HBAs in various positions around the bi-cycle and also examined the effect of reversing the 6,5-fused system so that morpholine was attached to the five-membered ring and phenyl to the six-membered ring. Finally, we also profiled a fused 5,5 bi-cycle.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Numbering for the imidazo[1,2-<i>a</i>]pyrimidine scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As we reported for a previous series, we had focused on reducing lipophilicity as a key strategy for improving solubility.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In that case, we targeted a PFI<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> <7 (PFI = property forecast index, ChromLogD + #Ar). Within the current series which contained three aromatic rings, this would equate to a cChromLogD below 4, so we utilized this as a key property for the designed scaffolds. We also targeted scaffolds which had a higher predicted solubility than <b>4</b> and scaffolds which increased cp<i>K</i><sub>a</sub>. The increased cp<i>K</i><sub>a</sub> would indicate potential for improved solubility, as well as allowing possible salt formation. We then further prioritized based on the potential synthetic tractability (based on literature precedent and in-house synthetic expertise), as with each scaffold requiring a bespoke synthesis, there would be a limited chemistry resource to develop completely novel routes.</div><div class="NLM_p">The initial scaffolds all examined the nature of the atom in the 1-position of the bi-cycle (<b>S-1</b> to <b>S-16</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Scaffolds <b>S-1–S-8</b> all examined the removal of the HBA, where the best predicted profiles were obtained for <b>S-1</b>, <b>S-4</b>, <b>S-5</b>, and <b>S-6</b>, all predicted to have cChromLogD below 4 and either higher cp<i>K</i><sub>a</sub>, improved solubility, or both when compared to <b>3</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Scaffolds <b>S-9</b> and <b>S-10</b> would demonstrate whether a hydrogen bond donor (HBD) was acceptable in position 1. Although <b>S-9</b> gave a more direct comparison to <b>3</b>, <b>S-10</b> proved to be more synthetically tractable. On this basis, <b>S-1</b> and <b>S-10</b> were synthesized with the desired substituents, <b>S-5</b> was synthesized as the non-fluorinated analogue, and <b>S-9</b> as the phenyl analogue. Although <b>S-4</b>, <b>S-6</b>, and <b>S-11</b> had good <i>in silico</i> profiles, the syntheses of <b>S-4</b> and <b>S-6</b> were not completed when it became apparent that the removal of HBA at the 1-position would lead to an inactive compound, and for <b>S-11</b>, there would be a possible tautomerization of the five-membered ring, making any data generated difficult to interpret so this scaffold was not synthesized (see <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). <b>S-12</b> would further probe the nature of the heteroatom in the 1-position and had a very good <i>in silico</i> profile. Scaffolds <b>S-13–S-16</b> all examined the replacement of the nitrogen in the 1-position with oxygen. All these compounds showed some advantage over <b>3</b> and so were targeted for synthesis, although <b>S-15</b> was synthesized without the fluoro substituent and <b>S-16</b> was not synthesized due to lack of a tractable route.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Tautomerization of scaffold <b>S-11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Scaffolds Identified by the Medicinal Chemistry Team for <i>In Silico</i> Profiling<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0026.gif" alt="" id="GRAPHIC-d7e1185-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0027.gif" alt="" id="gr24" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">cChromLogD calculated using GSK predictive software. Colored as green <4 and amber >4. cp<i>K</i><sub>a</sub> calculated using ACD labs p<i>K</i><sub>a</sub> calculator for the most basic nitrogen on the bi-cycle. Colored as green if >compound <b>4</b> (4.4) and amber if <compound <b>4</b>. cAq. Sol (pH 7.4) mg/mL is GastroPlus calculated aqueous solubility at pH 7.4, colored green if >compound <b>4</b> and amber if ≤compound <b>4</b>. Synthesis color scheme: green = desired compound synthesized, orange = alternative analogue synthesized (e.g., no F or phenyl instead of morpholinyl), red = not synthesized (no successful route or abandoned due to SAR learnings).</p></div></div><div></div></div><div class="NLM_p">Scaffolds <b>S-17–S-21</b> all retained the HBA nitrogen in positions 1 and 8 and examined the effect of varying the heteroatoms in the other positions around the rings. All of them showed some potential advantage over <b>3</b> and so were selected for synthesis (although a tractable synthesis of <b>S-21</b> was not successfully developed).</div><div class="NLM_p">Scaffolds <b>S-22–S-27</b> all examined the reversal of the 6,5-fused scaffold to a 5,6-fused scaffold. <b>S-22</b> had a cChromLogD below 4 and higher predicted p<i>K</i><sub>a</sub> compared to <b>3</b> and so was selected for synthesis. While <b>S-23–S-25</b> all had higher predicted solubility, they proved to be synthetically challenging and we only developed a tractable synthetic route to <b>S-24</b> with phenyl, rather than the morpholine substituent. <b>S-26</b>, which replaced the nitrogen in the five-membered ring with oxygen, had a poor <i>in silico</i> profile and so was not synthesized. Although <b>S-27</b> had predicted improved solubility, it was not synthesized due to our understanding that the <i>N</i>-methyl group would not be tolerated. Finally, we profiled some 5,5-bi-cycles, as exemplified by <b>S-28</b>. The only advantage this might confer would be a cChromLogD below 4, as the predicted solubility was lower than <b>3</b>, and the core did not contain the basic nitrogen. Because of this, and also because the vectors of the substituents would be very different to <b>3</b>, as well as a lack of literature precedent for synthesis, we elected not to synthesize this analogue.</div><div class="NLM_p">This led to a set of 10 scaffolds synthesized with the desired substituents, plus a further 4 which were synthesized with alternative substituents (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). From this, we gained some key SAR learnings. Scaffolds <b>S-1</b> (compound <b>15</b>) and <b>S-5</b> (compound <b>16</b>) showed that removing the HBA nitrogen from position 1 led to inactive compounds in the INMAC assay. Scaffolds <b>S-9</b> and <b>S-10</b> showed that a HBD in position 1 was not tolerated (compounds <b>17</b> and <b>18</b>, respectively). Scaffold <b>S-12</b> (compound <b>19</b>), with <i>N</i>-Me in the 1-position, was inactive. Scaffolds <b>S-13–S-15</b> (compounds <b>20–22</b>) which replaced the HBD nitrogen with oxygen showed a range of potencies, although all had poor aqueous solubility compared to <b>3</b>, with no improvement in FaSSIF solubility either. Scaffolds <b>S-17–S-20</b> (compounds <b>23–26</b>), which retained the HBD nitrogens in positions 1 and 8, all maintained good activity, with pEC<sub>50</sub> values of 6 or above. Scaffolds <b>S-17</b>, <b>S-18</b>, and <b>S-19</b> (compounds <b>23</b>, <b>24</b>, and <b>25</b> respectively) all showed a much improved FaSSIF solubility compared to <b>3</b>, with <b>24</b> and <b>25</b> having overall very similar profiles. The <b>S-19</b> scaffold has recently been published by Novartis.<a onclick="showRef(event, 'ref8 ref26'); return false;" href="javascript:void(0);" class="ref ref8 ref26">(8,26)</a> Although <b>S-20</b> (compound <b>26</b>) did have good potency, it showed no improvement in FaSSIF solubility compared to <b>3</b>. The compounds with a “reversed” bi-cycle (<b>S-22</b> and <b>S-24</b>, compounds <b>1</b> and <b>27</b>, respectively) proved to be very interesting. Compound <b>27</b> was only synthesized as the phenyl analogue; although this showed similar potency to <b>3</b>, it had very poor FaSSIF solubility. On the other hand, <b>1</b> was only slightly less potent than <b>3</b> and had the highest FaSSIF solubility of all the scaffold hop compounds. Based on these findings, compounds <b>23</b> (<b>S-17</b>) and <b>1</b> (<b>S-22</b>) were investigated further (<b>23</b> was selected over <b>24</b> as it proved much more straightforward to scale-up the synthesis to get suitable quantities for <i>in vivo</i> studies). The progression of <b>23</b> was subsequently stopped as the aniline resulting from the hydrolysis of the urea was positive in the Ames assay,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> indicating a potential genotoxicity issue. This led us to focus on <b>1</b> as the most promising scaffold for further development; although it was slightly less potent than <b>23</b>, it was the compound with the best solubility profile and had high stability in mouse liver microsomes.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Effect of Scaffold Hops on Activity and Physicochemical Properties</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0028.gif" alt="" id="GRAPHIC-d7e1443-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0029.gif" alt="" id="gr25" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Data reported previously for <b>1</b> and <b>24</b>.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">INMAC is the intramacrophage assay carried out in THP-1 cells with <i>L. donovani</i> amastigotes. Data are the result of at least three independent replicates and standard deviations are ≤0.4.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Aqueous solubility is the kinetic solubility measured by CLND.</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">FaSSIF solubility is the fasted state simulated intestinal fluid solubility.</p></div><div class="footnote" id="t5fn5"><sup><sup>e</sup></sup><p class="last">Cl<sub>i</sub> is the mouse liver microsomal intrinsic clearance.</p></div><div class="footnote" id="t5fn6"><sup><sup>f</sup></sup><p class="last">ND means not determined.</p></div></div><div></div></div><div class="NLM_p">To summarize the SAR, a HBD was essential in positions 8 (N) and 1 (N or O), whereas a HBD in the 7-position was detrimental to activity (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). A 6-substituent, particularly morpholine, was essential for activity and metabolic stability.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In the other positions around the ring (e.g., 3, 4, 5, 7, and 9) heteroatoms were tolerated but not essential to activity. Regarding the central phenyl ring, 4-fluoro boosted activity and 1-urea gave a better balance of potency, solubility, and metabolic stability than the corresponding amides (data reported previously).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Finally, it proved possible to reverse the central bi-cycle, a change which had a small detrimental effect on potency that was compensated for by the improvement in FaSSIF solubility.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Summary of the SAR around the core scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A key aim of the scaffold-hopping exercise was to identify compounds with improved solubility, in both aqueous and FaSSIF media. Of the 10 scaffolds synthesized with the same substituents as <b>4</b>, only three showed an improvement in solubility in both media (<b>24</b>, <b>25</b>, and <b>1</b>), with <b>23</b> showing an improvement only in FaSSIF solubility (<b>S-18</b>, <b>S-19</b>, <b>S-22</b>, and <b>S-17</b>, respectively). Compounds <b>23</b>, <b>24</b>, and <b>25</b> all had better <i>in silico</i> predictions for solubility than for compound <b>4</b>, whereas <b>1</b> was predicted to be similar. However, compound <b>1</b> had much better solubility than compound <b>4</b>, and of these four compounds, it had the highest FaSSIF solubility. Interestingly, scaffold <b>S-22</b> was predicted to have a much higher pKa than <b>S-17</b> and <b>S-18</b>, indicating that for compound <b>1</b> a significantly higher proportion is likely to be protonated at physiological pH. Therefore, while the <i>in silico</i> profiling helped to triage the number of scaffolds for synthesis, it was clear that a large number of scaffolds needed to be synthesized in order to identify the optimal scaffolds for progression.</div><div class="NLM_p">Because reversing the imidazo[1,2-<i>a</i>]pyrimidine scaffold (compounds <b>1</b> and <b>27</b>) was liable to orient the pendant amine and urea substituents slightly differently, we further explored the SAR around the 3-position of the bi-cycle, where morpholine was substituted (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). The replacement of morpholine of <b>4</b> with phenyl (<b>28</b>) gave an expected increase in potency alongside a decrease in solubility, while switching to pyridyl (<b>29</b>) maintained the improved potency alongside an increase in FaSSIF solubility compared to <b>28</b>. However, the Cl<sub>i</sub> was above our targeted level of <1 mL/min/g for a preclinical candidate. We were interested in exploring saturated substituents; isopropyl <b>30</b> showed a similar potency to morpholine but with poorer FaSSIF solubility, and isobutyl <b>31</b> showed a small improvement in potency but with poorer metabolic stability. In order to improve solubility, we explored the introduction of a basic center with methylene-linked morpholine <b>32</b> and directly linked morpholine <b>33</b>. While this was successful in delivering compounds with improved FaSSIF solubility compared to <b>1</b>, it unfortunately led to a loss of potency.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Effect of Modifications or Replacements to the Morpholine Group on Activity and Physicochemical Properties</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0030.gif" alt="" id="GRAPHIC-d7e1631-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0031.gif" alt="" id="gr26" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">INMAC is the intramacrophage assay carried out in THP-1 cells with <i>L. donovani</i> amastigotes. Data are the result of at least three independent replicates and standard deviations are ≤0.4.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">Aq. solubility is the kinetic solubility measured by CLND.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">FaSSIF solubility is the fasted state simulated intestinal fluid solubility.</p></div><div class="footnote" id="t6fn4"><sup><sup>d</sup></sup><p class="last">Cl<sub>i</sub> is the mouse liver microsomal intrinsic clearance.</p></div><div class="footnote" id="t6fn5"><sup><sup>e</sup></sup><p class="last">Data reported previously.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></p></div><div class="footnote" id="t6fn6"><sup><sup>f</sup></sup><p class="last">ND means not determined.</p></div></div><div></div></div><div class="NLM_p">We also further explored N-linked amines, where piperidine <b>34</b> showed good potency but with poor FaSSIF solubility. Piperazines <b>35–37</b> were inactive, although <b>36</b> and <b>37</b> did show enhanced FaSSIF solubility. As we had seen success with methylmorpholines in other series,<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> we synthesized rac-2-methyl morpholine <b>38</b> and the enantiomeric 3-methylmorpholines <b>39</b> and <b>40</b>. All of these compounds showed similar potency to <b>1</b> and improved FaSSIF solubility, although all the three were less metabolically stable. Likewise, dimethylmorpholines <b>41</b>, <b>42</b>, and <b>43</b> were synthesized, all showing similar potency to <b>1</b> but with poorer metabolic stability, although <b>42</b> and <b>43</b> did show improved FaSSIF solubility. Spiro analogue <b>44</b> again was less metabolically stable than <b>1</b>, and secondary amines <b>45</b> and <b>46</b> showed a drop in potency compared to <b>1</b>.</div><div class="NLM_p">From all the <i>in vitro</i> profiling, none of the changes to the morpholine ring led to compounds with an improved overall profile; therefore, <b>1</b> was identified as the most suitable compound for further <i>in vitro</i> and <i>in vivo</i> studies. As reported previously,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> a PK study of <b>1</b>, dosed at 25 mg/kg po, supported its progression into the infected mouse model, where it showed a candidate level efficacy against VL at this dose. When dosed orally twice a day for 10 days, <b>1</b> had an ED<sub>90</sub> of 16 mg/kg and ED<sub>99</sub> of 30 mg/kg. The compound had suitable PK for oral delivery and a good predicted safety margin of at least 37-fold when dosed in rats at 300 mg/kg. Critically, unlike compounds <b>4</b> and <b>23</b>, both <b>1</b> and the aniline derivative potentially released by hydrolysis of its urea were negative in the Ames assay, as reported previously.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Alongside the previously reported safety profiling, <b>1</b> was also screened against a representative set of three kinases (LCK, PI3Kγ, and AuroraB) and was inactive against them all (pIC<sub>50</sub> <4.5). The compound is now being advanced for the first time in human studies for VL.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Modeling</h3><div class="NLM_p">In parallel to these phenotypic optimization studies, attempts to identify the target of these series were carried out as previously reported.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> It was found that these compounds act through the inhibition of the chymotrypsin-like activity catalyzed by the β5 subunit of the <i>L. donovani</i> proteasome, demonstrating good selectivity over the human enzyme. A high-resolution cryo-EM structure of compound <b>1</b> bound to the <i>Leishmania tarentolae</i> proteasome<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> revealed a binding site that lies between the β4 and β5 subunits (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) and exploits an induced cavity that is lined on one side by β4 residues that are divergent between humans and kinetoplastid protozoan. The cryo-EM structure of a related compound in the complex with the <i>Leishmania tarentolae</i> proteasome has also been recently published by Novartis.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>1</b> bound to the β4 (light blue) and β5 (white) subunits of the <i>L. tarentolae</i> 20S structure. PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QM7">6QM7</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Description of the Binding Mode of Compound <b>1</b></h3><div class="NLM_p">A homology model of compound <b>1</b> bound to the <i>L. donovani</i> 20S proteasome β4 and β5 subunits was generated using the <i>L. tarentolae</i> 20S proteasome cryo-EM structure as a template. Compound <b>1</b> binds at the interface between the β4 and β5 subunits close to the catalytic Thr100 residue (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A), which is the first residue of the β5 subunit. The pyrrolidine carboxamide sits in the most buried part of the binding site, a mainly hydrophobic cavity important for selectivity against the human orthologue. The cavity is defined by Ile27, Ile29, and Phe24 from the β4 subunit and by Phe225, Val227, and Thr235 from the β5 subunit. The urea carbonyl oxygen is hydrogen bonded to the Gly228 backbone nitrogen, and the urea nitrogen is hydrogen bonded to the hydroxyl of the Tyr212 side chain. The phenyl ring is placed on top of Gly197 of the terminal part of the β-strand 7 of the β5 subunit with the fluorine substituent facing the Ser195 side chain hydroxyl. The “top edge” (see <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) of the imidazopyrimidine bi-cyclic system is mainly solvent exposed with the six-membered ring sitting on top of Gly146 and the sp<sup>2</sup> nitrogen of the five-membered ring interacting with the donor NH group of Ser229. The nitrogen on the “bottom edge” of the pyrimidine ring does not make any specific interactions; however, it contributes to the charge delocalization, resulting in a favorable charge interaction with Thr100 (see later). The morpholine group is largely solvent exposed and is directed toward the β hairpin motif critical for the recognition of bortezomib (β strands 3 and 4 of the subunit β5), establishing a hydrogen bond with the Gly122 backbone NH (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). (Bortezomib is a clinically used inhibitor of the human proteasome.)</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) View of compound <b>1</b> binding in the <i>L. donovani</i> 20S proteasome model β4 and β5 subunits. Shown in stick form are the 12 residues that have a FMO-PIE <−3 kcal/mol; colored red if FMO-PIE <−30 kcal/mol, orange if between −30 and −10 kcal/mol, and yellow if FMO-PIE between −10 and −3 kcal/mol. (B) FMO-PIE decomposition analysis results showing, for each residue within 5 Å, the contribution of the four energy terms: electrostatic (<b>yellow</b> bar), exchange-repulsion (<b>green</b> bar), charge transfer (<b>red</b> bar), and dispersion (<b>blue</b> bar). (C) FMO-PIE generated contribution to compound <b>1</b> binding energy per fragment residues within 5 Å from the ligand.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Computational Analysis of Binding Interactions</h3><div class="NLM_p">The fragment molecular orbital method (FMO-MP2)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> was used to calculate the interaction energy between compound <b>1</b> and the proteasome and to gain a deeper understanding of the molecular recognition event. Being a quantum-mechanical (QM)-based method, FMO-MP2 is capable of detecting and accounting for nonclassical interactions that are poorly parameterized in molecular mechanics-based force fields (e.g., CH−π, halogen−π, cation−π interactions, and nonclassical hydrogen bonds) resulting in a more accurate binding energy. To overcome the high computational costs associated with the QM calculation, the system is fragmented into smaller parts and QM calculations are performed on each individual fragment pair to derive pairwise interaction energy (PIE) between each of the fragments and the ligand. By combining the PIE of the ligand and the fragments, it is possible to derive the total interaction energy of the ligands with the target. The decomposition analysis of the PIE (PIEDA)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> allows the derivation of four different energy terms (electrostatic, charge transfer, dispersion, and exchange-repulsion) that provide a deeper residue-by-residue insight into the nature of the ligand interaction with the target. The electrostatic and charge transfer terms are dominant in H-bonds, polar (favorable and unfavorable) interactions, and salt bridges. The dispersion term is more prominent in hydrophobic and van der Waals interactions. The exchange-repulsion term describes the steric-repulsion between electrons of different atoms accounting for steric clashes.</div><div class="NLM_p">The FMO-PIEDA analysis shows that, out of the 40 residues in a 5 Å range from the ligand, there are 13 contributing significantly (PIE < −3 kcal/mol) to the overall calculated binding energy (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B,C). The initial work focused on analyzing the H-bonding and hydrophobic interactions revealed by the cryo-EM structure; the contribution to the binding energy from the residues directly involved in hydrogen bonding with the ligand was confirmed. The Gly228 hydrogen bond to the urea carbonyl is the strongest H-bonding interaction with a calculated electrostatic energy term of −15.9 kcal/mol (PIE −14.3 kcal/mol).</div><div class="NLM_p">In the cryo-EM structure of the <i>L. tarentolae</i> structure, a CH<sub>2</sub> group next to morpholine oxygen is adjacent to NH of Gly 122, which is a part of a semi-flexible loop. However, in the model of the <i>L. donovani</i> enzyme, the morpholine twists slightly, allowing N–H of Gly 122 to establish a strong hydrogen bond with the morpholino oxygen atom (PIE −9.0 kcal/mol, electrostatic term −9.0 kcal/mol). For Tyr212, the PIE energy is −8.7 kcal/mol which is the result of both the hydrogen bonding (electrostatic) with the urea NH and the favorable hydrophobic interaction with the pyrrolidine ring (dispersion). The FMO-PIEDA result also shows that the Ser229 interaction (PIE −6.26 kcal/mol) is mainly due to the favorable interaction between the β carbon atom of the side chain (dispersive interaction) with the heterocyclic scaffold of the ligand rather than the hydrogen bonding of the nitrogen in the 5-membered ring of imidazopyrimidine with the backbone NH. This is consistent with the poor geometry observed for the hydrogen bond present in both the <i>L. tarentolae</i> cryo-EM structure and the <i>L. donovani</i> model. The favorable contribution of hydrophobic contacts is also significant for Gly197 (−4.2 kcal/mol) and Gly146 (−6.8 kcal/mol) as both residues are in contact with the central phenyl ring. The contact between the pyrrolidine carboxamide and the Phe24 side chain has a contribution of −9.2 kcal/mol.</div><div class="NLM_p">Importantly, in addition to the interactions that could be identified from a visual inspection of the cryo-EM structure, the FMO-PIE analysis highlighted other residues that establish nonintuitive interactions and are important in the molecular recognition event. Thr100 (PIE −30.3 kcal/mol), Asp214, and Asp215 (PIE −16.4 and −16.0 kcal/mol, respectively) are indicated as the residues with the strongest interaction with the ligand. These are long-range electrostatic interactions between the protein and the unevenly distributed electrons of the ligand. The analysis of the electrostatic surface potential (ESP) of the protein binding site highlighted a positively charged patch consisting of the positively charged terminal Thr100 and the backbone amide of Ser229. A charge–dipole interaction is established between this positively charged patch of the protein with the negatively charged sp<sup>2</sup> nitrogen atoms of the imidazopyrimidine scaffold in positions 1 and 8 on the bottom edge (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). A similar effect is demonstrated by the presence of the fluorine atom on the phenyl ring, which increases potency by approximately 10-fold (see compounds <b>4</b> and <b>6</b>). As previously discussed,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> the ESP of the ligand shows that the presence of the fluorine atom on the phenyl ring causes an accumulation of the positive charge on positions 3 and 4 of the fluorophenyl ring giving rise to another strong dipole–charge interaction with the negatively charged Asp214 and Asp215. This effect of fluorine appears to be more important to binding than its interaction with Ser195. Val227 also provides a significant contribution to binding energy (PIE −12.7 kcal/mol) with the decomposition analysis indicating an equal contribution from the dispersive term (related to the hydrophobic side chain) and electrostatic term (related to the positively charged patch localized on the pyrrolidine ring—see <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). Therefore, FMO-PIE analysis showed that the binding of compound <b>1</b> to the proteasome is governed by a complex mixture of specific hydrogen bonds, stacking interactions, optimal electrostatic complementarity, and long-range electrostatic interactions between the protein and the ligand.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Molecular ESP maps for some of the studied analogues. Protein surfaces were generated using the APBS plugin for PyMol and colored by calculated charges (red −5 kbT/ec, blue +5 kbT/ec). The ligand surfaces were generated using Jaguar in Schrödinger and colored by the electrostatic potential (red −80 kcal/mol, blue +75 kcal/mol).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Computational Analysis of Structure Activity Relationships</h3><div class="NLM_p">To analyze the effect of the imidazopyrimidine scaffold replacement in the series related to compound <b>1</b>, all the synthesized scaffold hop compounds (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) were modeled in the <i>L. donovani</i> 20S proteasome model and studied by FMO-PIEDA and ESP. The compounds tended to be either active (pEC<sub>50</sub> 5.8–7.3) or inactive (pEC<sub>50</sub> < 4.3). Derivatives with a fluorine substituent on the phenyl ring ortho- to the bi-cycle were consistently more active than the hydrogen analogues. We and others have noted a correlation of activity between the inhibition of proteasome and activity against axenic <i>Leishmania</i> parasites.<a onclick="showRef(event, 'ref8 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref10">(8,10)</a> While there could be subtleties in INMAC activity due to physicochemical properties of compounds, this data allows an interpretation of the SAR.</div><div class="NLM_p">The modeling data generated confirmed the important role that the electrostatic complementarity between the ligands and the proteasome binding site plays in the optimization of the interaction. The ESP maps (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.1c00047/suppl_file/jm1c00047_si_001.pdf" class="ext-link">Supporting Information</a>), clearly show that even if the hydrogen acceptor interacting with the Ser229 backbone nitrogen is conserved, where there is a lack of the negative charge accumulation on the bottom edge (positions 1 and 8) of the imidazopyrimidine scaffold (as observed for compounds <b>15</b>, <b>18</b>, and <b>19</b>), these compounds are inactive (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). This is further supported by the FMO-PIEDA analysis results (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>), indicating that one of the strongest interactions that compound <b>1</b> establishes is with Thr100, an interaction primarily electrostatic in nature, which contributes with −30.3 kcal/mol. Compound <b>27</b> (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) is also characterized by a strong interaction between Thr100 (FMO-PIE −30.3 kcal/mol) and the negatively charged bottom face (positions 1 and 8) of the imidazotriazine scaffold. The scaffold of compound <b>27</b> also seems to enhance the partial positive charge on 3- and 4-positions of the phenyl ring and strengthen the interaction with Asp214 and Asp215 (see the ESP, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00047/suppl_file/jm1c00047_si_001.pdf" class="ext-link">Supporting Information</a>).</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. FMO-PIE generated contribution to binding energy in kcal/mol per fragment residues within 5 Å from the ligand calculated for compound <b>1</b> analogues. Red indicates favorable, whereas green indicates unfavorable interaction energies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The “reversed” 5–6 bi-cyclic system compounds <b>1</b> and <b>27</b> not only are characterized by a particularly favorable accumulation of the negative charge on position 1 of the bi-cyclic scaffold but also by a slightly different placement of the substituent in position 3 in relation to the 6–5 bi-cyclic systems of the other analogues. An inspection of the bound conformations shows that the vector of the substitution in the 3-position is similar between the 5–6 and 6–5 bi-cycles (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>), but in the 5–6 system, the substituent is about half a bond longer than in the 6–5 system. This results in the morpholine ring being pushed closer to Gly122 on the β strands 3 and 4 of the subunit β5 and might explain the lower potency of the compounds with a “reversed” scaffold. Docking studies suggest that in order to avoid a steric clash with Gly122 and the beta-hairpin involved in bortezomib binding, compound <b>24</b> appears to adopt a higher energy conformation with the morpholine ring almost perpendicular to the bi-cyclic scaffold. Due to this steric requirement, and together with an unfavorable electrostatic distribution on the bi-cyclic scaffold, resulting in the lack of a partial negative charge interacting with Thr100 (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00047/suppl_file/jm1c00047_si_001.pdf" class="ext-link">Supporting Information</a>), compounds <b>16</b> and <b>17</b>, where morpholine is replaced by a phenyl ring, failed to dock and are reported as inactive.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Superimposition of a 6,5-bi-cyclic system (compound <b>1</b>, shown in green) with a 5,6-bi-cyclic system (compound <b>24</b>, shown in orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Synthesis</h3><div class="NLM_p">To explore SAR around the central phenyl ring in the 2-phenylimidazo[1,2-<i>a</i>]pyrimidin-6-morpholine sub-series (e.g., compounds <b>5–13</b>), the route shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> is utilized. A suitably substituted 3-nitroacetophenone was brominated to give <b>47a,c,d</b> and then cyclized with <b>48</b> to give <b>49a,c,d</b>. The nitro reduction gave <b>50a–i</b> and subsequent urea formation with pyrrolidine-1-carbonyl chloride yielded <b>5</b>, <b>7</b>, and <b>8</b>. Alternatively, a relevant aminoheterocycle was treated with pyrrolidine-1-carbonyl chloride to give ureas <b>51b,e–i</b>, which were then brominated to give <b>52b,e–i</b>. Again, cyclization with <b>4</b>8 gave <b>6</b> and <b>9–13</b>.</div><figure id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>5–13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and Conditions: (a) trimethyl(phenyl)ammonium tribromide, THF, RT, 18 h; (b) MeCN, 60 °C, 4 d, 43% over two steps; (c) SnCl<sub>2</sub>, EtOH, reflux, 2 d, quant.; and (d) pyrrolidine-1-carbonyl chloride, DMAP, pyridine, 40 °C, 2 d, 9–36%.</p></p></figure><div class="NLM_p">All the different cores required the bespoke synthesis, as detailed in <a class="ref internalNav" href="#sch2" aria-label="Schemes 2">Schemes 2</a>– <named-content content-type="anchor" rid="sch3" type="simple"></named-content><named-content content-type="anchor" rid="sch4" type="simple"></named-content><named-content content-type="anchor" rid="sch5" type="simple"></named-content><named-content content-type="anchor" rid="sch6" type="simple"></named-content><named-content content-type="anchor" rid="sch7" type="simple"></named-content><named-content content-type="anchor" rid="sch8" type="simple"></named-content><a class="ref internalNav" href="#sch9" aria-label="9">9</a> below (the synthesis of compounds <b>1, 3, 4</b>, and <b>23</b> was described elsewhere<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a>).</div><figure id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>15</b> and <b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and Conditions: (a) trimethyl(phenyl)ammonium tribromide (1 equiv.), THF, RT, 18 h, 73%; (b) MeCN, 60 °C, 2 d, 43%; (c) trimethyl(phenyl)ammonium tribromide (1 equiv), THF, 60 °C, 18 h, 46%; (d) morpholine and THF, 35 °C, 18 h, then aminoguanidine bicarbonate, acetic acid, MeOH, 60 °C, 18 h, 26%; (e) 2-bromo-1,1-diethoxy-ethane, HBr, water, 90 °C, 30 min, 36%; (f) Br<sub>2</sub>, NaOAc, acetic acid, RT, 1 h, 50%; (g) Pd(PPh<sub>3</sub>)<sub>4</sub>, sodium carbonate, DMF, 80 °C, 18 h, 38%.</p></p></figure><figure id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and Conditions: (a) 2-bromopropanedial, AcOH, EtOH, 75 °C, 30 min, 66%; (b) benzeneboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, KOAc, dioxane, 3 h, 64%; (c) Fe, NH<sub>4</sub>Cl, EtOH, water, 75 °C, 2 h; (d) pyrrolidine-1-carbonyl chloride, DMAP, pyridine, DCM, 70 °C, 48 h, 62% over two steps.</p></p></figure><figure id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>17</b> and <b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and Conditions: (a) pyrrolidine-1-carbonyl chloride, DMAP, pyridine, DCM, 50 °C, 18 h, 79%; (b) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, CuI, NEt<sub>3</sub>, DMF, 80 °C, 18 h, 46%; (c) KO<i>t</i>Bu, NMP, 75 °C, 18 h, 57%; (d) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, CuI, NEt<sub>3</sub>, MeCN, RT, 6 h; (e) morpholine, 50 °C, 18 h, 12% over two steps.</p></p></figure><figure id="sch5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds <b>18</b>, <b>20</b>, <b>21</b>, and <b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and Conditions: (a) (i) Fe, NH<sub>4</sub>Cl, EtOH, water, 75 °C, 2 h. (ii) pyrrolidine-1-carbonyl chloride, DMAP, pyridine, DCM, 50 °C, 18 h, 78%; (b) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, CuI, NEt<sub>3</sub>, DMF, RT, 30 min, 23%; (c) KO<i>t</i>Bu, NMP, 75 °C, 2 h, 86%; (d) morpholine, Pd<sub>2</sub>dba<sub>3</sub>, Xphos, NaO<i>t</i>Bu, DMF, 110 °C, 2 h, 26%; (e) CuI, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>4</sub>, NEt<sub>3</sub>, DMF, 50 °C, 16 h, 69%; (f) morpholine, RuPhos, Pd<sub>2</sub>(dba)<sub>3</sub>, KHMDS, 1,3-dioxane, 90 °C, 15%; (g) CuI, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, NEt<sub>3</sub>, DMF, 80 °C, 2 h, 81%; (h) Silver nitrate, TFA, DCM, RT, 0.5 h, 89%; (i) morpholine, Pd<sub>2</sub>dba<sub>3</sub>, Xphos, NaO<i>t</i>Bu, DMF, 100 °C, 1 h, 33%; (j) LDA, ethyl chloroformate, THF, −78 °C, 2 h, 91%; (k) DBU, MeCN, RT, 18 h, 26%; (l) HBr, 120 °C, 1 h, 26%; (m) (i) iron, NH<sub>4</sub>Cl, EtOH, water, 80 °C, 4 h. (ii) Pyrrolidine-1-carbonyl chloride, DMAP, pyridine, DCM, 50 °C, 18 h, 24% over three steps.</p></p></figure><figure id="sch6" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compound <b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH, MeI, THF, 0 °C, 5 h, 70%; (b) morpholine, NaO<i>t</i>Bu, Pd<sub>2</sub>(dba)<sub>3</sub>, xantphos, toluene, 80 °C, 18 h, 48%; (c) DMAP, pyridine, DCM, 50 °C, 18 h, 82%; (d) Pd(OAc)<sub>2</sub>, 2-nitrobenzoic acid, Ag<sub>2</sub>O, DMF, 90 °C, 18 h, 2%.</p></p></figure><figure id="sch7" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0017.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compound <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>O</i>-(mesitylsulfonyl)hydroxylamine, DCM, MeOH, 0 °C, 10 min; (b) (i) pyrrolidine-1-carbonyl chloride, DMAP, pyridine, DCM, 60 °C, 3 h; (ii) NaOH, water, MeOH, RT, 18 h, 64% over two steps; (c) SOCl<sub>2</sub>, DCM, 50 °C, 1 h; (d) DIPEA, MeCN, 80 °C, 24 h, 13% over two steps.</p></p></figure><figure id="sch8" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0018.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Compound <b>25</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) hydrazine hydrate, MeOH, 80 °C, 18 h, 99%; (b) 2-fluoro-5-nitrobenzaldehyde, EtOH, RT, 18 h, 93%; (c) iodobenzene diacetate, DCM, RT, 18 h, 87%; (d) formic acid, reflux, 5 h, 90%; (e) iron, NH<sub>4</sub>Cl, EtOH, THF, water, 75 °C, 18 h, 79%; (f) (i) morpholine, 100 °C, 1 h. (ii) pyrrolidine-1-carbonyl chloride, DMAP, pyridine, 50 °C, 18 h, 29%.</p></p></figure><figure id="sch9" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0019.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Compound <b>29–31</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HBr, EtOH, 80 °C, 9 h; (b) Br<sub>2</sub>, NaOAc, MeOH, RT, 0.5 h, 34% over two steps; (c) 2-pyridineboronic acid, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, water, 100 °C, 10 h, 10%; (d) EtOH, reflux, 4 h, 25–59%.</p></p></figure><div class="NLM_p">Compounds <b>15</b> and <b>27</b> are prepared, as outlined in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Compound <b>53</b> could be brominated with trimethyl(phenyl)ammonium tribromide to yield either monobromo <b>54</b> or dibromo <b>55</b>. The thermal cyclization of <b>54</b> with pyridazine <b>56</b> led to <b>15</b>, whereas <b>55</b> could be cyclized with 1-aminoguanidine to give <b>57</b> which was further cyclized with 2-bromo-1,1-diethoxyethane to <b>58</b>. Bromination to give <b>59</b> was followed by Suzuki coupling with benzeneboronic acid to yield <b>27</b>.</div><div class="NLM_p">Compound <b>16</b> is synthesized according to <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, where commercially available 3-(3-nitrophenyl)-1<i>H</i>-pyrazol-5-amine was cyclized with 2-bromopropanedial to give <b>60</b>, which with subsequent Suzuki coupling with benzeneboronic acid gave <b>61</b>. The nitro group was then reduced, with subsequent urea formation to give <b>16</b>.</div><div class="NLM_p">The synthesis of compounds <b>17</b> and <b>22</b> started from 3-ethynylaniline, as shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. The urea formation to give <b>62</b> was followed by Sonagashira coupling with 3-bromo-5-phenylpyridin-2-amine to give <b>63</b>, which underwent base-catalyzed cyclization to give <b>17</b>. Alternatively, cyclization of <b>62</b> with 5-bromo-6-oxo-1,6-dihydropyridazin-3-yl triflate <b>64</b> gave <b>65</b>, with subsequent thermal displacement of the triflate with morpholine yielding <b>22</b>.</div><div class="NLM_p">The synthesis of compounds <b>18</b>, <b>20</b>, <b>21</b>, and <b>26</b> all started from 2-ethynyl-1-fluoro-4-nitrobenzene, as outlined in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>. Initially, <b>66</b> was synthesized from 2-ethynyl-1-fluoro-4-nitrobenzene by nitroreduction and subsequent urea formation. Compound <b>18</b> was then prepared <i>via</i> Sonagashira coupling of <b>66</b> with 3,5-dibromopyrazin-2-amine to give <b>67</b>, followed by a base-catalyzed cyclization to give 6,5-bi-cycle <b>68</b>. Buchwald–Hartwig cross-coupling with morpholine then led to <b>18</b>. Alternatively, acetylene <b>66</b> could be cyclized with 5-bromo-3-iodopyridin-2-one to give <b>69</b>, which was converted to <b>20</b><i>via</i> Buchwald–Hartwig cross-coupling. To synthesize <b>21</b>, Sonagashira coupling of <b>66</b> with 1-PMB protected 3,5-dichloropyrazin-2(1<i>H</i>)-one yielded <b>70</b>, which could be cyclized to <b>71</b> in the presence of silver nitrate and TFA. Again, Buchwald–Hartwig coupling facilitated the conversion of <b>71</b> to <b>21</b>. Finally, to synthesize <b>26</b>, 2-ethynyl-1-fluoro-4-nitrobenzene was treated with LDA then ethyl chloroformate to give <b>72</b>, with base-catalyzed cyclization with 1-amino-4-morpholinopyridazin-1-ium iodide <b>73</b> leading to <b>74</b>. Subsequent decarboxylation to give <b>75</b> was followed by nitro reduction and urea formation, to yield <b>26</b>.</div><div class="NLM_p">The preparation of <b>19</b> is reported in <a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>. First, 5-bromo-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine was methylated on the pyrrole nitrogen to give <b>76</b>, with Buchwald–Hartwig coupling leading to <b>77</b>. Alongside this, 4-fluoro-3-iodoaniline was treated with pyrrolidine-1-carbonyl chloride to give <b>78</b>, which underwent a palladium-catalyzed direct C-2 arylation with <b>77</b> to give <b>19</b>.</div><div class="NLM_p">Compound <b>24</b> (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>) was prepared starting from 3-amino-5-morpholinopyridazine which was aminated on the 2-position to give diamino compound <b>79</b>. Alongside this, ethyl 5-amino-2-fluorobenzoate was treated with pyrrolidine-1-carbonyl chloride, with subsequent ester hydrolysis giving <b>80</b>, which was converted to acid chloride <b>81</b> by treatment with sulfonyl chloride. Compounds <b>79</b> and <b>81</b> were then cyclized to give <b>24</b>.</div><div class="NLM_p">Compound <b>25</b> was synthesized according to <a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>, whereby 2-chloro-5-bromopyrimidine was treated with hydrazine to give <b>82</b>, which was condensed with 2-fluoro-5-nitrobenzaldehyde to give <b>83</b> and then cyclized to <b>84</b>. Thermal rearrangement led to <b>85</b>, with nitroreduction giving <b>86</b>. This was cross-coupled with morpholine and then treated with pyrrolidine-1-carbonyl chloride to give <b>25</b>.</div><div class="NLM_p">To explore the SAR around the 3-position of the 6-phenylimidazo[1,2-<i>a</i>]pyrimidine scaffold, two approaches were taken; either an initial cyclization, followed by functionalization of the 3-position of the bi-cycle or cyclization of a precursor with the 3-substituent in place. The synthesis of <b>28</b> was previously described,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and a similar route was used to synthesize the pyridyl analogue <b>29</b>, as shown in <a class="ref internalNav" href="#sch9" aria-label="Scheme 9">Scheme 9</a>, where the previously reported 2-aminopyrimidine <b>87</b> was cyclized with 2-bromo-1,1-dimethoxyethane to give <b>88</b>, which could be brominated to <b>89</b>.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The Suzuki coupling of <b>89</b> with 2-pyridineboronic acid then led to <b>29</b>. Alternatively, to access alkyl substitutions, <b>87</b> could be cyclized directly with a suitable α-bromoaldehyde to give <b>30</b> and <b>31</b>.</div><div class="NLM_p">Alternatively, to synthesize C-linked morpholine analogues <b>32</b> and <b>33</b>, the routes shown in <a class="ref internalNav" href="#sch10" aria-label="Scheme 10">Scheme 10</a> were utilized. Intermediate <b>90</b> could undergo a Mannich reaction to give <b>91</b>, with nitro reduction and subsequent urea formation giving <b>32</b>. A Vilsmeier–Haack reaction on <b>90</b> led to formylated <b>92</b>. Its treatment with a SnAP reagent<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> led to the carbon-linked morpholine substituent <b>93</b>, which could be Boc-protected to give <b>94</b>, the nitro group reduced, and converted to pyrrolidinyl urea <b>95</b>, with Boc deprotection and subsequent methylation giving <b>33</b>.</div><figure id="sch10" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0020.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthesis of Compounds <b>32</b> and <b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) paraformaldehyde, morpholine, acetic acid, 50 °C, 18 h; (b) (i) iron, NH<sub>4</sub>Cl, EtOH, water, 80 °C, 18 h; (ii) pyrrolidine-1-carbonyl chloride, DMAP, pyridine, DCM, 50 °C, 18 h, 7% over three steps; (c) POCl<sub>3</sub>, DMF, 80 °C, 20 h; (d) 2-[(tributylstannyl)methoxy]ethanamine (SnAP-M), DCM, then 2,6-lutidine, hexafluoro-2-propanol, Cu(OTf)<sub>2</sub>, 50 °C, 3 h, 50% over two steps; (e) Boc<sub>2</sub>O, MeOH, 50 °C, 3 h, 62%; (f) (i) iron, NH<sub>4</sub>Cl, EtOH, water, 75 °C, 3 h (ii) pyrrolidine-1-carbonyl chloride, DMAP, pyridine, DCM, 50 °C, 20 h, 36%; (g) (i) TFA DCM, RT, 1 h; (ii) paraformaldehyde, acetic acid, THF, RT, 4 h, then sodium triacetoxyborohydride, RT, 24 h, 28%.</p></p></figure><div class="NLM_p">The 3-amino analogues were synthesized according to <a class="ref internalNav" href="#sch11" aria-label="Schemes 11">Schemes 11</a> and <a class="ref internalNav" href="#sch12" aria-label="12">12</a>. Where applicable, the previously published route for compound <b>1</b> was utilized (<a class="ref internalNav" href="#sch11" aria-label="Scheme 11">Scheme 11</a>), whereby the relevant amine was condensed with glyoxal and benzotriazole to give 1,2-bis electrophiles <b>96a-i</b>, which were subsequently cyclized with <b>87</b> under Lewis acid-promoted conditions to give compounds <b>1</b>, <b>34–38</b>, and <b>41–43</b>. In cases where this was unsuccessful, due to the relevant <b>96</b> not forming, the alternative route<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> in <a class="ref internalNav" href="#sch12" aria-label="Scheme 12">Scheme 12</a> was utilized, whereby 2-chloropyrimidine analogue <b>97</b> was treated with relevant glycinamide <b>98a–e</b> to give <b>99a–e</b> which was cyclized to <b>100a–e</b>. Cbz-Deprotection, followed by generation of the urea thus led to compounds <b>39</b>, <b>40</b>, and <b>44</b>−<b>46</b>.</div><figure id="sch11" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0021.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Synthesis of Compounds <b>1</b>, <b>34–38</b>, and <b>41–43</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) EtOH, RT, 12 h, 83%; (b) ZnBr<sub>2</sub>, DCM, reflux, 12 h, 5–46%.</p></p></figure><figure id="sch12" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0022.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Synthesis of Compounds <b>39</b>, <b>40</b>, and <b>44–46</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DIPEA, 1,4-dioxane, 120 °C, 18 h, 56%; (b) POCl<sub>3</sub>, 80 °C, 1 h, 67%; (c) (i) Pd/C, H<sub>2</sub>, MeOH, RT, 18 h; (ii) CDI, DIPEA, DCM, 18 h, then pyrrolidine, RT, 4.5 h, 22–46%.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82730" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82730" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">2-Phenylimidazo[1,2-<i>a</i>]pyrimidine <b>3</b> was a suitable starting point for a phenotypic lead-optimization program for VL. Changes to the central phenyl ring demonstrated that it was possible to significantly improve FaSSIF solubility but failed to yield compounds with a suitable balance of potency, metabolic stability, and FaSSIF solubility; we, therefore, embarked on a scaffold-hopping exercise. A round of design and synthesis led to a set of 14 compounds with different cores, giving us an understanding of the requirements for potency, where HBA’s at positions 1 and 8 of the bi-cycle were critical for activity. While the scaffolds, which fulfilled these requirements, notably <b>20–26</b> and the “reversed” scaffolds <b>1</b> and <b>27</b>, all met our target potency in the INMAC assay, the solubilities, in both aqueous and FaSSIF media, were highly variable in ways that were difficult to predict.</div><div class="NLM_p">From this, compounds <b>1</b> and <b>23</b> were identified as the most promising for progression, although the development of <b>23</b> was halted due to a genotoxicity issue. Attempts were made to optimize the morpholine substituent in compound <b>1</b> with a variety of different analogues and replacements. While some of these showed greater potency, this came at the cost of solubility and/or microsomal stability. Compound <b>1</b> was selected for further profiling, showing that neither the parent, nor the aniline potentially released by the hydrolysis of the urea were positive in the Ames assay. After safety profiling, <b>1</b> was selected as a preclinical candidate for VL, as previously reported.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">Modeling studies were carried out using the cryoEM <i>L. tarentolae</i> proteasome structure that we had previously reported. This was used to generate a model of the <i>L. donovani</i> proteasome. The structure was not available until after the chemistry program had finished. By performing a pair interaction energy decomposition analysis (PIEDA) using the fragment molecular orbital method (FMO), we were able to predict which are the important interactions between the protein and ligand on a residue by residue basis. Important interactions were with Thr100, Gly122, Asp214, Asp215, Val227, and Gly228. The presence of a negative charge on the bottom edge of the bi-cycle (positions 1 and 8, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) was important for the interaction with Thr100 and positive charge on positions 3 and 4 for interaction with Asp214 and Asp215. The relative importance of the protein–ligand interactions would not have been identified unless such a sophisticated analysis had been carried out. We also analyzed the ESP of the ligands. When combining this with the FMO analysis, we were able to rationalize the SAR that we have seen. We suggest that this approach could be used going forward in predicting whether modifications to compounds are likely to improve binding.</div><div class="NLM_p">This project demonstrates the utility of Cryo-EM co-structures for rationalizing protein–ligand interactions. In this case, we were able to obtain structures of sufficient resolution to be able to understand in a detailed manner the protein–ligand interactions. As well as being able to rationalize the SAR, as we have previously reported, we were able to use the structural information to rationalize the selectivity of our compounds for the parasite proteasome compared to the human proteasome, as reported previously.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p last">The proteasome represents an exciting new drug target for VL and our lead compound, <b>1</b>, is being progressed toward human studies.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67025" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67025" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Chemistry</h3><div class="NLM_p last">Chemicals and solvents were purchased from the Aldrich Chemical Company, Fluka, ABCR, VWR, Acros, Fluorochem, and Alfa Aesar and were used as received. Air- and moisture-sensitive reactions were carried out under an inert atmosphere of argon in oven-dried glassware. Analytical thin-layer chromatography (TLC) was performed on precoated TLC plates (layer 0.20 mm silica gel 60 with fluorescent indicator UV254, from Merck). Developed plates were air-dried and analyzed under a UV lamp (UV254/365 nm). Flash column chromatography was performed using prepacked silica gel cartridges (230–400 mesh, 40–63 mm, from SiliCycle) using a Teledyne ISCO CombiFlash Companion, or CombiFlash Retrieve. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on a Bruker AVANCE DPX 500 spectrometer (<sup>1</sup>H at 500.1 MHz, <sup>13</sup>C at 125.8 MHz). Chemical shifts (δ) are expressed in ppm recorded using the residual solvent as the internal reference in all cases. Signal splitting patterns are described as singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), broad (b), or a combination thereof. Coupling constants (J) are quoted to the nearest 0.1 Hz. LC–MS analyses were performed with either an Agilent HPLC 1100 series connected to a Bruker Daltonics MicrOTOF or an Agilent Technologies 1200 series HPLC connected to an Agilent Technologies 6130 quadrupole LC/MS, where both instruments were connected to an Agilent diode array detector. The mobile phase was water/acetonitrile + 0.1% HCOOH or water/acetonitrile + 0.1% NH<sub>3</sub>; linear gradient 80:20 to 5:95 over 3.5 min, and then held for 1.5 min; flow rate 0.5 mL min<sup>–1</sup>. All intermediates had a measured purity ≥90% and all assay compounds had a measured purity of ≥95% as determined using this analytical LC–MS system (TIC and UV). High-resolution electrospray measurements were performed on a Bruker Daltonics MicrOTOF mass spectrometer. Microwave-assisted chemistry was performed using a Biotage initiator microwave synthesizer. The synthesis of all intermediates, and spectral data for final compounds, is included in the <a href="/doi/suppl/10.1021/acs.jmedchem.1c00047/suppl_file/jm1c00047_si_001.pdf" class="ext-link">Supporting Informatio</a>n.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>N</i>-(2-Fluoro-5-(6-morpholinoimidazo[1,2-<i>a</i>]pyrimidin-2-yl)phenyl)pyrrolidine-1-carboxamide (<b>5</b>)</h3><div class="NLM_p last">To a suspension of <b>50a</b> (0.32 g, 1.02 mmol) in pyridine (19 mL) was added 4-dimethylaminopyridine (DMAP) (0.0062 g, 0.051 mmol) and pyrrolidine-1-carbonyl chloride (0.169 mL, 1.532 mmol), and the resulting suspension stirred at RT for 40 h then at 40 °C for 24 h. Further pyrrolidine-1-carbonyl chloride (0.169 mL, 1.532 mmol) was added, and the resulting suspension stirred at 40 °C for 2 days. Further pyrrolidine-1-carbonyl chloride (0.113 mL, 1.021 mmol) was then added and the reaction mixture stirred at 40 °C for a further 24 h. The temperature was then increased to 55 °C and the mixture was stirred for another 48 h. The reaction mixture was then heated at 65 °C before adding more pyrrolidine-1-carbonyl chloride (0.205 g, 1.532 mmol). The resulting mixture was heated at 55 °C for 2 days. Solvents were evaporated, and the residue purified by flash chromatography (0–5% MeOH/DCM). Brown oil was obtained which was further purified by prep. HPLC to yield <b>5</b> as a yellow solid (0.05 g, 0.12 mmol, 12% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.54 (d, <i>J</i> = 2.9 Hz, 1H), 8.30 (d, <i>J</i> = 3.0 Hz, 1H), 8.06 (d, <i>J</i> = 7.2 Hz, 2H), 7.82 (s, 1H), 7.58 (ddd, <i>J</i> = 8.5, 4.6, 2.3 Hz, 1H), 7.17 (dd, <i>J</i> = 10.6, 8.5 Hz, 1H), 3.77–3.65 (m, 4H), 3.36–3.28 (m, 4H), 3.05–2.98 (m, 4H), 1.86–1.69 (m, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 156.3, 154.4, 154.2, 147.0, 145.8, 136.7, 130.2, 128.4 (d, <i>J</i><sub>CF</sub> = 12.1 Hz), 123.3, 122.1 (d, <i>J</i><sub>CF</sub> = 7.5 Hz), 119.1, 116.2 (d, <i>J</i><sub>CF</sub> = 20.1 Hz), 107.8, 66.3, 50.0, 46.2, 25.5; HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>24</sub>FN<sub>6</sub>O<sub>2</sub>, 411.1939; found, 411.1939.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-(3-(6-Morpholinoimidazo[1,2-<i>a</i>]pyrimidin-2-yl)phenyl)pyrrolidine-1-carboxamide (<b>6</b>)</h3><div class="NLM_p last">A mixture of <b>49</b> (0.347 g, 1.92 mmol) and <b>52b</b> (0.6 g, 1.92 mmol) in dimethylformamide (DMF) (5 mL) was stirred at 90 °C for 18 h. After cooling, the solvent was evaporated and the crude material was purified by flash chromatography (0–5% MeOH/DCM) to give <b>6</b> (0.035 g, 0.085 mmol, 5%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.64–8.62 (m, 1H), 8.42–8.40 (m, 1H), 8.25 (s, 1H), 8.14–8.13 (m, 1H), 8.11 (s, 1H), 7.56 (d, <i>J</i> = 8.0 Hz, 1H), 7.49 (d, <i>J</i> = 7.6 Hz, 1H), 7.29 (dd, <i>J</i> = 7.9 and 7.3 Hz, 1H), 3.81–3.78 (m, 4H), 3.42–3.38 (m, 4H), 3.12–3.09 (m, 4H), 1.89–1.85 (m, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 154.4, 146.8, 145.9, 145.6, 141.6, 136.6, 134.2, 129.1, 119.4, 119.2, 119.1, 117.0, 107.8, 66.4, 50.2, 46.2, 25.6; HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>25</sub>N<sub>6</sub>O<sub>2</sub>, 393.2039; found, 393.2054.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-(4-Methoxy-3-(6-morpholinoimidazo[1,2-<i>a</i>]pyrimidin-2-yl)phenyl)pyrrolidine-1-carboxamide (<b>7</b>)</h3><div class="NLM_p last">To a suspension of <b>50c</b> (0.158 g, 0.486 mmol) in pyridine (9.2 mL), DMAP (0.003 g, 0.024 mmol) and pyrrolidine-1-carbonyl chloride (0.080 mL, 0.728 mmol) were added, and the resulting suspension was stirred at RT for 40 h. Solvents were evaporated and the crude product was purified by flash chromatography (0–10% MeOH/DCM). Brown oil was obtained which was triturated with acetone and further purified by preparative HPLC to yield <b>7</b> (0.074 g, 0.17 mmol, 36% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.53 (d, <i>J</i> = 2.9 Hz, 1H), 8.38 (d, <i>J</i> = 2.9 Hz, 1H), 8.23 (d, <i>J</i> = 2.8 Hz, 1H), 8.14 (s, 1H), 8.05 (s, 1H), 7.49 (dd, <i>J</i> = 8.9, 2.8 Hz, 1H), 6.93 (d, <i>J</i> = 9.0 Hz, 1H), 3.83 (s, 3H), 3.71 (dd, <i>J</i> = 5.9, 3.5 Hz, 4H), 3.34–3.26 (m, 4H), 3.04–2.97 (m, 4H), 1.81–1.74 (m, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 154.7, 152.2, 147.0, 144.9, 141.4, 136.3, 134.4, 121.9, 120.8, 120.5, 119.2, 111.8, 111.7, 66.3, 56.2, 50.1, 46.1, 25.6; HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>27</sub>N<sub>6</sub>O<sub>3</sub>, 423.2139; found, 423.2138.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-(2-Methoxy-5-(6-morpholinoimidazo[1,2-<i>a</i>]pyrimidin-2-yl)phenyl)pyrrolidine-1-carboxamide (<b>8</b>)</h3><div class="NLM_p last">To a suspension of <b>50d</b> (0.094 g, 0.289 mmol) in pyridine (5.45 mL) were added DMAP (1.8 mg, 0.014 mmol) and pyrrolidine-1-carbonyl chloride (0.048 mL, 0.433 mmol), and the resulting suspension was stirred at RT for 40 h. More pyrrolidine-1-carbonyl chloride (0.048 mL, 0.433 mmol) was added, and the resulting solution was stirred at RT over 3 days. Solvents were evaporated and the crude material was purified by flash chromatography (0–10% MeOH/DCM). The resulting yellow solid was dissolved in DCM/MeOH (5 mL) and washed with water (15 mL). The aqueous layer was further extracted with DCM (2 × 5 mL). The organic phases were combined, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give a brown pale solid, which was dried under vacuum to yield <b>8</b> (0.011 g, 0.03 mmol, 9%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.50 (d, <i>J</i> = 2.9 Hz, 1H), 8.39 (d, <i>J</i> = 2.1 Hz, 1H), 8.29 (d, <i>J</i> = 2.9 Hz, 1H), 7.96 (s, 1H), 7.49 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 7.12 (s, 1H), 6.99 (d, <i>J</i> = 8.6 Hz, 1H), 3.80 (s, 3H), 3.76–3.65 (m, 4H), 3.35–3.26 (m, 4H), 3.06–2.97 (m, 4H), 1.81 (t, <i>J</i> = 6.5 Hz, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 153.9, 149.3, 146.3, 145.9, 145.8, 136.5, 129.5, 126.6, 120.2, 119.0, 118.2, 111.3, 107.0, 66.3, 56.5, 50.1, 45.9, 25.6; HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>27</sub>N<sub>6</sub>O<sub>3</sub>, 423.2145; found, 423.2139.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>N</i>-(6-(6-Morpholinoimidazo[1,2-<i>a</i>]pyrimidin-2-yl)pyridin-2-yl)pyrrolidine-1-carboxamide (<b>9</b>)</h3><div class="NLM_p last"><b>9</b> was synthesized by an analogous method to <b>6</b> from <b>49</b> (0.21 g, 1.17 mmol) and <b>50e</b> (0.364 g, 1.17 mmol) with purification done by flash chromatography (2–10% MeOH/DCM) to give <b>9</b> (0.1 g, 0.25 mmol, 22%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.69–8.67 (m, 1H), 8.50–8.48 (m, 1H), 8.45 (s, 1H), 8.21 (s, 1H), 7.83–7.69 (m, 3H), 3.82–3.78 (m, 4H), 3.48–3.42 (m, 4H), 3.14–3.10 (m, 4H), 1.90 1.84 (m, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 153.8, 153.5, 151.2, 147.4, 145.7, 145.3, 138.8, 136.7, 119.2, 114.4, 112.9, 110.1, 66.3, 49.9, 46.2, 25.4; HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>24</sub>N<sub>7</sub>O<sub>2</sub>, 394.1986; found, 394.1984.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-(6-(6-Morpholinoimidazo[1,2-<i>a</i>]pyrimidin-2-yl)pyrimidin-4-yl)pyrrolidine-1-carboxamide (<b>10</b>)</h3><div class="NLM_p last"><b>10</b> was synthesized by an analogous method to <b>6</b> from <b>49</b> (0.306 g, 1.7 mmol) and <b>52f</b> (0.682 g, 1.7 mmol) with purification by flash chromatography (0.5–2% MeOH/DCM) to give <b>10</b> (0.322 g, 0.82 mmol, 48%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.32 (s, 1H), 8.76–8.74 (m, 2H), 8.58 (s, 1H), 8.47–8.45 (m, 1H), 8.37 (s, 1H), 3.82–3.78 (m, 4H), 3.51–3.42 (m, 4H), 3.14–3.10 (m, 4H), 1.89–1.82 (m, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 160.6, 159.7, 158.4, 153.2, 148.6, 145.9, 143.7, 137.0, 66.3, 50.0, 46.4, 31.0; HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>23</sub>N<sub>8</sub>O<sub>2</sub>, 395.1938; found, 395.1939.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-(6-(6-Morpholinoimidazo[1,2-<i>a</i>]pyrimidin-2-yl)pyrazin-2-yl)pyrrolidine-1-carboxamide (<b>11</b>)</h3><div class="NLM_p last"><b>11</b> was synthesized by an analogous method to <b>6</b> from <b>49</b> (0.208 g, 1.16 mmol) and <b>52g</b> (0.452 g, 1.45 mmol), with purification by prep. HPLC to give <b>11</b> (0.071 g, 0.18 mmol, 12%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.06–9.04 (m, 2H), 8.86 (s, 1H), 8.75–8.73 (m, 1H), 8.53–8.51 (m, 1H), 8.26 (s, 1H), 3.82–3.79 (m, 4H), 3.50–3.43 (m, 4H), 3.15–3.11 (m, 4H), 1.92–1.84 (m, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 153.5, 149.9, 148.2, 145.9, 145.7, 142.7, 136.9, 135.8, 134.6, 119.2, 111.1, 66.2, 49.8, 46.4, 30.5; HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>23</sub>N<sub>8</sub>O<sub>2</sub>, 395.1938; found, 395.1946.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-(4-(6-Morpholinoimidazo[1,2-<i>a</i>]pyrimidin-2-yl)pyrimidin-2-yl)pyrrolidine-1-carboxamide (<b>12</b>)</h3><div class="NLM_p last"><b>12</b> was synthesized by an analogous method to <b>6</b> from <b>49</b> (0.206 g, 1.14 mmol) and crude <b>52h</b> (1 equiv), with purification by flash chromatography (0.5–3% MeOH/DCM) giving <b>12</b> (0.293 g, 0.73 mmol). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.20 (s, 1H), 8.77–8.74 (m, 1H), 8.60 (d, <i>J</i> = 5.0 Hz, 1H), 8.53–8.50 (m, 1H), 8.33 (s, 1H), 7.60 (d, <i>J</i> = 5.0 Hz, 1H), 3.82–3.78 (m, 4H), 3.47–3.40 (m, 1H), 3.15–3.10 (m, 4H), 1.89–1.84 (m, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 160.6, 159.8, 159.4, 153.1, 148.6, 145.9, 143.1, 136.9, 119.1, 112.3, 110.3, 66.2, 49.7, 46.5, 25.6; HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>23</sub>N<sub>8</sub>O<sub>2</sub>, 395.1938; found, 395.1954.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-(6-(6-Morpholinoimidazo[1,2-<i>a</i>]pyrimidin-2-yl)pyridazin-4-yl)pyrrolidine-1-carboxamide (<b>13</b>)</h3><div class="NLM_p last"><b>13</b> was synthesized by an analogous method to <b>6</b> from <b>49</b> (0.208 g, 1.15 mmol) and <b>52i</b> (0.355 g, 1.43 mmol), with purification by flash chromatography (0–5% MeOH/DCM) giving <b>13</b> (0.013 g, 0.03 mmol, 2%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.40–9.38 (m, 1H), 8.96 (s, 1H), 8.73–8.71 (m, 1H), 8.56–8.54 (m, 1H), 8.51–8.49 (m, 1H), 8.43 (s, 1H), 3.82–3.79 (m, 4H), 3.47–3.41 (m, 4H), 3.14–3.11 (m, 4H), 1.92–1.87 (m, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 155.2, 153.3, 147.9, 145.8, 142.8, 142.6, 141.0, 136.9, 119.2, 110.5, 109.9, 66.8, 49.9, 46.4, 25.3; HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>23</sub>N<sub>8</sub>O<sub>2</sub>, 395.1944; found, 395.1961.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-[4-Fluoro-3-(7-morpholinoimidazo[1,2-<i>b</i>]pyridazin-2-yl)phenyl]pyrrolidine-1-carboxamide (<b>15</b>)</h3><div class="NLM_p last">A solution of 5-morpholinopyridazin-3-amine<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> (<b>56</b>, 0.12 g, 0.67 mmol) and <b>54</b> (0.241 g, 0.73 mmol) in MeCN (10 mL) was heated to 60 °C for 2 days. After cooling, the resulting precipitate was collected by filtration, loaded onto a column, and purified by flash chromatography (10% MeOH/EtOAc). Clean fractions were combined and concentrated, and the resulting yellow solid was triturated and collected by filtration to give <b>15</b> (0.121 g, 0.29 mmol, 43%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.66 (d, <i>J</i> = 1.8 Hz, 1H), 8.36 (d, <i>J</i> = 4.4 Hz, 1H), 8.30 (s, 1H), 8.21 (d, <i>J</i> = 3.7 Hz, 1H), 7.56–7.54 (m, 1H), 7.20–7.14 (m, 2H), 3.80 (s, 4H), 3.39 (s, 4H), 3.30 (s, 4H), 1.87 (s, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 156.0, 154.5, 154.0, 143.0, 140.3, 138.9, 137.7 (d, <i>J</i><sub>CF</sub> = 19.9 Hz), 121.2 (d, <i>J</i><sub>CF</sub> = 13.5 Hz), 120.5 (d, <i>J</i><sub>CF</sub> = 7.9 Hz), 119.4, 115.7 (d, <i>J</i><sub>CF</sub> = 10.1 Hz), 113.8 (d, <i>J</i><sub>CF</sub> = 13.1 Hz), 102.4, 66.1, 48.1, 46.1, 25.5; [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>24</sub>FN<sub>6</sub>O<sub>2</sub>, 411.1945; found 411.1948.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>N</i>-(3-(6-Phenylpyrazolo[1,5-<i>a</i>]pyrimidin-2-yl)phenyl)pyrrolidine-1-carboxamide (<b>16</b>)</h3><div class="NLM_p last">To a suspension of crude <b>61</b> (0.350 g, 1.11 mmol) in EtOH (20 mL) was added a solution of ammonium chloride (0.237 g, 4.43 mmol) in water (3 mL). The stirred mixture was heated to 75 °C and then treated in a single portion with finely divided iron (0.495 g, 8.85 mmol). The reaction mixture was stirred at this temperature for 2 h, cooled to RT, and filtered through a pad of celite, further eluting with MeOH. The resulting solution was concentrated under reduced pressure, and the residue partitioned between DCM and water. The aqueous layer was further extracted with DCM, and the combined organics were washed with brine, dried over MgSO<sub>4</sub>, and concentrated to give crude 3-(6-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-2-yl)aniline (0.272 g, 0.95 mmol), which was used without purification. The crude material (0.250 g, 0.87 mmol) was taken up in pyridine (1 mL)/DCM (10 mL), treated dropwise with pyrrolidine-1-carbonyl chloride (0.175 g, 1.31 mmol), and stirred at 70 °C for 48 h. After cooling, the reaction was diluted with DCM (20 mL), washed with sat. NaHCO<sub>3</sub>, dried (MgSO<sub>4</sub>), and the solvent was evaporated. The resulting solid was triturated with EtOAc, collected by filtration, and chromatographed (100% EtOAc) to give <b>16</b> (0.234 g, 0.55 mmol, 62%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.47 (s, 1H), 8.97–8.92 (m, 1H), 8.29 (d, <i>J</i> = 8.3 Hz, 2H), 7.88 (d, <i>J</i> = 7.6 Hz, 2H), 7.64–7.60 (m, 2H), 7.57–7.53 (m, 2H), 7.49–7.44 (m, 1H), 7.39–7.34 (m, 1H), 7.17 (s, 1H), 3.44–3.40 (m, 4H), 1.92–1.86 (m, 4H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 156.4, 154.4, 149.9, 148.7, 141.7, 134.2, 132.9, 132.7, 129.7, 129.3, 128.7, 127.3, 121.9, 120.6, 120.2, 117.5, 93.3, 46.2, 25.5; <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>22</sub>N<sub>5</sub>O, 384.1836; found, 384.1824.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>N</i>-(3-(5-Phenyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)phenyl)pyrrolidine-1-carboxamide (<b>17</b>)</h3><div class="NLM_p last">To <b>63</b> (0.075 g, 0.20 mmol) in <i>N</i>-methyl-2-pyrrolidone (NMP) (1 mL) was added potassium <i>tert</i>-butoxide (0.066 g, 0.59 mmol) and stirred at 75 °C overnight. After cooling to RT, the RM was partitioned between satd. NH<sub>4</sub>Cl and DCM. The aqueous layer was further extracted with DCM, and the combined organics were washed with brine, dried over MgSO<sub>4</sub>, and the solvent was evaporated. The crude material was chromatographed (0–1% MeOH/EtOAc) to give <b>17</b> (0.045 g, 0.11 mmol, 57%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 9.77 (br s, 1H), 8.57 (d, <i>J</i> = 2.1 Hz, 1H), 8.10 (d, <i>J</i> = 1.6 Hz, 1H), 8.01–7.99 (m, 1H), 7.69–7.66 (m, 2H), 7.53–7.49 (m, 2H), 7.45–7.39 (m, 4H), 6.86 (d, <i>J</i> = 2.1 Hz, 1H), 6.28 (s, 1H), 3.52–3.48 (m, 4H), 2.02–1.99 (m, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 154.4, 149.7, 142.2, 141.6, 140.2, 139.5, 132.1, 129.4, 129.3, 129.1, 127.3, 126.2, 121.5, 120.1, 119.3, 117.4, 97.5, 46.2, 25.5; <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>23</sub>N<sub>4</sub>O, 383.1872; found, 383.1882.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>N</i>-(4-Fluoro-3-(2-morpholino-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazin-6-yl)phenyl)pyrrolidine-1-carboxamide (<b>18</b>)</h3><div class="NLM_p last">To <b>68</b> (0.225 g, 0.56 mmol), morpholine (0.242 g, 2.78 mmol), tris(dibenzylideneacetone)dipalladium(0) (Pd<sub>2</sub>dba<sub>3</sub>) (0.0255 g, 0.028 mmol), and 2-dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl (Xphos) (0.265 g, 0.56 mmol) in DMF (5 mL) was added sodium <i>tert</i>-butoxide (0.0053 g, 0.056 mmol), sealed, evacuated, flushed with N<sub>2</sub>, and stirred at 110 °C for 2 h. After cooling, RM was partitioned between water/EtOAc, and the organics was evaporated and chromatographed (0–6% MeOH/EtOAc). Fractions containing the product were combined, evaporated, and the resulting solid washed with MeOH and dried under vacuum to give <b>18</b> (0.063 g, 0.15 mmol, 26%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 11.95 (s, 1H), 8.26 (s, 1H), 8.07 (s, 1H), 7.97 (dd, <i>J</i> = 2.7, 6.9 Hz, 1H), 7.50 (ddd, <i>J</i> = 2.7, 4.3 and 8.9 Hz, 1H), 7.24 (dd, <i>J</i> = 8.9, 10.8 Hz, 1H), 6.65 (dd, <i>J</i> = 2.2, 2.2 Hz, 1H), 3.77 (t, <i>J</i> = 4.8 Hz, 4H), 3.47 (t, <i>J</i> = 4.8 Hz, 4H), 3.41–3.37 (m, 4H), 1.88 (t, <i>J</i> = 6.6 Hz, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 155.9, 154.5, 153.9, 153.1, 137.7 (d, <i>J</i><sub>CF</sub> = 30.2 Hz), 136.2 (d, <i>J</i><sub>CF</sub> = 44.9 Hz), 126.6, 122.0 (d, <i>J</i><sub>CF</sub> = 8.1 Hz), 120.6, 119.6 (d, <i>J</i><sub>CF</sub> = 13.1 Hz), 116.4 (d, <i>J</i><sub>CF</sub> = 23.0 Hz), 100.1 (d, <i>J</i><sub>CF</sub> = 7.4 Hz), 66.5, 46.8, 46.1, 25.5; <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>24</sub>N<sub>6</sub>O<sub>2</sub>F, 411.1945; found, 411.1957.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-[4-Fluoro-3-(1-methyl-5-morpholino-pyrrolo[2,3-<i>b</i>]pyridin-2-yl)phenyl]pyrrolidine-1-carboxamide (<b>19</b>)</h3><div class="NLM_p last">In a sealed vial, <b>78</b> (0.4614 g, 1.38 mmol), Pd(OAc)<sub>2</sub> (0.0077 g, 0.03 mmol), 2-nitrobenzoic acid (0.1731 g, 1.04 mmol), and Ag<sub>2</sub>O (0.120 g, 0.52 mmol) were flushed with nitrogen. A solution of <b>77</b> (0.150 g, 0.69 mmol) in DMF (1 mL) was added, and the reaction mixture stirred at 90 °C overnight. The RM was allowed to cool to RT, filtered through a pad of celite, and eluted with DCM and then MeOH to give a brown solution. The solvent was evaporated, and the crude material was purified by flash chromatography (0–100% EtOAc/heptane then 0–10% MeOH/EtOAc). Fractions containing the product were combined and purified by prep. HPLC (20–95% MeCN) to afford <b>19</b> (0.005 g, 0.01 mmol, 2%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.22 (d, <i>J</i> = 2.6 Hz, 1H), 7.53 (dd, <i>J</i> = 2.7, 6.3 Hz, 1H), 7.51–7.47 (m, 2H), 7.16–7.13 (m, 1H), 6.48 (s, 1H), 6.24 (br s, 1H), 3.96–3.93 (m, 4H), 3.79 (d, <i>J</i> = 1.5 Hz, 3H), 3.50–3.48 (m, 4H), 3.17–3.15 (m, 4H), 2.01–1.99 (m, 4H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 155.7, 154.4, 153.8, 143.9 (d, <i>J</i><sub>CF</sub> = 175 Hz), 137.7 (d, <i>J</i><sub>CF</sub> = 2.5 Hz), 136.3, 136.1, 122.7, 122.0 (d, <i>J</i><sub>CF</sub> = 7.7 Hz), 119.9 (d, <i>J</i><sub>CF</sub> = 15.9 Hz), 116.1 (d, <i>J</i><sub>CF</sub> = 22.9 Hz), 115.3, 100.5, 66.7, 51.3, 46.2, 29.7, 25.5; HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>27</sub>FN<sub>5</sub>O<sub>2</sub>, 424.2143; found 424.2167.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>N</i>-(4-Fluoro-3-(5-morpholinofuro[2,3-<i>b</i>]pyridin-2-yl)phenyl)pyrrolidine-1-carboxamide (<b>20</b>)</h3><div class="NLM_p last">To a degassed suspension of <b>69</b> (0.462 g, 1.14 mmol) in 1,4-dioxane (11 mL) were added morpholine (300 μl, 3.43 mmol) and potassium bis(trimethylsilyl)amide (KHMDS) (4.6 ml, 2.29 mmol, 0.5 M in toluene). The resulting mixture was purged with nitrogen and then 2-dicyclohexylphosphino-2′,6′-diisopropoxybiphenyl (RuPhos) (0.107 g, 0.23 mmol) and (Pd2dba3) (0.105 g, 0.11 mmol) were added. The RM was stirred at 90 °C for 16 h, cooled, filtered through celite, and washed with DCM. The solvent was evaporated, and the crude material was purified by flash chromatography (0–40% EtOH/EtOAc (1:3)/cyclohexane) to give the crude product, which was further purified by flash chromatography (0–2% MeOH/DCM) to give <b>20</b> (0.070 g, 0.17 mmol, 15%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.08–8.04 (m, 1H), 7.87–7.80 (m, 1H), 7.75–7.71 (m, 1H), 7.46 (s, 1H), 7.16–7.09 (m, 2H), 6.31 (s, 1H), 3.95–3.88 (m, 4H), 3.54–3.45 (m, 4H), 3.23–3.14 (m, 4H), 2.03–1.96 (m, 4H); <i>m</i>/<i>z</i> 410.6 [M + H]<sup>+</sup>; <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 156.4, 155.5, 154.4, 153.6, 150.0 (d, <i>J</i><sub>CF</sub> = 3.8 Hz), 145.9, 138.1, 135.5, 121.9 (d, <i>J</i><sub>CF</sub> = 7.9 Hz), 121.2, 117.7, 117.1, 116.6 (d, <i>J</i><sub>CF</sub> = 22.3 Hz), 105.9 (d, <i>J</i><sub>CF</sub> = 12.7 Hz), 66.6, 50.3, 46.2, 25.5; <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>24</sub>N<sub>4</sub>O<sub>3</sub>F, 411.1832; found, 411.1840.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>N</i>-[4-Fluoro-3-(2-morpholinofuro[2,3-<i>b</i>]pyrazin-6-yl)phenyl]pyrrolidine-1-carboxamide (<b>21</b>)</h3><div class="NLM_p last">Pd<sub>2</sub>dba<sub>3</sub> (0.0013 g, 0.0014 mmol), sodium <i>tert</i>-butoxide (0.027 g, 0.28 mmol), and Xphos (0.002 g, 0.0042 mmol) in a sealed vial were purged with nitrogen, and a suspension of <b>71</b> (0.05 g, 0.14 mmol) in DMF (1 mL) was added, followed by morpholine (0.06 g, 0.69 mmol). The RM was stirred at 100 °C for 1 h, cooled to RT and partitioned between water and EtOAc. The aqueous layer was further extracted with EtOAc, and the combined organics washed with brine, dried over MgSO<sub>4</sub>, and concentrated. The crude mixture was purified by flash chromatography (0–5% EtOAc/heptane) and fractions containing the product were combined and the solvent was removed. The residue was further purified by prep. HPLC (20–95% MeCN, 0.1% NH<sub>4</sub>OH) to give <b>21</b> (0.02 g, 0.046 mmol, 33%). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.84–7.81 (m, 3H), 7.26 (d, <i>J</i> = 3.2 Hz, 1H), 7.16 (dd, <i>J</i> = 9.0, 10.7 Hz, 1H), 6.29 (s, 1H), 3.93–3.90 (m, 4H), 3.61–3.58 (m, 4H), 3.52 (dd, <i>J</i> = 6.6, 6.6 Hz, 4H), 2.05–2.02 (m, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 155.6, 155.2, 154.3, 153.6, 153.0 (d, <i>J</i><sub>C–F</sub> = 3.8 Hz), 149.8, 138.2, 137.8, 126.2, 122.4 (d, <i>J</i><sub>C–F</sub> = 7.8 Hz), 117.2, 116.7 (d, <i>J</i><sub>C–F</sub> = 20.1 Hz), 106.0 (d, <i>J</i><sub>C–F</sub> = 15.0 Hz), 66.3, 46.2, 46.1, 25.5; <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>5</sub>O<sub>3</sub>F, 412.1785; found, 412.1797.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>N</i>-(4-Fluoro-3-(3-morpholinofuro[2,3-c]pyridazin-6-yl)phenyl)pyrrolidine-1-carboxamide (<b>22</b>)</h3><div class="NLM_p">To a stirred solution of 4-bromo-1,2-dihydropyridazine-3,6-dione (3 g, 15.7 mmol) in pyridine (27 mL) under Ar at 5 °C was added triflic anhydride (2.64 mmol, 15.7 mmol) and stirred for 2h. The solvent was evaporated and RM was diluted with EtOAc, washed with sat. aqueous NaHCO<sub>3</sub> and brine, and the combined organic layers was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give <b>64</b> (3.7 g, 11.49 mmol, 73%), which was used without purification.</div><div class="NLM_p last">A suspension of <b>64</b> (0.590 g, 1.82 mmol), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (0.038 g, 0.05 mmol), copper (I) iodide (0.034 g, 0.18 mmol), and 62 (0.506 g, 2.37 mmol) in a mixture of MeCN/NEt<sub>3</sub> (3 mL, 10:1) was stirred at RT for 6 h. DCM was added and the mixture was washed with water. The organic phase was dried and evaporated to obtain crude <b>65</b> which was used in the next step without further purification (0.892 g, 1.9 mmol). <b>65</b> was dissolved in dry morpholine (30 mL) and stirred at 50 °C overnight. After cooling, EtOAc was added followed by water. The organic phase was separated, the solvent was evaporated, and the crude material purified by flash chromatography (EtOAc/cyclohexane 0–100%). The resulting product was further purified by a SCX column, eluting with 2 M ammonia in MeOH. A second purification by SCX column, eluting with MeOH and then with 2 M ammonia in MeOH yielded <b>22</b> (0.093 g, 0.24 mmol, 12%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.40 (s, 1H), 8.24–8.22 (m, 1H), 7.76–7.73 (m, 1H), 7.63–7.61 (m, 1H), 7.52 (s, 1H), 7.44–7.40 (m, 1H), 7.31 (s, 1H), 3.79–3.76 (m, 4H), 3.54–3.50 (m, 4H), 3.42–3.39 (m, 4H), 1.90–1.87 (m, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 162.1, 160.4, 159.7, 154.2, 142.0, 129.8, 128.5, 127.9, 121.8, 119.7, 116.6, 106.0, 100.2, 66.4, 46.9, 46.2, 25.5; <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>24</sub>N<sub>5</sub>O<sub>3</sub>, 394.1879; found, 394.1895.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>N</i>-(4-Fluoro-3-(2-morpholinoimidazo[1,2-b][1,2,4]triazin-6-yl)phenyl)pyrrolidine-1-carboxamide (<b>23</b>)</h3><div class="NLM_p last">Previously described in ref <a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>N</i>-(4-Fluoro-3-(7-morpholino-[1,2,4]triazolo[1,5-<i>b</i>]pyridazin-2-yl)phenyl)pyrrolidine-1-carboxamide (<b>24</b>)</h3><div class="NLM_p last">To a mixture of <b>80</b> (0.2 g, 0.80 mmol) in DCM (5 mL) was added thionyl chloride (0.174 mL, 2.379 mmol) and stirred at 50 °C for 1 h. The solvent was evaporated, further DCM was added, and evaporated (2 × 10 mL) to give crude <b>81,</b> which was used without purification. To <b>79</b> and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA) (0.174 mL, 0.994 mmol) in MeCN (3 mL) was added crude <b>81</b> (0.13 g, 0.66 mmol), and the mixture stirred at 80 °C for 24 h. After cooling, the mixture was filtered to remove the solid, and the filtrate concentrated and purified by flash chromatography (0–40% EtOH/EtOAc(1:3)/cyclohexane) to give <b>24</b> (0.035 g, 0.17 mmol, 13%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.83–8.71 (m, 1H), 8.42–8.30 (m, 2H), 7.79–7.62 (m, 1H), 7.46–7.35 (m, 1H), 7.30–7.16 (m, 1H), 3.86–3.72 (m, 4H), 3.48–3.30 (m, 8H), 1.93–1.80 (m, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 159.0 (d, <i>J</i><sub>CF</sub> = 5.3 Hz), 156.4, 154.5, 146.7, 145.7, 137.7, 137.6 (d, <i>J</i><sub>CF</sub> = 2.7 Hz), 123.0 (d, <i>J</i><sub>CF</sub> = 7.7 Hz), 121.4, 118.5 (d, <i>J</i><sub>CF</sub> = 12.0 Hz), 116.7 (d, <i>J</i><sub>CF</sub> = 22.5 Hz), 110.9, 66.0, 47.4, 46.1, 25.5; <i>m</i>/<i>z</i> 412.1 [M + H]<sup>+</sup>. <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>23</sub>N<sub>7</sub>O<sub>2</sub>F, 412.1897; found, 412.1901.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>N</i>-(4-Fluoro-3-(6-morpholino-[1,2,4]triazolo[1,5-<i>a</i>]pyrimidin-2-yl)phenyl)pyrrolidine-1-carboxamide (<b>25</b>)</h3><div class="NLM_p last">A mixture of <b>85</b> (9 g, 29.2 mmol) and morpholine (115 mL, 1314 mmol) was stirred at 100 °C for 1 h. The mixture was concentrated to dryness and the crude solid washed with MeOH (2 × 50 mL), collected, and dried to give crude 4-fluoro-3-(6-morpholino-[1,2,4]triazolo[1,5-<i>a</i>]pyrimidin-2-yl)aniline (<b>86</b>, 6.4 g, 20.4 mmol, 70% crude yield), which was used without further purification. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.98 (d, <i>J</i> = 3.0 Hz, 1H), 8.90 (d, <i>J</i> = 2.8 Hz, 1H), 7.37 (dd, <i>J</i> = 6.2 and 2.9 Hz, 1H), 7.02 (dd, <i>J</i> = 10.9 and 8.8 Hz, 1H), 6.68 (dt, <i>J</i> = 8.5 and 3.6 Hz, 1H), 5.18 (s, 2H), 3.84–3.73 (m, 4H), 3.27–3.15 (m, 4H). To crude <b>86</b> (1.5 g, 4.77 mmol) and DMAP (0.029 g, 0.239 mmol) in pyridine (40 mL) was added pyrrolidine-1-carbonyl chloride (0.790 mL, 7.16 mmol), and the solution was stirred at 50 °C overnight. The resulting suspension was concentrated to dryness, and the crude residue was purified by flash chromatography (0–100% EtOH/EtOAc (1:3)/cyclohexane). The fractions containing the product were evaporated, EtOAc (100 mL) was added, and washed with water (250 mL)/HCl (2 M, 20 mL). The phases were separated and the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give <b>25</b> (0.57 g, 1.4 mmol, 29%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.01 (d, <i>J</i> = 2.8 Hz, 1H), 8.92 (d, <i>J</i> = 2.8 Hz, 1H), 8.43–8.31 (m, 2H), 7.77–7.67 (m, 1H), 7.29–7.20 (m, 1H), 3.87–3.74 (m, 4H), 3.44–3.35 (m, 4H), 3.26–3.18 (m, 4H), 1.91–1.82 (m, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 161.1 (d, <i>J</i><sub>CF</sub> = 5.3 Hz), 156.3, 154.4, 154.3, 151.4, 150.8, 138.6, (d, <i>J</i><sub>CF</sub> = 2.8 Hz), 123.0 (d, <i>J</i><sub>CF</sub> = 18.7 Hz), 121.3 (d, <i>J</i><sub>CF</sub> = 4.8 Hz), 118.4 (d, <i>J</i><sub>CF</sub> = 12.0 Hz), 116.7 (d, <i>J</i><sub>CF</sub> = 22.4 Hz), 66.2, 49.5, 46.2, 25.5; <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>23</sub>N<sub>7</sub>O<sub>3</sub>F, 412.1897; found, 412.1903.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>N</i>-(4-Fluoro-3-(5-morpholinopyrazolo[1,5-b]pyridazin-2-yl)phenyl)pyrrolidine-1-carboxamide (<b>26</b>)</h3><div class="NLM_p last"><b>74</b> (0.035 g, 0.08 mmol) in HBr (2 mL, 48% aqueous) was heated in a microwave (120 °C, 1 h). The solvent was evaporated, water was added, and the solution was neutralized by the addition of sat. NaHCO<sub>3</sub>. The resulting solid was collected, washed with water, and dried to give crude <b>75</b> which was used directly in the next step (0.028 g, 0.08 mmol, 97%, <i>m</i>/<i>z</i> [M + H]<sup>+</sup> 344.1). To crude <b>75</b> in EtOH (4 mL) was added iron (0.0325 g, 0.58 mmol) and ammonium chloride (0.0156 g, 0.29 mmol, in water (1 mL)) and stirred at 80 °C for 4 h. RM was filtered through celite, the solvent was evaporated and partitioned between water/EtOAc, and the organics was evaporated to dryness. This crude material was taken up in DCM (4 mL)/Pyridine (1 mL), and DMAP (0.001 g, 0.007 mmol) and pyrrolidine-1-carbonyl chloride (0.0146 g, 0.11 mmol) added. After stirring overnight at 50 °C, further pyrrolidine-1-carbonyl chloride (0.0146 g, 0.11 mmol) was added and stirred for a further night at 50 °C. After cooling, further DCM (10 ml) was added and washed with water, 1 M HCl, brine and the solvent evaporated. Crude material was purified by prep. HPLC to give <b>26</b> (0.008 g, 0.018 mmol, 24% over three steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.56 (d, <i>J</i> = 3.0 Hz, 1H), 8.31 (s, 1H), 8.24 (dd, <i>J</i> = 2.9, 6.8 Hz, 1H), 7.66 (ddd, <i>J</i> = 2.8, 4.4, 9.0 Hz, 1H), 7.33 (d, <i>J</i> = 3.1 Hz, 1H), 7.23–7.17 (m, 1H), 6.76 (d, <i>J</i> = 4.0 Hz, 1H), 3.84–3.77 (m, 4H), 3.41–3.36 (m, 4H), 3.27 (t, <i>J</i> = 4.8 Hz, 4H), 1.89–1.84 (m, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 156.7, 154.4, 154.3, 146.0, 141.0, 137.9, 137.7, 136.1, 121.3 (d, <i>J</i><sub>CF</sub> = 7.7 Hz), 120.2 (d, <i>J</i><sub>CF</sub> = 12.3 Hz), 119.5, 116.3 (d, <i>J</i><sub>CF</sub> = 22.9 Hz), 104.8, 95.0 (d, <i>J</i><sub>CF</sub> = 11.2 Hz), 66.1, 48.1, 46.2, 25.5; <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>24</sub>N<sub>6</sub>O<sub>2</sub>F, 411.1945; found, 411.1955.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>N</i>-(3-(7-Phenylimidazo[1,2-<i>b</i>][1,2,4]triazin-3-yl)phenyl)pyrrolidine-1-carboxamide (<b>27</b>)</h3><div class="NLM_p last">A mixture of <b>59</b> (0.030 g, 0.074 mmol), 4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (0.030 g, 0.15 mmol), sodium carbonate (0.023 g, 0.22 mmol), and tetrakis(triphenylphosphine)palladium(0) (0.0011 g, 0.0015 mmol) in DMF (1.5 mL)/water (0.5000 mL) was heated to 80 °C in a sealed tube overnight. After cooling, water (10 mL) and EtOAc (10 mL) were added, the layers were separated, and the organic layer was evaporated. The crude product was purified by prep. HPLC to yield <b>27</b> (0.012 g, 0.028 mmol, 38%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.16 (s, 1H), 8.61 (s, 1H), 8.49 (s, 1H), 8.35–8.31 (m, 1H), 8.20 (d, <i>J</i> = 7.5 Hz, 2H), 7.89–7.84 (m, 1H), 7.61–7.55 (m, 2H), 7.48–7.43 (m, 1H), 7.37–7.32 (m, 1H), 3.42–3.38 (m, 4H), 1.91–1.84 (m, 4H); <i>m</i>/<i>z</i> 403.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>N</i>-(4-Fluoro-3-(3-phenylimidazo[1,2-<i>a</i>]pyrimidin-7-yl)phenyl)pyrrolidine-1-carboxamide (<b>28</b>)</h3><div class="NLM_p last">As described in ref <a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a>.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>N</i>-(4-Fluoro-3-(3-(pyridin-2-yl)imidazo[1,2-<i>a</i>]pyrimidin-7-yl)phenyl)pyrrolidine-1-carboxamide (<b>29</b>)</h3><div class="NLM_p last">A mixture of <b>89</b> (0.19 g, 0.47 mmol), 2-pyridineboronic acid (0.195 g, 0.94 mmol), Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub> (0.077 g, 0.094 mmol), and potassium carbonate (0.195 g, 1.41 mmol) in 1,4-dioxane (30 mL)/water (2 mL) was stirred under nitrogen at 100 °C for 10 h. The mixture was cooled to RT, evaporated, diluted with water (20 mL), and extracted with EtOAc (5 × 30 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the solvent was evaporated. The crude material was purified by flash chromatography (1–5% MeOH/DCM) to give <b>29</b> as a yellow solid (0.02 g, 0.048 mmol, 10%). <sup>1</sup>H NMR (MeOD): δ 10.42 (d, <i>J</i> = 7.5 Hz, 1H), 8.91 (br s, 1H), 8.70 (d, <i>J</i> = 4.6 Hz, 1H), 8.32–8.27 (m, 1H), 7.89–7.76 (m, 3H), 7.43–7.38 (m, 1H), 7.33 (dd, <i>J</i> = 5.4, 6.7 Hz, 1H), 7.11 (dd, <i>J</i> = 11.2, 9.3 Hz, 1H), 3.30–3.26 (m, 4H), 1.94–1.89 (m, 4H). <i>m</i>/<i>z</i> 403.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>N</i>-(4-Fluoro-3-(3-isopropylimidazo[1,2-<i>a</i>]pyrimidin-7-yl)phenyl)pyrrolidine-1-carboxamide (<b>30</b>)</h3><div class="NLM_p last">A mixture of <b>87</b> (0.15 g, 0.5 mmol) and 2-bromo-3-methylbutanal (0.123 g, 0.75 mmol) in EtOH (2 mL) was heated to reflux for 4 h. The reaction mixture was cooled to RT, and the solvent was evaporated. The crude material was purified by prep. HPLC to obtain <b>30</b>, which was then diluted in DCM (5 mL) and treated dropwise with 2 N HCl in Et<sub>2</sub>O (0.191 mL, 0.381 mmol). The resulting solution was stirred at RT for 2 h, the solvent was evaporated, and the resulting solid was dried at 50 °C to give <b>30·HCl</b> (0.12 g, 0.297 mmol, 59%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.39 (d, <i>J</i> = 7.2 Hz, 1H), 8.51 (s, 1H), 8.42 (dd, <i>J</i> = 6.8 and 2.8 Hz, 1H), 8.19 (s, 1H), 7.97 (dd, <i>J</i> = 7.2 and 1.6 Hz, 1H), 7.75 (ddd, <i>J</i> = 8.8, 7.2 and 2.8 Hz, 1H), 7.37 (dd, <i>J</i> = 11.2 and 8.8 Hz, 1H), 3.51–3.41 (m, 1H), 3.39 (t, <i>J</i> = 6.8 Hz, 4H), 1.87 (t, <i>J</i> = 6.8 Hz, 4H), 1.37 (d, <i>J</i> = 7.2 Hz, 6H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 158.8, 155.2, 154.3, 144.0, 138.4, 136.5, 131.9, 125.3 (<i>J</i><sub>CF</sub> = 7.3 Hz), 123.3 (<i>J</i><sub>CF</sub> = 10.9 Hz), 121.2, 117.2 (<i>J</i><sub>CF</sub> = 24.4 Hz), 113.4 (<i>J</i><sub>CF</sub> = 7.8 Hz), 101.4, 46.2, 25.9, 23.4, 21.0; <i>m</i>/<i>z</i> 368.1 [M + H]<sup>+</sup>. HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>23</sub>FN<sub>5</sub>O, 368.1887; found, 368.1899.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>N</i>-(4-Fluoro-3-(3-isobutylimidazo[1,2-<i>a</i>]pyrimidin-7-yl)phenyl)pyrrolidine-1-carboxamide (<b>31</b>)</h3><div class="NLM_p last">A mixture of <b>87</b> (0.15 g, 0.5 mmol) and 2-bromo-4-methylpentanal (0.18 g, 1 mmol) in EtOH was heated to reflux for 24 h. The reaction mixture was cooled to RT and partitioned between 10% aq NaHCO<sub>3</sub> and EtOAc. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and the solvent evaporated. The crude material was purified by prep. HPLC to afford <b>31</b> (0.047 g, 0.123 mmol, 25%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.36 (d, <i>J</i> = 7.2 Hz, 1H), 8.48 (s, 1H), 8.42 (dd, <i>J</i> = 6.8 and 2.4 Hz, 1H), 8.15 (s, 1H), 7.93 (d, <i>J</i> = 6.4 Hz, 1H), 7.73 (ddd, <i>J</i> = 8.8, 7.6 and 2.8 Hz, 1H), 7.37 (dd, <i>J</i> = 11.2 and 9.2 Hz, 1H), 3.38 (t, <i>J</i> = 6.8 Hz, 4H), 2.88 (d, <i>J</i> = 6.8 Hz, 2H), 2.11–2.01 (m, 1H), 1.87 (t, <i>J</i> = 6.4 Hz, 4H), 0.99 (d, <i>J</i> = 6.8 Hz, 6H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 158.4 (d, <i>J</i><sub>CF</sub> = 33.6 Hz), 157.0, 155.0, 154.3, 138.4, 136.1, 125.1, 125.0, 123.6, 121.2, 117.2 (d, <i>J</i><sub>CF</sub> = 24.4 Hz), 115.7, 113.1, 46.2, 31.5, 26.9, 25.5, 22.5; HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>25</sub>FN<sub>5</sub>O<sub>2</sub>, 382.2038; found, 382.2040.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>N</i>-(4-Fluoro-3-(3-(morpholinomethyl)imidazo[1,2-<i>a</i>]pyrimidin-7-yl)phenyl)pyrrolidine-1-carboxamide (<b>32</b>)</h3><div class="NLM_p last">A mixture of <b>90</b> (0.774 g, 3 mmol), paraformaldehyde (0.087 g, 3 mmol), and morpholine (0.261 g, 3 mmol) in glacial acetic acid (10 mL) was stirred at 50 °C overnight. After cooling, the RM was basified with 2 N NaOH to pH approx. 8 and extracted with DCM (3 × 30 mL). The combined organics were washed with brine (2 × 50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the solvent was evaporated to give crude <b>91</b>. This was taken up in EtOH (15 mL) to which iron (0.753 g, 13.4 mmol), and ammonium chloride (0.758 g, 6.7 mmol, in 4 mL water) were added, and the RM was heated to 80 °C for 1 h, cooled to RT, filtered through celite, and the solvent was evaporated. Water was added and extracted with EtOAc (3 × 50 mL), and the combined organics were dried over anh. Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give a crude residue. This was taken up in pyridine (2 mL)/DCM (10 mL), DMAP (0.0056 g, 0.046 mmol), and pyrrolidine-1-carbonyl chloride (0.122 g, 0.92 mmol), and the RM was heated at 50 °C overnight. The solvent was evaporated and the crude material was purified by prep. HPLC to give <b>32</b> (0.083 g, 0.196 mmol, 7% over three steps). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.80 (d, <i>J</i> = 7.2 Hz, 1H), 8.15–7.74 (m, 3H), 7.59 (d, <i>J</i> = 6.8 Hz, 1H), 7.12 (dd, <i>J</i> = 10.8 and 9.2 Hz, 1H), 6.71 (broad s, 1H), 3.88 (br s, 2H), 3.74–3.67 (m, 4H), 3.53–3.46 (m, 4H), 2.55–2.44 (m, 4H), 2.05–1.92 (m, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 154.8, 154.4, 152.5, 148.8, 138.1, 135.8, 134.4, 125.2 (d, <i>J</i> = 11.7 Hz), 123.3 (d, <i>J</i> = 8.0 Hz), 121.3, 119.7, 116.7 (d, <i>J</i> = 23.8 Hz), 109.0 (d, <i>J</i> = 10.9 Hz), 66.6, 53.3, 51.6, 46.2, 25.5. HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>26</sub>FN<sub>6</sub>O<sub>2</sub>, 425.2096; found, 425.2104.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> <i>N</i>-(4-Fluoro-3-(3-(4-methylmorpholin-3-yl)imidazo[1,2-<i>a</i>]pyrimidin-7-yl)phenyl)pyrrolidine-1-carboxamide (<b>33</b>)</h3><div class="NLM_p last">To a solution of <b>95</b> (0.08 g, 0.16 mmol) in DCM (1 mL), trifluoroacetic acid (0.5 mL, 6.53 mmol) was added, and the resulting mixture stirred for 1 h and evaporated to dryness. To the crude compound was added acetic acid (0.6 mL, 10.5 mmol) and paraformaldehyde (0.045 g, 1.5 mmol) in tetrahydrofuran (THF) (3 mL), and the mixture stirred at RT for 4 h. Sodium triacetoxyborohydride (0.127 g, 0.6 mmol) was added, and the RM was stirred at RT for 24 h, evaporated to dryness, and purified by prep. HPLC to afford <b>33</b> (0.018 g, 0.042 mmol, 28%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.29 (d, <i>J</i> = 7.3 Hz, 1H), 8.43 (s, 1H), 8.24–8.22 (m, 1H), 7.80–7.77 (m, 2H), 7.47 (d, <i>J</i> = 7.3 and 2.2 Hz, 1H), 7.27 (dd, <i>J</i> = 11.4 and 8.9 Hz, 1H), 3.88–3.85 (m, 1H), 3.77–3.69 (m, 4H), 3.41–3.37 (m, 4H), 2.91–2.88 (d, <i>J</i> = 11.7 Hz, 1H), 2.35–2.33 (m, 1H), 2.02 (s, 3H), 1.89–1.85 (m, 4H); <i>m</i>/<i>z</i> 425.19 [M + H]<sup>+</sup>. HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>26</sub>FN<sub>6</sub>O<sub>2</sub>, 425.2101; found, 425.2088.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>N</i>-(4-Fluoro-3-(3-(piperidin-1-yl)imidazo[1,2-<i>a</i>]pyrimidin-7-yl)phenyl)pyrrolidine-1-carboxamide (<b>34</b>)</h3><div class="NLM_p last"><b>34</b> was synthesized by an analogous method to <b>1</b>, from <b>87</b> (0.2 g, 0.66 mmol), <b>96b</b> (0.567 g, 1.32 mmol), and zinc bromide (0.148 g, 0.66 mmol) with purification by prep. HPLC to yield <b>34</b> (0.021 g, 0.061 mmol, 9%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.64 (d, <i>J</i> = 7.2 Hz, 1H), 8.43 (s, 1H), 8.23–8.20 (m, 1H), 7.80–7.76 (m, 1H), 7.45 (s, 1H), 7.41 (d, <i>J</i> = 6.9 Hz, 1H), 7.26 (dd, <i>J</i> = 9.5 and 10.7 Hz, 1H), 3.41–3.37 (m, 4H), 3.01–2.98 (m, 4H), 1.88–1.84 (m, 4H), 1.76–1.71 (m, 4H), 1.62–1.58 (m, 2H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 156.7, 154.8, 154.4, 151.1 (d, <i>J</i><sub>CF</sub> = 2.7 Hz), 144.3, 138.0, 135.0, 131.7, 125.2 (d, <i>J</i><sub>CF</sub> = 11.6 Hz), 123.11, 121.1, 116.7 (d, <i>J</i><sub>CF</sub> = 23.8 Hz), 108.8 (d, <i>J</i><sub>CF</sub> = 11.4 Hz), 52.6, 46.2, 25.9, 25.5, 24.1; HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>26</sub>FN<sub>6</sub>O, 409.2147; found, 409.2154.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>N</i>-(4-Fluoro-3-(3-(piperazin-1-yl)imidazo[1,2-<i>a</i>]pyrimidin-7-yl)phenyl)pyrrolidine-1-carboxamide (<b>35</b>)</h3><div class="NLM_p last"><b>35</b> was synthesized by an analogous method to <b>1</b>, from <b>87</b> (0.3 g, 1 mmol), <b>96c</b> (0.693 g, 1.1 mmol), and zinc bromide (0.045 g, 0.19 mmol) to give crude <b>Boc</b>-<b>35</b>. This was treated with TFA (3 mL)/DCM (6 mL), the solvent was evaporated, and crude material was purified by prep. HPLC to give <b>35</b> as the TFA salt (0.092 g, 0.23 mmol, 23% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.06–8.98 (m, 3H), 8.45 (s, 1H), 8.34–8.31 (m, 1H), 7.91 (s, 1H), 7.78–7.74 (m, 1H), 7.73–7.70 (m, 1H), 7.35–7.30 (m, 1H), 3.42–3.34 (m, 8H), 3.30–3.27 (m, 4H), 1.89–1.85 (m, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 158.7, 158.4, 156.9, 154.9, 154.3, 138.2 (d, <i>J</i><sub>CF</sub> = 2.3 Hz), 133.6, 133.2, 124.3, 121.2, 117.0 (d, <i>J</i><sub>CF</sub> = 23.8 Hz), 48.4, 46.2, 43.4, 25.5; <i>m</i>/<i>z</i> 409.9 [M + H]<sup>+</sup>. <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>25</sub>N<sub>7</sub>OF, 410.2105; found, 410.2119.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>N</i>-(3-(3-(4-Acetylpiperazin-1-yl)imidazo[1,2-<i>a</i>]pyrimidin-7-yl)-4-fluorophenyl)pyrrolidine-1-carboxamide (<b>36</b>)</h3><div class="NLM_p last">To a mixture of <i>N</i>-(3-(2-aminopyrimidin-4-yl)-4-fluorophenyl)pyrrolidine-1-carboxamide (<b>87</b>, 0.5 g, 1.66 mmol) in 1,2-DCE (11 mL) were added <b>96d</b> (1.29 g, 2.49 mmol) and zinc bromide (0.187 g, 0.83 mmol) and stirred at 80 °C overnight. The solvent was evaporated and the residue was purified by column chromatography (0–10% MeOH/DCM), followed by prep. HPLC. The resulting solid was triturated with MeOH (5 mL) and dried to yield <b>36</b> (0.039 g, 0.08 mmol, 5%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.78 (d, <i>J</i> = 7.2 Hz, 1H), 8.41 (s, 1H), 8.22 (dd, <i>J</i> = 2.8 and 7.1 Hz, 1H), 7.80–7.75 (m, 1H), 7.53 (s, 1H), 7.47–7.43 (m, 1H), 7.29–7.23 (m, 1H), 3.70–3.65 (m, 4H), 3.41–3.36 (m, 4H), 3.08–2.97 (m, 4H), 2.09 (s, 3H), 1.89–1.85 (m, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 168.9, 157.0, 154.6, 154.4, 151.7, 144.5, 138.1, 113.7, 131.9, 125.2 (d, <i>J</i><sub>CF</sub> = 11.8 Hz), 123.8, 123.2 (d, <i>J</i><sub>CF</sub> = 8.3 Hz), 121.2, 116.7 (d, <i>J</i><sub>CF</sub> = 23.8 Hz), 109.0 (d, <i>J</i><sub>CF</sub> = 11.1 Hz), 51.7, 51.4, 46.2, 25.5, 21.7; <i>m</i>/<i>z</i> 452.1 [M + H]<sup>+</sup>. <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>5</sub>O<sub>3</sub>F, 452.2210; found, 452.2229.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>N</i>-(4-Fluoro-3-(3-(3-oxopiperazin-1-yl)imidazo[1,2-<i>a</i>]pyrimidin-7-yl)phenyl)pyrrolidine-1-carboxamide (<b>37</b>)</h3><div class="NLM_p last"><b>37</b> was synthesized by an analogous method to <b>1</b>, from <b>87</b> (0.5 g, 1.66 mmol), <b>96e</b> (1.15 g, 2.49 mmol), and zinc bromide (0.187 g, 0.83 mmol) with purification by flash chromatography (0–10% MeOH/DCM), followed by trituration with MeOH to give <b>37</b> (0.06 g, 0.14 mmol, 8%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.76 (d, <i>J</i> = Hz, 1H), 7.2 Hz, 8.41 (s, 1H), 8.21 (dd, <i>J</i> = 7.2 and 2.8 Hz, 1H), 8.03 (s, 1H), 7.81–7.76 (m, 1H), 7.55 (s, 1H), 7.42 (dd, <i>J</i> = 2.1 and 7.1 Hz, 1H), 7.25 (dd, <i>J</i> = 9.0 and 11.3 Hz, 1H), 3.69 (s, 2H), 3.42–3.36 (m, 6H), 3.24–3.20 (m, 2H), 1.89–1.84 (m, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 167.3, 156.8, 154.8, 154.4, 151.7, 144.7, 138.1 (d, <i>J</i><sub>CF</sub> = 2.1 Hz), 132.3, 132.1, 125.1 (d, <i>J</i><sub>CF</sub> = 11.6 Hz), 124.4, 123.3 (d, <i>J</i><sub>CF</sub> = 8.1 Hz), 121.2, 116.6 (d, <i>J</i><sub>CF</sub> = 23.9 Hz), 109.0 (d, <i>J</i><sub>CF</sub> = 11.1 Hz), 54.7, 48.2, 46.2, 40.8, 25.5; <i>m</i>/<i>z</i> 424.0 [M + H]<sup>+</sup>. <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>7</sub>O<sub>2</sub>F, 424.1897; found, 424.1902.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>N</i>-(4-Fluoro-3-(3-(2-methylmorpholino)imidazo[1,2-<i>a</i>]pyrimidin-7-yl)phenyl)pyrrolidine-1-carboxamide (<b>38</b>)</h3><div class="NLM_p last">A mixture of <b>87</b> (0.15 g, 0.5 mmol), <b>96f</b> (0.345 g, 0.75 mmol), and zinc bromide (0.056 g, 0.25 mmol) 1,2-DCE (5 mL) was heated to reflux for 6 h. The reaction was cooled to RT, solvent was evaporated, and the residue was purified by prep. HPLC to give <b>38</b> (0.036 g, 0.13 mmol, 17%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.76 (d, <i>J</i> = 7.2 Hz, 1H), 8.43 (s, 1H), 8.23–8.19 (m, 1H), 7.80–7.75 (m, 1H), 7.50 (s, 1H), 7.42 (d, <i>J</i> = 6.8 Hz, 1H), 7.28 (dd, <i>J</i> = 9.5 and 10.7 Hz, 1H), 3.93–3.89 (m, 1H), 3.83–3.76 (m, 2H), 3.41–3.37 (m, 4H), 3.20 (d, <i>J</i> = 11.3 Hz, 1H), 3.13 (d, <i>J</i> = 11.4 Hz, 1H), 2.91–2.84 (m, 1H), 2.59 (dd, <i>J</i> = 10.5 and 10.9 Hz, 1H), 1.88–1.85 (m, 4H), 1.14 (d, <i>J</i> = 6.2 Hz, 3H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 156.7, 154.7, 154.4, 151.5, 144.5, 138.0, 133.8, 131.9, 125.2 (d, <i>J</i><sub>CF</sub> = 11.6 Hz), 123.4, 121.2, 116.7 (d, <i>J</i><sub>CF</sub> = 24.0 Hz), 108.9 (d, <i>J</i><sub>CF</sub> = 11.5 Hz), 71.7, 66.3, 57.5, 51.0, 46.2, 25.5, 19.1; HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>26</sub>FN<sub>6</sub>O<sub>2</sub>, 425.2096; found, 425.2100.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (<i>R</i>)-<i>N</i>-(4-Fluoro-3-(3-(3-methylmorpholino)imidazo[1,2-<i>a</i>]pyrimidin-7-yl)phenyl)pyrrolidine-1-carboxamide (<b>39</b>)</h3><div class="NLM_p last">A mixture of <b>100a</b> (0.343 g, 0.743 mmol) and 10% activated palladium on carbon (0.040 g, 0.037 mmol) was cooled to −78 °C and MeOH (7.43 mL) was added. The flask was purged with N<sub>2</sub> and H<sub>2</sub>, and the resulting mixture stirred at RT under a H<sub>2</sub> atmosphere overnight. The RM was filtered through a celite pad, washed with DCM (5 × 20 mL), and the eluent was concentrated to dryness and dried under high vacuum to afford (<i>R</i>)-4-fluoro-3-(3-(3-methylmorpholino)imidazo[1,2-<i>a</i>]pyrimidin-7-yl)aniline which was used without purification. The crude material was taken up in DCM (10 mL) to which CDI (0.213 g, 1.314 mmol) and DIPEA (0.229 mL, 1.314 mmol) were added and stirred overnight. Pyrrolidine (0.110 mL, 1.314 mmol) was added dropwise and the RM was stirred at RT for 4.5 h. Further pyrrolidine (0.02 mL) was added and the reaction was stirred at RT for a further 30 min, then poured into 2 M NaOH (50 mL), and extracted with DCM (5 × 20 mL). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated, and the crude material was purified by flash chromatography (0–50% EtOAc/EtOH (3:1)/cyclohexane). Fractions containing the product were further purified by flash chromatography (0–50% EtOAc/EtOH (3:1)/cyclohexane) to give <b>39</b> (0.127 g, 0.34 mmol, 46%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.79 (d, <i>J</i> = 7.2 Hz, 1H), 8.41 (s, 1H), 8.21 (dd, <i>J</i> = 7.1, 2.8 Hz, 1H), 7.77 (ddd, <i>J</i> = 9.0, 4.4, 2.8 Hz, 1H), 7.68 (s, 1H), 7.44 (dd, <i>J</i> = 7.2, 2.1 Hz, 1H), 7.25 (dd, <i>J</i> = 11.4, 9.0 Hz, 1H), 3.91–3.80 (m, 2H), 3.72 (ddd, <i>J</i> = 11.3, 9.5, 2.9 Hz, 1H), 3.45–3.33 (m, 5H), 3.21 (dqd, <i>J</i> = 9.1, 6.2, 2.8 Hz, 1H), 3.04 (dddd, <i>J</i> = 21.5, 12.0, 9.2, 3.0 Hz, 2H), 1.92–1.80 (m, 4H), 0.78 (d, <i>J</i> = 6.3 Hz, 3H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 156.7, 154.8, 154.4, 152.0, 144.7, 138.0, 131.9 (d, <i>J</i><sub>CF</sub> 9.1 Hz), 127.5, 125.2 (d, <i>J</i><sub>CF</sub> 11.8 Hz), 123.2 (d, <i>J</i><sub>CF</sub> 8.1 Hz), 121.2, 116.7 (d, <i>J</i><sub>CF</sub> 23.9 Hz), 109.1 (d, <i>J</i><sub>CF</sub> 11.1 Hz), 72.6, 67.3, 55.5, 52.4, 46.2, 25.5, 14.6; HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>26</sub>FN<sub>6</sub>O<sub>2</sub>, 425.2096; found, 425.2093.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (<i>S</i>)-<i>N</i>-(4-Fluoro-3-(3-(3-methylmorpholino)imidazo[1,2-<i>a</i>]pyrimidin-7-yl)phenyl)pyrrolidine-1-carboxamide (<b>40</b>)</h3><div class="NLM_p last"><b>40</b> was prepared by an analogous method to <b>39</b>, from <b>100b</b> (0.37 g, 0.802 mmol) using 10% activated palladium on carbon (0.0427 g, 0.04 mmol), then CDI (0.155 g, 0.953 mmol), DIPEA (0.166 mL, 0.953 mmol), and pyrrolidine (0.080 mL, 0.953 mmol), purifying by prep. HPLC to yield <b>42</b> (0.12 g, 0.28 mmol, 35% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.80 (d, <i>J</i> = 7.2 Hz, 1H), 8.43 (s, 1H), 8.24–8.20 (m, 1H), 7.80–7.76 (m, 1H), 7.69 (s, 1H), 7.44 (d, <i>J</i> = 6.7 Hz, 1H), 7.26 (dd, <i>J</i> = 9.5 and 10.8 Hz, 1H), 3.90–3.83 (m, 2H), 3.75–3.69 (m, 1H), 3.42–3.35 (m, 5H), 3.24–3.19 (m, 1H), 3.11–2.98 (m, 2H), 1.90–1.83 (m, 4H), 0.79 (d, <i>J</i> = 6.2 Hz, 3H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 156.7, 154.8, 154.4, 152.0, 144.7, 138.0, 131.9 (d, <i>J</i><sub>CF</sub> 9.5 Hz), 127.5, 125.2 (d, <i>J</i><sub>CF</sub> 11.9 Hz), 123.3 (d, <i>J</i><sub>CF</sub> 8.0 Hz), 121.2, 116.7 (d, <i>J</i><sub>CF</sub> 23.9 Hz), 109.1 (d, <i>J</i><sub>CF</sub> 11.2 Hz), 72.6, 67.2, 55.5, 52.4, 46.2, 25.5, 14.5; HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>26</sub>FN<sub>6</sub>O<sub>2</sub>, 425.2101; found, 425.2113.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> <i>N</i>-(3-(3-((2<i>S</i>,6<i>R</i>)-2,6-Dimethylmorpholino)imidazo[1,2-<i>a</i>]pyrimidin-7-yl)-4-fluorophenyl)pyrrolidine-1-carboxamide (<b>41</b>)</h3><div class="NLM_p last">To a mixture of <b>87</b> (3.5 g, 11.62 mmol) in 1,2-DCE (77 mL), <b>96g</b> (8.55 g, 17.42 mmol) and zinc bromide (1.308 g, 5.81 mmol) were added and then stirred at 80 °C under a N<sub>2</sub> atmosphere for 2 h, cooled to RT, and stirred overnight. The solvent was evaporated, and the residue purified by flash chromatography (0–10% MeOH/DCM). The resulting solid was triturated with MeOH (20 mL), and the solids were collected by filtration to give <b>41</b> (1.0 g, 2.28 mmol, 20%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.16 (d, <i>J</i> = 7.2 Hz, 1H), 8.49 (s, 1H), 8.39 (dd, <i>J</i> = 7.1, 2.8 Hz, 1H), 8.01 (s, 1H), 7.87 (dd, <i>J</i> = 7.3, 1.7 Hz, 1H), 7.74 (ddd, <i>J</i> = 9.0, 4.4, 2.8 Hz, 1H), 7.35 (dd, <i>J</i> = 11.3, 9.0 Hz, 1H), 3.93–3.80 (m, 2H), 3.43–3.32 (m, 4H), 3.22 (d, <i>J</i> = 2.1 Hz, 2H), 2.55 (dd, <i>J</i> = 11.8, 10.2 Hz, 2H), 1.91–1.80 (m, 4H), 1.14 (d, <i>J</i> = 6.3 Hz, 6H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 157.0, 155.1, 154.3, 141.3, 138.4, 134.9, 134.4, 125.2, 123.5 (d, <i>J</i><sub>CF</sub> = 11.1 Hz), 121.2, 117.2 (d, <i>J</i><sub>CF</sub> = 24.0 Hz), 113.2, 71.3, 56.5, 46.2, 25.5, 19.1; HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>28</sub>FN<sub>6</sub>O<sub>2</sub>, 429.2252; found, 439.2227.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> <i>N</i>-(3-(3-(2,2-Dimethylmorpholino)imidazo[1,2-<i>a</i>]pyrimidin-7-yl)-4-fluorophenyl)pyrrolidine-1-carboxamide (<b>42</b>)</h3><div class="NLM_p last">A mixture of <b>87</b> (0.2 g, 0.66 mmol), <b>96h</b> (0.486 g, 0.99 mmol), and zinc bromide (0.223 g, 0.99 mmol) in MeCN (4 mL) was stirred at 40 °C for 18 h. The solvent was evaporated, and the crude product purified by prep. HPLC to give <b>42</b> (0.134 g, 46% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.98 (d, <i>J</i> = 7.0 Hz, 1H), 8.48 (s, 1H), 8.38–8.35 (m, 1H), 7.90 (s, 1H), 7.80 (d, <i>J</i> = 7.8 Hz, 1H), 7.77–7.73 (m, 1H), 7.35 (dd, <i>J</i> = 7.4 and 10.6 Hz, 1H), 3.89–3.85 (m, 4H), 3.42–3.37 (m, 4H), 3.00–2.97 (m, 2H), 2.91–2.88 (m, 2H), 1.89–1.85 (m, 4H), 1.33 (s, 6H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 157.3, 154.9, 154.3, 141.6, 138.4, 134.8, 134.4, 125.1 (d, <i>J</i><sub>CF</sub> = 8.4 Hz), 123.5 (d, <i>J</i><sub>CF</sub> = 11.1 Hz), 121.2, 117.1 (d, <i>J</i><sub>CF</sub> = 23.7 Hz), 114.0, 113.1 (d, <i>J</i><sub>CF</sub> = 11.6 Hz), 71.2, 60.5, 60.4, 51.7, 46.2, 25.5, 24.9; HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>28</sub>FN<sub>6</sub>O<sub>2</sub>, 439.2258; found, 439.2252.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> <i>N</i>-(3-(3-(3,3-Dimethylmorpholino)imidazo[1,2-<i>a</i>]pyrimidin-7-yl)-4-fluorophenyl)pyrrolidine-1-carboxamide (<b>43</b>)</h3><div class="NLM_p last">A mixture of <b>87</b> (0.676 g, 2.243 mmol), <b>96i</b> (1.642 g, 3.347 mmol), and zinc bromide (0.777 g, 3.45 mmol) in MeCN (12 mL) was stirred at 60 °C for 4 h and evaporated to dryness. The crude material was purified by flash chromatography (2% MeOH/DCM) and then by prep. HPLC to obtain <b>43</b> (0.11 g, 0.25 mmol, 12%). <sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 9.26 (d, <i>J</i> = 7.2 Hz, 1H), 8.46 (dd, <i>J</i> = 6.8 and 2.8 Hz, 1H), 8.15 (s, 1H), 8.10 (d, <i>J</i> = 6.8 Hz, 1H), 7.63 (ddd, <i>J</i> = 8.8, 7.2 and 2.8 Hz, 1H), 7.29 (dd, <i>J</i> = 11.2 and 9.2 Hz, 1H), 4.01–3.78 (m, 2H), 3.65 (s, 2H), 3.49 (t, <i>J</i> = 6.8 Hz, 4H), 3.06–2.74 (m, 2H), 2.00 (t, <i>J</i> = 6.4 Hz, 4H), 1.54–0.80 (m, 6H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 158.7, 158.4, 157.0, 155.1, 154.3, 141.9, 138.4, 135.0, 130.8, 125.1 (d, <i>J</i><sub>CF</sub> = 8.6 Hz), 123.6 (d, <i>J</i><sub>CF</sub> = 11.2 Hz), 121.2, 117.2 d, (<i>J</i><sub>CF</sub> = 23.3 Hz), 76.9, 67.7, 55.8, 48.3, 46.2, 25.5, 17.4; HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>28</sub>FN<sub>6</sub>O<sub>2</sub>, 439.2258; found, 439.2265.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>N</i>-(3-(3-(2-Oxa-7-azaspiro[4.4]nonan-7-yl)imidazo[1,2-<i>a</i>]pyrimidin-7-yl)-4-fluorophenyl)pyrrolidine-1-carboxamide (<b>44</b>)</h3><div class="NLM_p last"><b>44</b> was prepared by an analogous method to <b>39</b>, from <b>100c</b> (0.283 g, 0.580 mmol) using 10% activated palladium on carbon (0.0309 g, 0.029 mmol), then CDI (0.125 g, 0.770 mmol), DIPEA (0.134 mL, 0.770 mmol), and pyrrolidine (0.064 mL, 0.770 mmol), purifying by flash chromatography (0–4% EtOAc/EtOH (3:1)/cyclohexanes) to yield <b>44</b> (0.07 g, 0.155 mmol, 27% over two steps). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.73 (d, <i>J</i> = 7.6 Hz, 1H), 8.40 (s, 1H), 8.20 (dd, <i>J</i> = 7.2 and 2.8 Hz, 1H), 7.76 (ddd, <i>J</i> = 8.8, 7.2 and 2.8 Hz, 1H), 7.40 (s, 1H), 7.36 (dd, <i>J</i> = 7.6 and 2.4 Hz, 1H), 7.24 (dd, <i>J</i> = 11.2 and 8.8 Hz, 1H), 3.84–3.77 (m, 2H), 3.71 (t, <i>J</i> = 8 Hz, 1H), 3.61 (t, <i>J</i> = 8.4 Hz, 1H), 3.42–3.34 (m, 6H), 3.26 (d, <i>J</i> = 9.2 Hz, 6H), 3.22 (d, <i>J</i> = 9.2 Hz, 6H), 2.06–1.95 (m, 4H), 1.86 (t, <i>J</i> = 6.8 Hz, 4H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 156.7, 154.8, 154.4, 150.4, 144.0, 138.0, 133.5, 132.1, 125.3 (d, <i>J</i><sub>CF</sub> = 11.8 Hz), 123.0 (d, <i>J</i><sub>CF</sub> = 7.9 Hz), 121.1 (d, <i>J</i><sub>CF</sub> = 15.3 Hz), 116.8 (d, <i>J</i><sub>CF</sub> = 24.0 Hz), 108.7 (d, <i>J</i><sub>CF</sub> = 11.4 Hz), 77.1, 67.4, 60.8, 50.9, 49.7, 46.2, 37.7, 35.2, 25.5; HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>28</sub>FN<sub>6</sub>O<sub>2</sub>, 451.2252; found, 451.2234.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>N</i>-(4-Fluoro-3-(3-(isopropylamino)imidazo[1,2-<i>a</i>]pyrimidin-7-yl)phenyl)pyrrolidine-1-carboxamide (<b>45</b>)</h3><div class="NLM_p last"><b>45</b> was synthesized by an analogous method to <b>39</b>, from <b>100d</b> (0.27 m, 0.64 mmol) and 10% activated palladium on carbon (0.034 g, 0.03 mmol), followed by DIPEA (233 μL, 1.33 mmol), CDI (0.216 g, 1.33 mmol), and pyrrolidine (111 μL, 1.33 mmol), purifying by prep. HPLC to give <b>45</b> (0.056 g, 0.15 mmol, 22%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.61 (d, <i>J</i> = 7.3 Hz, 1H), 8.41 (s, 1H), 8.20–8.16 (m, 1H), 7.78–7.73 (m, 1H), 7.35 (d, <i>J</i> = 7.0 Hz, 1H), 7.23 (dd, <i>J</i> = 9.5 and 10.9 Hz, 1H), 7.16 (s, 1H), 5.37 (d, J = 6.3 Hz, 1H), 3.56–3.46 (m, 1H), 3.42–3.36 (m, 1H), 1.91–1.84 (m, 4H), 1.22 (d, <i>J</i> = 6.3 Hz, 6H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 154.7, 154.4, 148.8, 142.9, 138.0, 131.3, 130.6, 125.5 (d, <i>J</i><sub>CF</sub> = 12.1 Hz), 122.7 (d, <i>J</i><sub>CF</sub> = 8.1 Hz), 121.1, 118.8, 116.5 (d, <i>J</i><sub>CF</sub> = 23.9 Hz), 108.0 (d, <i>J</i><sub>CF</sub> = 11.3 Hz), 46.6, 46.2, 25.5, 23.2; HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>20</sub>H<sub>24</sub>FN<sub>6</sub>O, 383.1996; found, 383.1999.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> <i>N</i>-(4-Fluoro-3-(3-((4-methoxybutan-2-yl)amino)imidazo[1,2-<i>a</i>]pyrimidin-7-yl)phenyl)pyrrolidine-1-carboxamide (<b>46</b>)</h3><div class="NLM_p last"><b>46</b> was prepared by an analogous method to <b>39</b> from <b>100e</b> (0.24 g, 0.53 mmol) and 10% activated palladium on carbon (0.028 g, 0.03 mmol), followed by DIPEA (0.188 mL, 1.08 mmol), CDI (0.175 g, 1.08 mmol), and pyrrolidine (0.090 mL, 1.08 mmol), purifying by prep. HPLC to yield <b>46</b> (0.098 g, 0.24 mmol, 44%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.64 (d, <i>J</i> = 7.2 Hz, 1H), 8.41 (s, 1H), 8.20–8.17 (m, 1H), 7.79–7.74 (m, 1H), 7.38–7.35 (m, 1H), 7.27–7.20 (m, 2H), 5.39 (d, <i>J</i> = 6.5 Hz, 1H), 3.57–3.50 (m, 1H), 3.44–3.32 (m, 5H, under solvent signal), 3.31–3.28 (m, 4H), 1.90–1.83 (m, 4H), 1.19 (d, <i>J</i> = 6.4 Hz, 3H); <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): δ 156.7, 154.7, 154.4, 149.1, 143.0, 137.9, 130.9 (d, <i>J</i><sub>CF</sub> = 11.1 Hz), 125.5 (d, <i>J</i><sub>CF</sub> = 11.8 Hz), 122.8 (d, <i>J</i><sub>CF</sub> = 7.4 Hz), 121.1, 119.3, 116.7 (d, <i>J</i><sub>CF</sub> = 23.8 Hz), 108.1 (d, <i>J</i><sub>CF</sub> = 11.3 Hz), 76.2, 58.8, 50.7, 46.2, 25.5, 18.4; HRMS (ES<sup>+</sup>): <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>26</sub>FN<sub>6</sub>O<sub>2</sub>, 413.2101; found, 413.2083.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71"><a href="/doi/suppl/10.1021/acs.jmedchem.1c00047" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56116" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56116" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.1c00047?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00047</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental information, synthesis of intermediates, methods for parasitology and modeling, molecular ESP maps and HPLC traces of key compounds, <i>in vitro</i> and <i>in vivo</i> assays, and <i>in vivo</i> pharmacokinetics (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00047/suppl_file/jm1c00047_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Homology model of <i>L. donovani</i> protease subunits β4 and β5 (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00047/suppl_file/jm1c00047_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Molecular formula strings for key compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00047/suppl_file/jm1c00047_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00047/suppl_file/jm1c00047_si_001.pdf">jm1c00047_si_001.pdf (6.77 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00047/suppl_file/jm1c00047_si_002.pdb">jm1c00047_si_002.pdb (748.27 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00047/suppl_file/jm1c00047_si_003.csv">jm1c00047_si_003.csv (3.35 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00047" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10705" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10705" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Marco</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Tres Cantos 28760, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2442-0021" title="Orcid link">http://orcid.org/0000-0002-2442-0021</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#137e72617a723d7e3d7e7261707c537460783d707c7e"><span class="__cf_email__" data-cfemail="e885899a8189c685c685899a8b87a88f9b83c68b8785">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ian H. Gilbert</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division
of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5238-1314" title="Orcid link">http://orcid.org/0000-0002-5238-1314</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4d246325632a24212f283f390d293823292828632c2e633826"><span class="__cf_email__" data-cfemail="2d440345034a44414f485f596d495843494848034c4e035846">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Thomas</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division
of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0377-0281" title="Orcid link">http://orcid.org/0000-0003-0377-0281</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Brand</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division
of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manu De Rycker</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division
of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3171-3519" title="Orcid link">http://orcid.org/0000-0002-3171-3519</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabio Zuccotto</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division
of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3888-7423" title="Orcid link">http://orcid.org/0000-0002-3888-7423</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Iva Lukac</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division
of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter G. Dodd</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division
of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eun-Jung Ko</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division
of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1222-1938" title="Orcid link">http://orcid.org/0000-0003-1222-1938</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sujatha Manthri</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division
of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kate McGonagle</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division
of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8485-7180" title="Orcid link">http://orcid.org/0000-0001-8485-7180</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Osuna-Cabello</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division
of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer Riley</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division
of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Caterina Pont</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division
of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederick Simeons</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division
of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laste Stojanovski</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division
of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Thomas</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division
of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Thompson</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division
of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elisabet Viayna</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division
of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jose M. Fiandor</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Tres Cantos 28760, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julio Martin</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Tres Cantos 28760, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1887-0859" title="Orcid link">http://orcid.org/0000-0003-1887-0859</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul G. Wyatt</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division
of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0397-245X" title="Orcid link">http://orcid.org/0000-0002-0397-245X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy J. Miles</span> - <span class="hlFld-Affiliation affiliation">Global
Health R&D, GlaxoSmithKline, Tres Cantos 28760, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7407-7404" title="Orcid link">http://orcid.org/0000-0001-7407-7404</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin D. Read</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division
of Biological Chemistry, University of Dundee, Dundee DD1 5EH, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8536-0130" title="Orcid link">http://orcid.org/0000-0002-8536-0130</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>M.T. and S.B. contributed equally to the project.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Several authors have shares in GlaxoSmithKline.<br /></br><p class="inlineNote">All regulated procedures on living animals in Dundee were carried out under the authority of a project license issued by the Home Office under the Animals (Scientific Procedures) Act 1986, as amended in 2012 (and in compliance with EU Directive EU/2010/63). License applications have been approved by the University’s Ethical Review Committee (ERC) before submission to the Home Office. The ERC has a general remit to develop and oversee policy on all aspects of the use of animals on University premises and is a subcommittee of the University Court, its highest governing body. All animal studies were reviewed by GlaxoSmithKline’s (GSK) internal ethical review committee and performed in accordance with Animals (Scientific Procedures) Act 1986 and the GSK Policy on the Care, Welfare, and Treatment of Laboratory Animals (UK 1986).</p></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80466" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80466" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We would like to acknowledge the Wellcome Trust for the support (092340, 100476, 105021, 203134, and 204672). We thank Gina MacKay, Daniel Fletcher, Darren Edwards, and Denise Barrett for performing HRMS analyses and for assistance with performing other NMR and MS analyses, the Galchimia chemistry team for synthesizing key compounds, Susan Wyllie and team for elucidating the MoA, and Alastair Pate, Francesco Gastaldello, James Burkinshaw, and Kashish Sharma for data management.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">CLND</td><td class="NLM_def"><p class="first last">chemiluminescent nitrogen detection</p></td></tr><tr><td class="NLM_term">ESP</td><td class="NLM_def"><p class="first last">electrostatic surface potential</p></td></tr><tr><td class="NLM_term">FaSSIF</td><td class="NLM_def"><p class="first last">fasted state simulated intestinal fluid</p></td></tr><tr><td class="NLM_term">FMO</td><td class="NLM_def"><p class="first last">Frontier molecular orbital method</p></td></tr><tr><td class="NLM_term">INMAC</td><td class="NLM_def"><p class="first last">intracellular <i>L. donovani</i> assay</p></td></tr><tr><td class="NLM_term">MoA</td><td class="NLM_def"><p class="first last">mechanism of Action</p></td></tr><tr><td class="NLM_term">PFI</td><td class="NLM_def"><p class="first last">property forecast index</p></td></tr><tr><td class="NLM_term">PIE, PIEDA</td><td class="NLM_def"><p class="first last">pair interaction energy decomposition analysis</p></td></tr><tr><td class="NLM_term">VL</td><td class="NLM_def"><p class="first last">visceral leishmaniasis</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87070" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87070" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alves, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilbe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blesson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monnerat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mowbray, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muthoni
Ouattara, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pécoul, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rijal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rode, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strub-Wourgaft, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasunna, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zijlstra, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arana, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvar, J.</span></span> <span> </span><span class="NLM_article-title">Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives</span>. <i>Clin. Microbiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">e00048</span>– <span class="NLM_lpage">00018</span>, <span class="refDoi"> DOI: 10.1128/cmr.00048-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1128%2FCMR.00048-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=30158301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVKjtLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2018&pages=e00048-00018&author=F.+Alvesauthor=G.+Bilbeauthor=S.+Blessonauthor=V.+Goyalauthor=S.+Monneratauthor=C.+Mowbrayauthor=G.+Muthoni%0AOuattaraauthor=B.+P%C3%A9coulauthor=S.+Rijalauthor=J.+Rodeauthor=A.+Solomosauthor=N.+Strub-Wourgaftauthor=M.+Wasunnaauthor=S.+Wellsauthor=E.+E.+Zijlstraauthor=B.+Aranaauthor=J.+Alvar&title=Recent+Development+of+Visceral+Leishmaniasis+Treatments%3A+Successes%2C+Pitfalls%2C+and+Perspectives&doi=10.1128%2Fcmr.00048-18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Recent development of visceral leishmaniasis treatments: successes, pitfalls, and perspectives</span></div><div class="casAuthors">Alves, Fabiana; Bilbe, Graeme; Blesson, Severine; Goyal, Vishal; Monnerat, Severine; Mowbray, Charles; Ouattara, Gina Muthoni; Pecoul, Bernard; Rijal, Suman; Rode, Joelle; Solomos, Alexandra; Strub-Wourgaft, Nathalie; Wasunna, Monique; Wells, Susan; Zijlstra, Eduard E.; Arana, Byron; Alvar, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e00048</span>CODEN:
                <span class="NLM_cas:coden">CMIREX</span>;
        ISSN:<span class="NLM_cas:issn">1098-6618</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Research in visceral leishmaniasis in the last decade has been focused on how better to use the existing medicines as monotherapy or in combination.  Systematic research by geog. regions has shown that a universal treatment is far from today's reality.  Substantial progress has been made in the elimination of kala-azar in South Asia, with a clear strategy on first- and second-line therapy options of single-dose liposomal amphotericin B and a combination of paromomycin and miltefosine, resp., among other interventions.  In Eastern Africa, sodium stibogluconate (SSG) and paromomycin in combination offer an advantage compared to the previous SSG monotherapy, although not exempted of limitations, as this therapy requires 17 days of painful double injections and bears the risk of SSG-related cardiotoxicity.  In this region, attempts to improve the combination therapy have been unsuccessful.  However, pharmacokinetic studies have led to a better understanding of underlying mechanisms, like the underexposure of children to miltefosine treatment, and an improved regimen using an allometric dosage.  Given this global scenario of progress and pitfalls, we here review what steps need to be taken with existing medicines and highlight the urgent need for oral drugs.  Furthermore, it should be noted that six candidates belonging to five new chem. classes are reaching phase I, ensuring an optimistic near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDPEfQ3wVInrVg90H21EOLACvtfcHk0lieD10-EgwtaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVKjtLbK&md5=2e599e12de044cffa746fc336bbc0c11</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1128%2FCMR.00048-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00048-18%26sid%3Dliteratum%253Aachs%26aulast%3DAlves%26aufirst%3DF.%26aulast%3DBilbe%26aufirst%3DG.%26aulast%3DBlesson%26aufirst%3DS.%26aulast%3DGoyal%26aufirst%3DV.%26aulast%3DMonnerat%26aufirst%3DS.%26aulast%3DMowbray%26aufirst%3DC.%26aulast%3DMuthoni%2BOuattara%26aufirst%3DG.%26aulast%3DP%25C3%25A9coul%26aufirst%3DB.%26aulast%3DRijal%26aufirst%3DS.%26aulast%3DRode%26aufirst%3DJ.%26aulast%3DSolomos%26aufirst%3DA.%26aulast%3DStrub-Wourgaft%26aufirst%3DN.%26aulast%3DWasunna%26aufirst%3DM.%26aulast%3DWells%26aufirst%3DS.%26aulast%3DZijlstra%26aufirst%3DE.%2BE.%26aulast%3DArana%26aufirst%3DB.%26aulast%3DAlvar%26aufirst%3DJ.%26atitle%3DRecent%2520Development%2520of%2520Visceral%2520Leishmaniasis%2520Treatments%253A%2520Successes%252C%2520Pitfalls%252C%2520and%2520Perspectives%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2018%26volume%3D31%26spage%3De00048%26epage%3D00018%26doi%3D10.1128%2Fcmr.00048-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Field, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, M. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrie, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span> <span> </span><span class="NLM_article-title">Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1038/nrmicro.2016.193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1038%2Fnrmicro.2016.193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=28239154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVSms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=217-231&author=M.+C.+Fieldauthor=D.+Hornauthor=A.+H.+Fairlambauthor=M.+A.+J.+Fergusonauthor=D.+W.+Grayauthor=K.+D.+Readauthor=M.+De+Ryckerauthor=L.+S.+Torrieauthor=P.+G.+Wyattauthor=S.+Wyllieauthor=I.+H.+Gilbert&title=Anti-trypanosomatid+drug+discovery%3A+an+ongoing+challenge+and+a+continuing+need&doi=10.1038%2Fnrmicro.2016.193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need</span></div><div class="casAuthors">Field, Mark C.; Horn, David; Fairlamb, Alan H.; Ferguson, Michael A. J.; Gray, David W.; Read, Kevin D.; De Rycker, Manu; Torrie, Leah S.; Wyatt, Paul G.; Wyllie, Susan; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">217-231</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The WHO recognizes human African trypanosomiasis, Chagas disease and the leishmaniases as neglected tropical diseases.  These diseases are caused by parasitic trypanosomatids and range in severity from mild and self-curing to near invariably fatal.  Public health advances have substantially decreased the effect of these diseases in recent decades but alone will not eliminate them.  In this Review, we discuss why new drugs against trypanosomatids are required, approaches that are under investigation to develop new drugs and why the drug discovery pipeline remains essentially unfilled.  In addn., we consider the important challenges to drug discovery strategies and the new technologies that can address them.  The combination of new drugs, new technologies and public health initiatives is essential for the management, and hopefully eventual elimination, of trypanosomatid diseases from the human population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIBpRGL7YaP7Vg90H21EOLACvtfcHk0lieD10-EgwtaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVSms7Y%253D&md5=1585d954d6eb695196a6c8921a84e300</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro.2016.193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro.2016.193%26sid%3Dliteratum%253Aachs%26aulast%3DField%26aufirst%3DM.%2BC.%26aulast%3DHorn%26aufirst%3DD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DGray%26aufirst%3DD.%2BW.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DAnti-trypanosomatid%2520drug%2520discovery%253A%2520an%2520ongoing%2520challenge%2520and%2520a%2520continuing%2520need%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2017%26volume%3D15%26spage%3D217%26epage%3D231%26doi%3D10.1038%2Fnrmicro.2016.193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baragaña, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duce, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span> <span> </span><span class="NLM_article-title">Challenges and recent progress in drug discovery for tropical diseases</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>559</i></span>,  <span class="NLM_fpage">498</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1038/s41586-018-0327-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1038%2Fs41586-018-0327-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=30046073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtl2jt7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=559&publication_year=2018&pages=498-506&author=M.+De%0ARyckerauthor=B.+Baraga%C3%B1aauthor=S.+L.+Duceauthor=I.+H.+Gilbert&title=Challenges+and+recent+progress+in+drug+discovery+for+tropical+diseases&doi=10.1038%2Fs41586-018-0327-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges and recent progress in drug discovery for tropical diseases</span></div><div class="casAuthors">De Rycker, Manu; Baragana, Beatriz; Duce, Suzanne L.; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">559</span>
        (<span class="NLM_cas:issue">7715</span>),
    <span class="NLM_cas:pages">498-506</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Infectious tropical diseases have a huge effect in terms of mortality and morbidity, and impose a heavy economic burden on affected countries.  These diseases predominantly affect the world's poorest people.  Currently available drugs are inadequate for the majority of these diseases, and there is an urgent need for new treatments.  This Review discusses some of the challenges involved in developing new drugs to treat these diseases and highlights recent progress.  While there have been notable successes, there is still a long way to go.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-L8-tHy6aTbVg90H21EOLACvtfcHk0lhu-j_VYGm9EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtl2jt7zP&md5=3bc57ce68776462cf6a053efa276a989</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fs41586-018-0327-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-018-0327-4%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DBaraga%25C3%25B1a%26aufirst%3DB.%26aulast%3DDuce%26aufirst%3DS.%2BL.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DChallenges%2520and%2520recent%2520progress%2520in%2520drug%2520discovery%2520for%2520tropical%2520diseases%26jtitle%3DNature%26date%3D2018%26volume%3D559%26spage%3D498%26epage%3D506%26doi%3D10.1038%2Fs41586-018-0327-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><a href="http://www.who.int/mediacentre/factsheets/fs375/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs375/en/</a> (accessed March 13, 2021).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs375%2Fen%2F+%28accessed+March+13%2C+2021%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><a href="https://dndi.org/research-development/portfolio/" class="extLink">https://dndi.org/research-development/portfolio/</a>. (accessed March 13, 2021).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fdndi.org%2Fresearch-development%2Fportfolio%2F.+%28accessed+March+13%2C+2021%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gresham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbaniak, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLean, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccotto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homeyer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pflaumer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boesche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sastry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berriman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidelli-Disse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiandor, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, M. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span> <span> </span><span class="NLM_article-title">Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>560</i></span>,  <span class="NLM_fpage">192</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.1038/s41586-018-0356-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1038%2Fs41586-018-0356-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=30046105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtl2jt77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=560&publication_year=2018&pages=192-197&author=S.+Wyllieauthor=M.+Thomasauthor=S.+Pattersonauthor=S.+Crouchauthor=M.+De+Ryckerauthor=R.+Loweauthor=S.+Greshamauthor=M.+D.+Urbaniakauthor=T.+D.+Ottoauthor=L.+Stojanovskiauthor=F.+R.+C.+Simeonsauthor=S.+Manthriauthor=L.+M.+MacLeanauthor=F.+Zuccottoauthor=N.+Homeyerauthor=H.+Pflaumerauthor=M.+Boescheauthor=L.+Sastryauthor=P.+Connollyauthor=S.+Albrechtauthor=M.+Berrimanauthor=G.+Drewesauthor=D.+W.+Grayauthor=S.+Ghidelli-Disseauthor=S.+Dixonauthor=J.+M.+Fiandorauthor=P.+G.+Wyattauthor=M.+A.+J.+Fergusonauthor=A.+H.+Fairlambauthor=T.+J.+Milesauthor=K.+D.+Readauthor=I.+H.+Gilbert&title=Cyclin-dependent+kinase+12+is+a+drug+target+for+visceral+leishmaniasis&doi=10.1038%2Fs41586-018-0356-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis</span></div><div class="casAuthors">Wyllie, Susan; Thomas, Michael; Patterson, Stephen; Crouch, Sabrinia; De Rycker, Manu; Lowe, Rhiannon; Gresham, Stephanie; Urbaniak, Michael D.; Otto, Thomas D.; Stojanovski, Laste; Simeons, Frederick R. C.; Manthri, Sujatha; MacLean, Lorna M.; Zuccotto, Fabio; Homeyer, Nadine; Pflaumer, Hannah; Boesche, Markus; Sastry, Lalitha; Connolly, Paul; Albrecht, Sebastian; Berriman, Matt; Drewes, Gerard; Gray, David W.; Ghidelli-Disse, Sonja; Dixon, Susan; Fiandor, Jose M.; Wyatt, Paul G.; Ferguson, Michael A. J.; Fairlamb, Alan H.; Miles, Timothy J.; Read, Kevin D.; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">560</span>
        (<span class="NLM_cas:issue">7717</span>),
    <span class="NLM_cas:pages">192-197</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Visceral leishmaniasis causes considerable mortality and morbidity in many parts of the world.  There is an urgent need for the development of new, effective treatments for this disease.  Here we describe the development of an anti-leishmanial drug-like chem. series based on a pyrazolopyrimidine scaffold.  The leading compd. from this series (7, DDD853651/GSK3186899) is efficacious in a mouse model of visceral leishmaniasis, has suitable physicochem., pharmacokinetic and toxicol. properties for further development, and has been declared a preclin. candidate.  Detailed mode-of-action studies indicate that compds. from this series act principally by inhibiting the parasite cdc-2-related kinase 12 (CRK12), thus defining a druggable target for visceral leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWvpd9EzGFxLVg90H21EOLACvtfcHk0lhu-j_VYGm9EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtl2jt77I&md5=bea43a232049ade6ed9abea3e0510221</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fs41586-018-0356-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-018-0356-z%26sid%3Dliteratum%253Aachs%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DCrouch%26aufirst%3DS.%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DLowe%26aufirst%3DR.%26aulast%3DGresham%26aufirst%3DS.%26aulast%3DUrbaniak%26aufirst%3DM.%2BD.%26aulast%3DOtto%26aufirst%3DT.%2BD.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DManthri%26aufirst%3DS.%26aulast%3DMacLean%26aufirst%3DL.%2BM.%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DHomeyer%26aufirst%3DN.%26aulast%3DPflaumer%26aufirst%3DH.%26aulast%3DBoesche%26aufirst%3DM.%26aulast%3DSastry%26aufirst%3DL.%26aulast%3DConnolly%26aufirst%3DP.%26aulast%3DAlbrecht%26aufirst%3DS.%26aulast%3DBerriman%26aufirst%3DM.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DGray%26aufirst%3DD.%2BW.%26aulast%3DGhidelli-Disse%26aufirst%3DS.%26aulast%3DDixon%26aufirst%3DS.%26aulast%3DFiandor%26aufirst%3DJ.%2BM.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DMiles%26aufirst%3DT.%2BJ.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DCyclin-dependent%2520kinase%252012%2520is%2520a%2520drug%2520target%2520for%2520visceral%2520leishmaniasis%26jtitle%3DNature%26date%3D2018%26volume%3D560%26spage%3D192%26epage%3D197%26doi%3D10.1038%2Fs41586-018-0356-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajakane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Álvarez-Pedraglio, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boesche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantizani-Perez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleghorn, L. A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copley, R. C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouch, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daugan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidelli-Disse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gresham, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hindley, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLean, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miguel-Siles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osuna-Cabello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pena, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quesada-Campos, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revill, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Gomez, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shishikura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinks, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underwood, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiandor, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, T. J.</span></span> <span> </span><span class="NLM_article-title">Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1180</span>– <span class="NLM_lpage">1202</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01218</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01218" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFGhtLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=1180-1202&author=M.+G.+Thomasauthor=M.+De+Ryckerauthor=M.+Ajakaneauthor=S.+Albrechtauthor=A.+I.+%C3%81lvarez-Pedraglioauthor=M.+Boescheauthor=S.+Brandauthor=L.+Campbellauthor=J.+Cantizani-Perezauthor=L.+A.+T.+Cleghornauthor=R.+C.+B.+Copleyauthor=S.+D.+Crouchauthor=A.+Dauganauthor=G.+Drewesauthor=S.+Ferrerauthor=S.+Ghidelli-Disseauthor=S.+Gonzalezauthor=S.+L.+Greshamauthor=A.+P.+Hillauthor=S.+J.+Hindleyauthor=R.+M.+Loweauthor=C.+J.+MacKenzieauthor=L.+MacLeanauthor=S.+Manthriauthor=F.+Martinauthor=J.+Miguel-Silesauthor=V.+L.+Nguyenauthor=S.+Norvalauthor=M.+Osuna-Cabelloauthor=A.+Woodlandauthor=S.+Pattersonauthor=I.+Penaauthor=M.+T.+Quesada-Camposauthor=I.+H.+Reidauthor=C.+Revillauthor=J.+Rileyauthor=J.+R.+Ruiz-Gomezauthor=Y.+Shishikuraauthor=F.+R.+C.+Simeonsauthor=A.+Smithauthor=V.+C.+Smithauthor=D.+Spinksauthor=L.+Stojanovskiauthor=J.+Thomasauthor=S.+Thompsonauthor=T.+Underwoodauthor=D.+W.+Grayauthor=J.+M.+Fiandorauthor=I.+H.+Gilbertauthor=P.+G.+Wyattauthor=K.+D.+Readauthor=T.+J.+Miles&title=Identification+of+GSK3186899%2FDDD853651+as+a+Preclinical+Development+Candidate+for+the+Treatment+of+Visceral+Leishmaniasis&doi=10.1021%2Facs.jmedchem.8b01218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of GSK3186899/DDD853651 as a preclinical development candidate for the treatment of visceral leishmaniasis</span></div><div class="casAuthors">Thomas, Michael G.; De Rycker, Manu; Ajakane, Myriam; Albrecht, Sebastian; Alvarez-Pedraglio, Ana Isabel; Boesche, Markus; Brand, Stephen; Campbell, Lorna; Cantizani-Perez, Juan; Cleghorn, Laura A. T.; Copley, Royston C. B.; Crouch, Sabrinia D.; Daugan, Alain; Drewes, Gerard; Ferrer, Santiago; Ghidelli-Disse, Sonja; Gonzalez, Silvia; Gresham, Stephanie L.; Hill, Alan P.; Hindley, Sean J.; Lowe, Rhiannon M.; MacKenzie, Claire J.; MacLean, Lorna; Manthri, Sujatha; Martin, Franck; Miguel-Siles, Juan; Nguyen, Van Loc; Norval, Suzanne; Osuna-Cabello, Maria; Woodland, Andrew; Patterson, Stephen; Pena, Imanol; Quesada-Campos, Maria Teresa; Reid, Iain H.; Revill, Charlotte; Riley, Jennifer; Ruiz-Gomez, Jose Ramon; Shishikura, Yoko; Simeons, Frederick R. C.; Smith, Alasdair; Smith, Victoria C.; Spinks, Daniel; Stojanovski, Laste; Thomas, John; Thompson, Stephen; Underwood, Tim; Gray, David W.; Fiandor, Jose M.; Gilbert, Ian H.; Wyatt, Paul G.; Read, Kevin D.; Miles, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1180-1202</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The leishmaniases are diseases that affect millions of people across the world, in particular visceral leishmaniasis (VL) which is fatal unless treated.  Current std. of care for VL suffers from multiple issues and there is a limited pipeline of new candidate drugs.  As such, there is a clear unmet medical need to identify new treatments.  This paper describes the optimization of a phenotypic hit against Leishmania donovani, the major causative organism of VL.  The key challenges were to balance soly. and metabolic stability while maintaining potency.  Herein, strategies to address these shortcomings and enhance efficacy are discussed, culminating in the discovery of preclin. development candidate GSK3186899/DDD853651 (1) for VL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3K_YbhzFzXbVg90H21EOLACvtfcHk0lizxzbnZlG_CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFGhtLfP&md5=6c0c7ed8d7b5b38b6fe1eb5bbe655bb1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01218%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DM.%2BG.%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DAjakane%26aufirst%3DM.%26aulast%3DAlbrecht%26aufirst%3DS.%26aulast%3D%25C3%2581lvarez-Pedraglio%26aufirst%3DA.%2BI.%26aulast%3DBoesche%26aufirst%3DM.%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DL.%26aulast%3DCantizani-Perez%26aufirst%3DJ.%26aulast%3DCleghorn%26aufirst%3DL.%2BA.%2BT.%26aulast%3DCopley%26aufirst%3DR.%2BC.%2BB.%26aulast%3DCrouch%26aufirst%3DS.%2BD.%26aulast%3DDaugan%26aufirst%3DA.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DGhidelli-Disse%26aufirst%3DS.%26aulast%3DGonzalez%26aufirst%3DS.%26aulast%3DGresham%26aufirst%3DS.%2BL.%26aulast%3DHill%26aufirst%3DA.%2BP.%26aulast%3DHindley%26aufirst%3DS.%2BJ.%26aulast%3DLowe%26aufirst%3DR.%2BM.%26aulast%3DMacKenzie%26aufirst%3DC.%2BJ.%26aulast%3DMacLean%26aufirst%3DL.%26aulast%3DManthri%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DF.%26aulast%3DMiguel-Siles%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DV.%2BL.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DOsuna-Cabello%26aufirst%3DM.%26aulast%3DWoodland%26aufirst%3DA.%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DPena%26aufirst%3DI.%26aulast%3DQuesada-Campos%26aufirst%3DM.%2BT.%26aulast%3DReid%26aufirst%3DI.%2BH.%26aulast%3DRevill%26aufirst%3DC.%26aulast%3DRiley%26aufirst%3DJ.%26aulast%3DRuiz-Gomez%26aufirst%3DJ.%2BR.%26aulast%3DShishikura%26aufirst%3DY.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DV.%2BC.%26aulast%3DSpinks%26aufirst%3DD.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DThompson%26aufirst%3DS.%26aulast%3DUnderwood%26aufirst%3DT.%26aulast%3DGray%26aufirst%3DD.%2BW.%26aulast%3DFiandor%26aufirst%3DJ.%2BM.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DMiles%26aufirst%3DT.%2BJ.%26atitle%3DIdentification%2520of%2520GSK3186899%252FDDD853651%2520as%2520a%2520Preclinical%2520Development%2520Candidate%2520for%2520the%2520Treatment%2520of%2520Visceral%2520Leishmaniasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D1180%26epage%3D1202%26doi%3D10.1021%2Facs.jmedchem.8b01218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathison, C. J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myburgh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stinson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, H. X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venable, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursulaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spraggon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brock, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mottram, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supek, F.</span></span> <span> </span><span class="NLM_article-title">Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>537</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1038/nature19339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1038%2Fnature19339" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=27501246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVyhtr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=537&publication_year=2016&pages=229-233&author=S.+Khareauthor=A.+S.+Nagleauthor=A.+Biggartauthor=Y.+H.+Laiauthor=F.+Liangauthor=L.+C.+Davisauthor=S.+W.+Barnesauthor=C.+J.+N.+Mathisonauthor=E.+Myburghauthor=M.-Y.+Gaoauthor=J.+R.+Gillespieauthor=X.+Liuauthor=J.+L.+Tanauthor=M.+Stinsonauthor=I.+C.+Riveraauthor=J.+Ballardauthor=V.+Yehauthor=T.+Groesslauthor=G.+Federeauthor=H.+X.+Y.+Kohauthor=J.+D.+Venableauthor=B.+Bursulayaauthor=M.+Shapiroauthor=P.+K.+Mishraauthor=G.+Spraggonauthor=A.+Brockauthor=J.+C.+Mottramauthor=F.+S.+Bucknerauthor=S.+P.+S.+Raoauthor=B.+G.+Wenauthor=J.+R.+Walkerauthor=T.+Tuntlandauthor=V.+Molteniauthor=R.+J.+Glynneauthor=F.+Supek&title=Proteasome+inhibition+for+treatment+of+leishmaniasis%2C+Chagas+disease+and+sleeping+sickness&doi=10.1038%2Fnature19339"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness</span></div><div class="casAuthors">Khare, Shilpi; Nagle, Advait S.; Biggart, Agnes; Lai, Yin H.; Liang, Fang; Davis, Lauren C.; Barnes, S. Whitney; Mathison, Casey J. N.; Myburgh, Elmarie; Gao, Mu-Yun; Gillespie, J. Robert; Liu, Xianzhong; Tan, Jocelyn L.; Stinson, Monique; Rivera, Ianne C.; Ballard, Jaime; Yeh, Vince; Groessl, Todd; Federe, Glenn; Koh, Hazel X. Y.; Venable, John D.; Bursulaya, Badry; Shapiro, Michael; Mishra, Pranab K.; Spraggon, Glen; Brock, Ansgar; Mottram, Jeremy C.; Buckner, Frederick S.; Rao, Srinivasa P. S.; Wen, Ben G.; Walker, John R.; Tuntland, Tove; Molteni, Valentina; Glynne, Richard J.; Supek, Frantisek</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">537</span>
        (<span class="NLM_cas:issue">7619</span>),
    <span class="NLM_cas:pages">229-233</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chagas disease, leishmaniasis and sleeping sickness affect 20 million people worldwide and lead to more than 50,000 deaths annually.  The diseases are caused by infection with the kinetoplastid parasites Trypanosoma cruzi, Leishmania spp. and Trypanosoma brucei spp., resp.  These parasites have similar biol. and genomic sequence, suggesting that all three diseases could be cured with drugs that modulate the activity of a conserved parasite target.  However, no such mol. targets or broad spectrum drugs have been identified to date.  Here we describe a selective inhibitor of the kinetoplastid proteasome (GNF6702) with unprecedented in vivo efficacy, which cleared parasites from mice in all three models of infection.  GNF6702 inhibits the kinetoplastid proteasome through a non-competitive mechanism, does not inhibit the mammalian proteasome or growth of mammalian cells, and is well-tolerated in mice.  Our data provide genetic and chem. validation of the parasite proteasome as a promising therapeutic target for treatment of kinetoplastid infections, and underscore the possibility of developing a single class of drugs for these neglected diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_PXMn1-tj_7Vg90H21EOLACvtfcHk0lizxzbnZlG_CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVyhtr%252FL&md5=a05e7ce0f6b912b3003c5b3f42a005bb</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature19339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19339%26sid%3Dliteratum%253Aachs%26aulast%3DKhare%26aufirst%3DS.%26aulast%3DNagle%26aufirst%3DA.%2BS.%26aulast%3DBiggart%26aufirst%3DA.%26aulast%3DLai%26aufirst%3DY.%2BH.%26aulast%3DLiang%26aufirst%3DF.%26aulast%3DDavis%26aufirst%3DL.%2BC.%26aulast%3DBarnes%26aufirst%3DS.%2BW.%26aulast%3DMathison%26aufirst%3DC.%2BJ.%2BN.%26aulast%3DMyburgh%26aufirst%3DE.%26aulast%3DGao%26aufirst%3DM.-Y.%26aulast%3DGillespie%26aufirst%3DJ.%2BR.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTan%26aufirst%3DJ.%2BL.%26aulast%3DStinson%26aufirst%3DM.%26aulast%3DRivera%26aufirst%3DI.%2BC.%26aulast%3DBallard%26aufirst%3DJ.%26aulast%3DYeh%26aufirst%3DV.%26aulast%3DGroessl%26aufirst%3DT.%26aulast%3DFedere%26aufirst%3DG.%26aulast%3DKoh%26aufirst%3DH.%2BX.%2BY.%26aulast%3DVenable%26aufirst%3DJ.%2BD.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DShapiro%26aufirst%3DM.%26aulast%3DMishra%26aufirst%3DP.%2BK.%26aulast%3DSpraggon%26aufirst%3DG.%26aulast%3DBrock%26aufirst%3DA.%26aulast%3DMottram%26aufirst%3DJ.%2BC.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DRao%26aufirst%3DS.%2BP.%2BS.%26aulast%3DWen%26aufirst%3DB.%2BG.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DMolteni%26aufirst%3DV.%26aulast%3DGlynne%26aufirst%3DR.%2BJ.%26aulast%3DSupek%26aufirst%3DF.%26atitle%3DProteasome%2520inhibition%2520for%2520treatment%2520of%2520leishmaniasis%252C%2520Chagas%2520disease%2520and%2520sleeping%2520sickness%26jtitle%3DNature%26date%3D2016%26volume%3D537%26spage%3D229%26epage%3D233%26doi%3D10.1038%2Fnature19339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Be, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciotti, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pybus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreishman-Deitrick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursulaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathison, C. J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerario, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chianelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiricek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggimann, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luneau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudewicz, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spraggon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, V.</span></span> <span> </span><span class="NLM_article-title">Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">10773</span>– <span class="NLM_lpage">10781</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00499</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00499" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtl2jurzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=10773-10781&author=A.+Nagleauthor=A.+Biggartauthor=C.+Beauthor=H.+Srinivasauthor=A.+Heinauthor=D.+Caridhaauthor=R.+J.+Sciottiauthor=B.+Pybusauthor=M.+Kreishman-Deitrickauthor=B.+Bursulayaauthor=Y.+H.+Laiauthor=M.-Y.+Gaoauthor=F.+Liangauthor=C.+J.+N.+Mathisonauthor=X.+Liuauthor=V.+Yehauthor=J.+Smithauthor=I.+Lerarioauthor=Y.+Xieauthor=D.+Chianelliauthor=M.+Gibneyauthor=A.+Bermanauthor=Y.-L.+Chenauthor=J.+Jiricekauthor=L.+C.+Davisauthor=X.+Liuauthor=J.+Ballardauthor=S.+Khareauthor=F.+K.+Eggimannauthor=A.+Luneauauthor=T.+Groesslauthor=M.+Shapiroauthor=W.+Richmondauthor=K.+Johnsonauthor=P.+J.+Rudewiczauthor=S.+P.+S.+Raoauthor=C.+Thompsonauthor=T.+Tuntlandauthor=G.+Spraggonauthor=R.+J.+Glynneauthor=F.+Supekauthor=C.+Wiesmannauthor=V.+Molteni&title=Discovery+and+Characterization+of+Clinical+Candidate+LXE408+as+a+Kinetoplastid-Selective+Proteasome+Inhibitor+for+the+Treatment+of+Leishmaniases&doi=10.1021%2Facs.jmedchem.0c00499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases</span></div><div class="casAuthors">Nagle, Advait; Biggart, Agnes; Be, Celine; Srinivas, Honnappa; Hein, Andreas; Caridha, Diana; Sciotti, Richard J.; Pybus, Brandon; Kreishman-Deitrick, Mara; Bursulaya, Badry; Lai, Yin H.; Gao, Mu-Yun; Liang, Fang; Mathison, Casey J. N.; Liu, Xiaodong; Yeh, Vince; Smith, Jeffrey; Lerario, Isabelle; Xie, Yongping; Chianelli, Donatella; Gibney, Michael; Berman, Ashley; Chen, Yen-Liang; Jiricek, Jan; Davis, Lauren C.; Liu, Xianzhong; Ballard, Jaime; Khare, Shilpi; Eggimann, Fabian Kurt; Luneau, Alexandre; Groessl, Todd; Shapiro, Michael; Richmond, Wendy; Johnson, Kevin; Rudewicz, Patrick J.; Rao, Srinivasa P. S.; Thompson, Christopher; Tuntland, Tove; Spraggon, Glen; Glynne, Richard J.; Supek, Frantisek; Wiesmann, Christian; Molteni, Valentina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">10773-10781</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Visceral leishmaniasis is responsible for up to 30,000 deaths every year.  Current treatments have shortcomings that include toxicity and variable efficacy across endemic regions.  Previously, we reported the discovery of GNF6702, a selective inhibitor of the kinetoplastid proteasome, which cleared parasites in murine models of leishmaniasis, Chagas disease, and human African trypanosomiasis.  Here, we describe the discovery and characterization of LXE408(I), a structurally related kinetoplastid-selective proteasome inhibitor currently in Phase 1 human clin. trials.  Furthermore, we present high-resoln. cryo-EM structures of the Leishmania tarentolae proteasome in complex with LXE408, which provides a compelling explanation for the noncompetitive mode of binding of this novel class of inhibitors of the kinetoplastid proteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFHqvdoR1fT7Vg90H21EOLACvtfcHk0lh-4E7YhyXJ0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtl2jurzM&md5=30d8293eed0e94a7bdb75c9d794f52ce</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00499%26sid%3Dliteratum%253Aachs%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DBiggart%26aufirst%3DA.%26aulast%3DBe%26aufirst%3DC.%26aulast%3DSrinivas%26aufirst%3DH.%26aulast%3DHein%26aufirst%3DA.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DSciotti%26aufirst%3DR.%2BJ.%26aulast%3DPybus%26aufirst%3DB.%26aulast%3DKreishman-Deitrick%26aufirst%3DM.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DLai%26aufirst%3DY.%2BH.%26aulast%3DGao%26aufirst%3DM.-Y.%26aulast%3DLiang%26aufirst%3DF.%26aulast%3DMathison%26aufirst%3DC.%2BJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DYeh%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DLerario%26aufirst%3DI.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DChianelli%26aufirst%3DD.%26aulast%3DGibney%26aufirst%3DM.%26aulast%3DBerman%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.-L.%26aulast%3DJiricek%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DL.%2BC.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBallard%26aufirst%3DJ.%26aulast%3DKhare%26aufirst%3DS.%26aulast%3DEggimann%26aufirst%3DF.%2BK.%26aulast%3DLuneau%26aufirst%3DA.%26aulast%3DGroessl%26aufirst%3DT.%26aulast%3DShapiro%26aufirst%3DM.%26aulast%3DRichmond%26aufirst%3DW.%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DRudewicz%26aufirst%3DP.%2BJ.%26aulast%3DRao%26aufirst%3DS.%2BP.%2BS.%26aulast%3DThompson%26aufirst%3DC.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DSpraggon%26aufirst%3DG.%26aulast%3DGlynne%26aufirst%3DR.%2BJ.%26aulast%3DSupek%26aufirst%3DF.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DMolteni%26aufirst%3DV.%26atitle%3DDiscovery%2520and%2520Characterization%2520of%2520Clinical%2520Candidate%2520LXE408%2520as%2520a%2520Kinetoplastid-Selective%2520Proteasome%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Leishmaniases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D10773%26epage%3D10781%26doi%3D10.1021%2Facs.jmedchem.0c00499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C.-w.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pena, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bueren-Calabuig, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantizani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cebrian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craggs, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goswami, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobrath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeacock, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, E.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korczynska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLean, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mata-Cantero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moniz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nühs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osuna-Cabello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shishikura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinks, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viayna Gaza, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccotto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, M. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiandor, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span> <span> </span><span class="NLM_article-title">Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">9318</span>– <span class="NLM_lpage">9323</span>, <span class="refDoi"> DOI: 10.1073/pnas.1820175116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1073%2Fpnas.1820175116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=30962368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovFGlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=9318-9323&author=S.+Wyllieauthor=S.+Brandauthor=M.+Thomasauthor=M.+De+Ryckerauthor=C.-w.+Chungauthor=I.+Penaauthor=R.+P.+Binghamauthor=J.+A.+Bueren-Calabuigauthor=J.+Cantizaniauthor=D.+Cebrianauthor=P.+D.+Craggsauthor=L.+Fergusonauthor=P.+Goswamiauthor=J.+Hobrathauthor=J.+Howeauthor=L.+Jeacockauthor=E.-J.+Koauthor=J.+Korczynskaauthor=L.+MacLeanauthor=S.+Manthriauthor=M.+S.+Martinezauthor=L.+Mata-Canteroauthor=S.+Monizauthor=A.+N%C3%BChsauthor=M.+Osuna-Cabelloauthor=E.+Pintoauthor=J.+Rileyauthor=S.+Robinsonauthor=P.+Rowlandauthor=F.+R.+C.+Simeonsauthor=Y.+Shishikuraauthor=D.+Spinksauthor=L.+Stojanovskiauthor=J.+Thomasauthor=S.+Thompsonauthor=E.+Viayna+Gazaauthor=R.+J.+Wallauthor=F.+Zuccottoauthor=D.+Hornauthor=M.+A.+J.+Fergusonauthor=A.+H.+Fairlambauthor=J.+M.+Fiandorauthor=J.+Martinauthor=D.+W.+Grayauthor=T.+J.+Milesauthor=I.+H.+Gilbertauthor=K.+D.+Readauthor=M.+Marcoauthor=P.+G.+Wyatt&title=Preclinical+candidate+for+the+treatment+of+visceral+leishmaniasis+that+acts+through+proteasome+inhibition&doi=10.1073%2Fpnas.1820175116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition</span></div><div class="casAuthors">Wyllie, Susan; Brand, Stephen; Thomas, Michael; De Rycker, Manu; Chung, Chun-wa; Pena, Imanol; Bingham, Ryan P.; Bueren-Calabuig, Juan A.; Cantizani, Juan; Cebrian, David; Craggs, Peter D.; Ferguson, Liam; Goswami, Panchali; Hobrath, Judith; Howe, Jonathan; Jeacock, Laura; Ko, Eun-Jung; Korczynska, Justyna; MacLean, Lorna; Manthri, Sujatha; Martinez, Maria S.; Mata-Cantero, Lydia; Moniz, Sonia; NA1/4hs, Andrea; Osuna-Cabello, Maria; Pinto, Erika; Riley, Jennifer; Robinson, Sharon; Rowland, Paul; Simeons, Frederick R. C.; Shishikura, Yoko; Spinks, Daniel; Stojanovski, Laste; Thomas, John; Thompson, Stephen; Gaza, Elisabet Viayna; Wall, Richard J.; Zuccotto, Fabio; Horn, David; Ferguson, Michael A. J.; Fairlamb, Alan H.; Fiandor, Jose M.; Martin, Julio; Gray, David W.; Miles, Timothy J.; Gilbert, Ian H.; Read, Kevin D.; Marco, Maria; Wyatt, Paul G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">9318-9323</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Visceral leishmaniasis (VL), caused by the protozoan parasites Leishmania donovani and Leishmania infantum, is one of the major parasitic diseases worldwide.  There is an urgent need for new drugs to treat VL, because current therapies are unfit for purpose in a resource-poor setting.  Here, we describe the development of a preclin. drug candidate, GSK3494245/DDD01305143/compd. 8, with potential to treat this neglected tropical disease.  The compd. series was discovered by repurposing hits from a screen against the related parasite Trypanosoma cruzi.  Subsequent optimization of the chem. series resulted in the development of a potent cidal compd. with activity against a range of clin. relevant L. donovani and L. infantum isolates.  Compd. 8 demonstrates promising pharmacokinetic properties and impressive in vivo efficacy in our mouse model of infection comparable with those of the current oral antileishmanial miltefosine.  Detailed mode of action studies confirm that this compd. acts principally by inhibition of the chymotrypsin-like activity catalyzed by the β5 subunit of the L. donovani proteasome.  High-resoln. cryo-EM structures of apo and compd. 8-bound Leishmania tarentolae 20S proteasome reveal a previously undiscovered inhibitor site that lies between the β4 and β5 proteasome subunits.  This induced pocket exploits β4 residues that are divergent between humans and kinetoplastid parasites and is consistent with all of our exptl. and mutagenesis data.  As a result of these comprehensive studies and due to a favorable developability and safety profile, compd. 8 is being advanced toward human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiLTLZPb2MCLVg90H21EOLACvtfcHk0lim758Ob6n_mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovFGlsb0%253D&md5=799defb4ef812d64ffe230c78aff3511</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1820175116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1820175116%26sid%3Dliteratum%253Aachs%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DChung%26aufirst%3DC.-w.%26aulast%3DPena%26aufirst%3DI.%26aulast%3DBingham%26aufirst%3DR.%2BP.%26aulast%3DBueren-Calabuig%26aufirst%3DJ.%2BA.%26aulast%3DCantizani%26aufirst%3DJ.%26aulast%3DCebrian%26aufirst%3DD.%26aulast%3DCraggs%26aufirst%3DP.%2BD.%26aulast%3DFerguson%26aufirst%3DL.%26aulast%3DGoswami%26aufirst%3DP.%26aulast%3DHobrath%26aufirst%3DJ.%26aulast%3DHowe%26aufirst%3DJ.%26aulast%3DJeacock%26aufirst%3DL.%26aulast%3DKo%26aufirst%3DE.-J.%26aulast%3DKorczynska%26aufirst%3DJ.%26aulast%3DMacLean%26aufirst%3DL.%26aulast%3DManthri%26aufirst%3DS.%26aulast%3DMartinez%26aufirst%3DM.%2BS.%26aulast%3DMata-Cantero%26aufirst%3DL.%26aulast%3DMoniz%26aufirst%3DS.%26aulast%3DN%25C3%25BChs%26aufirst%3DA.%26aulast%3DOsuna-Cabello%26aufirst%3DM.%26aulast%3DPinto%26aufirst%3DE.%26aulast%3DRiley%26aufirst%3DJ.%26aulast%3DRobinson%26aufirst%3DS.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DShishikura%26aufirst%3DY.%26aulast%3DSpinks%26aufirst%3DD.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DThompson%26aufirst%3DS.%26aulast%3DViayna%2BGaza%26aufirst%3DE.%26aulast%3DWall%26aufirst%3DR.%2BJ.%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DHorn%26aufirst%3DD.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DFiandor%26aufirst%3DJ.%2BM.%26aulast%3DMartin%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DD.%2BW.%26aulast%3DMiles%26aufirst%3DT.%2BJ.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DMarco%26aufirst%3DM.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26atitle%3DPreclinical%2520candidate%2520for%2520the%2520treatment%2520of%2520visceral%2520leishmaniasis%2520that%2520acts%2520through%2520proteasome%2520inhibition%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2019%26volume%3D116%26spage%3D9318%26epage%3D9323%26doi%3D10.1073%2Fpnas.1820175116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moawad, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganame, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioset, J.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span> <span> </span><span class="NLM_article-title">Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e1896</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0001896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1371%2Fjournal.pntd.0001896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=23209849" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2012&author=M.+L.+Sykesauthor=J.+B.+Baellauthor=M.+Kaiserauthor=E.+Chatelainauthor=S.+R.+Moawadauthor=D.+Ganameauthor=J.-R.+Iosetauthor=V.+M.+Avery&title=Identification+of+compounds+with+anti-proliferative+activity+against+Trypanosoma+brucei+brucei+strain+427+by+a+whole+cell+viability+based+HTS+campaign&doi=10.1371%2Fjournal.pntd.0001896"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0001896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0001896%26sid%3Dliteratum%253Aachs%26aulast%3DSykes%26aufirst%3DM.%2BL.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DMoawad%26aufirst%3DS.%2BR.%26aulast%3DGaname%26aufirst%3DD.%26aulast%3DIoset%26aufirst%3DJ.-R.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26atitle%3DIdentification%2520of%2520compounds%2520with%2520anti-proliferative%2520activity%2520against%2520Trypanosoma%2520brucei%2520brucei%2520strain%2520427%2520by%2520a%2520whole%2520cell%2520viability%2520based%2520HTS%2520campaign%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2012%26volume%3D6%26doi%3D10.1371%2Fjournal.pntd.0001896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smithson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holbrook, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiplin Guy, R.</span></span> <span> </span><span class="NLM_article-title">Optimization of the electrophile of chloronitrobenzamide leads active against <i>Trypanosoma brucei</i></span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4127</span>– <span class="NLM_lpage">4131</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1016%2Fj.bmcl.2013.05.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=23746473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVCqur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4127-4131&author=J.+Y.+Hwangauthor=D.+C.+Smithsonauthor=G.+Holbrookauthor=F.+Zhuauthor=M.+C.+Connellyauthor=M.+Kaiserauthor=R.+Brunauthor=R.+Kiplin+Guy&title=Optimization+of+the+electrophile+of+chloronitrobenzamide+leads+active+against+Trypanosoma+brucei&doi=10.1016%2Fj.bmcl.2013.05.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of the electrophile of chloronitrobenzamide leads active against Trypanosoma brucei</span></div><div class="casAuthors">Hwang, Jong Yeon; Smithson, David C.; Holbrook, Gloria; Zhu, Fangyi; Connelly, Michele C.; Kaiser, Marcel; Brun, Reto; Kiplin Guy, R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4127-4131</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We previously reported the phenylchloronitrobenzamides (PCNBs), a novel class of compds. active against the species of trypanosomes that cause Human African Trypanosomiasis (HAT).  Herein, we explored the potential to adjust the reactivity of the electrophilic chloronitrobenzamide core.  These studies identified compd. 7d that potently inhibited the growth of trypanosomes (EC50 = 120 nM for Trypanosoma b. brucei, 18 nM for Trypanosoma b. rhodesiense, and 38 nM for Trypanosoma b. gambiense) without significant cytotoxicity against mammalian cell lines (EC50 > 25 μM for HepG2, HEK293, Raji, and BJ cell lines) and also had good stability in microsomal models (t1/2 > 4 h in both human and mouse).  Overall these properties indicate the compd. 7d and its analogs are worth further exploration as potential leads for HAT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH59s5PcHo4bVg90H21EOLACvtfcHk0lim758Ob6n_mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVCqur8%253D&md5=94a03896f45223eeb0f4ed6f3e5b6800</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.049%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DJ.%2BY.%26aulast%3DSmithson%26aufirst%3DD.%2BC.%26aulast%3DHolbrook%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DF.%26aulast%3DConnelly%26aufirst%3DM.%2BC.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DKiplin%2BGuy%26aufirst%3DR.%26atitle%3DOptimization%2520of%2520the%2520electrophile%2520of%2520chloronitrobenzamide%2520leads%2520active%2520against%2520Trypanosoma%2520brucei%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4127%26epage%3D4131%26doi%3D10.1016%2Fj.bmcl.2013.05.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tatipaka, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norcross, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulverson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranade, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagendar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creason, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McQueen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duster, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, M. H.</span></span> <span> </span><span class="NLM_article-title">Substituted 2-phenylimidazopyridines: a new class of drug leads for human African trypanosomiasis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">828</span>– <span class="NLM_lpage">835</span>, <span class="refDoi"> DOI: 10.1021/jm401178t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401178t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFKqtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=828-835&author=H.+B.+Tatipakaauthor=J.+R.+Gillespieauthor=A.+K.+Chatterjeeauthor=N.+R.+Norcrossauthor=M.+A.+Hulversonauthor=R.+M.+Ranadeauthor=P.+Nagendarauthor=S.+A.+Creasonauthor=J.+McQueenauthor=N.+A.+Dusterauthor=A.+Nagleauthor=F.+Supekauthor=V.+Molteniauthor=T.+Wenzlerauthor=R.+Brunauthor=R.+Glynneauthor=F.+S.+Bucknerauthor=M.+H.+Gelb&title=Substituted+2-phenylimidazopyridines%3A+a+new+class+of+drug+leads+for+human+African+trypanosomiasis&doi=10.1021%2Fjm401178t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted 2-Phenylimidazopyridines: A New Class of Drug Leads for Human African Trypanosomiasis</span></div><div class="casAuthors">Tatipaka, Hari Babu; Gillespie, J. Robert; Chatterjee, Arnab K.; Norcross, Neil R.; Hulverson, Matthew A.; Ranade, Ranae M.; Nagendar, Pendem; Creason, Sharon A.; McQueen, Joshua; Duster, Nicole A.; Nagle, Advait; Supek, Frantisek; Molteni, Valentina; Wenzler, Tanja; Brun, Reto; Glynne, Richard; Buckner, Frederick S.; Gelb, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">828-835</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A phenotypic screen of a compd. library for antiparasitic activity on Trypanosoma brucei, the causative agent of human African trypanosomiasis, led to the identification of substituted 2-(3-aminophenyl)-oxazolopyridines as a starting point for hit-to-lead medicinal chem.  A total of 110 analogs were prepd., which led to the identification of I, a substituted 2-(3-aminophenyl)-imidazopyridine.  This compd. showed antiparasitic activity in vitro with an EC50 of 2 nM and displayed reasonable druglike properties when tested in a no. of in vitro assays.  I was orally bioavailable and displayed good plasma and brain exposure in mice.  I cured mice infected with Trypanosoma brucei when dosed orally down to 2.5 mg/kg.  Given its potent antiparasitic properties and its ease of synthesis, I represents a new lead for the development of drugs to treat human African trypanosomiasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKqZdMjPCMsrVg90H21EOLACvtfcHk0lg48_JRbqu6UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFKqtLzK&md5=3ed810c038784126456b0d6d93f099eb</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm401178t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401178t%26sid%3Dliteratum%253Aachs%26aulast%3DTatipaka%26aufirst%3DH.%2BB.%26aulast%3DGillespie%26aufirst%3DJ.%2BR.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DNorcross%26aufirst%3DN.%2BR.%26aulast%3DHulverson%26aufirst%3DM.%2BA.%26aulast%3DRanade%26aufirst%3DR.%2BM.%26aulast%3DNagendar%26aufirst%3DP.%26aulast%3DCreason%26aufirst%3DS.%2BA.%26aulast%3DMcQueen%26aufirst%3DJ.%26aulast%3DDuster%26aufirst%3DN.%2BA.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DSupek%26aufirst%3DF.%26aulast%3DMolteni%26aufirst%3DV.%26aulast%3DWenzler%26aufirst%3DT.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DGlynne%26aufirst%3DR.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26atitle%3DSubstituted%25202-phenylimidazopyridines%253A%2520a%2520new%2520class%2520of%2520drug%2520leads%2520for%2520human%2520African%2520trypanosomiasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D828%26epage%3D835%26doi%3D10.1021%2Fjm401178t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferrins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahmani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teston, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almohaywi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span> <span> </span><span class="NLM_article-title">3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid <i>Trypanosoma brucei</i>, the causative agent for human African trypanosomiasis</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">465</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1016%2Fj.ejmech.2013.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=23831695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Sktb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2013&pages=450-465&author=L.+Ferrinsauthor=R.+Rahmaniauthor=M.+L.+Sykesauthor=A.+J.+Jonesauthor=V.+M.+Averyauthor=E.+Testonauthor=B.+Almohaywiauthor=J.+Yinauthor=J.+Smithauthor=C.+Hylandauthor=K.+L.+Whiteauthor=E.+Ryanauthor=M.+Campbellauthor=S.+A.+Charmanauthor=M.+Kaiserauthor=J.+B.+Baell&title=3-%28Oxazolo%5B4%2C5-b%5Dpyridin-2-yl%29anilides+as+a+novel+class+of+potent+inhibitors+for+the+kinetoplastid+Trypanosoma+brucei%2C+the+causative+agent+for+human+African+trypanosomiasis&doi=10.1016%2Fj.ejmech.2013.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis</span></div><div class="casAuthors">Ferrins, Lori; Rahmani, Raphael; Sykes, Melissa L.; Jones, Amy J.; Avery, Vicky M.; Teston, Eliott; Almohaywi, Basmah; Yin, Jie Xiang; Smith, Jason; Hyland, Chris; White, Karen L.; Ryan, Eileen; Campbell, Michael; Charman, Susan A.; Kaiser, Marcel; Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">450-465</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A whole organism high-throughput screen of approx. 87,000 compds. against Trypanosoma brucei brucei led to the recent discovery of several novel compd. classes with low micromolar activity against this organism and without appreciable cytotoxicity to mammalian cells.  Herein we report a structure-activity relation (SAR) investigation around one of these hit classes, the 3-(oxazolo[4,5-b]pyridin-2-yl)anilides.  Sharp SAR is revealed, with our most active compd. (I) exhibiting an IC50 of 91 nM against the human pathogenic strain T.b. rhodesiense and being more than 700 times less toxic towards the L6 mammalian cell line.  Physicochem. properties are attractive for many compds. in this series.  For the most potent representatives, we show that soly. and metabolic stability are key parameters to target during future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruFGlHJ2ScL7Vg90H21EOLACvtfcHk0lg48_JRbqu6UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Sktb7L&md5=12ad544172d828822118646b5b95bf6d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DFerrins%26aufirst%3DL.%26aulast%3DRahmani%26aufirst%3DR.%26aulast%3DSykes%26aufirst%3DM.%2BL.%26aulast%3DJones%26aufirst%3DA.%2BJ.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DTeston%26aufirst%3DE.%26aulast%3DAlmohaywi%26aufirst%3DB.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DHyland%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3D3-%2528Oxazolo%255B4%252C5-b%255Dpyridin-2-yl%2529anilides%2520as%2520a%2520novel%2520class%2520of%2520potent%2520inhibitors%2520for%2520the%2520kinetoplastid%2520Trypanosoma%2520brucei%252C%2520the%2520causative%2520agent%2520for%2520human%2520African%2520trypanosomiasis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D66%26spage%3D450%26epage%3D465%26doi%3D10.1016%2Fj.ejmech.2013.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagendar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbst, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranade, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molasky, N. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faghih, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, F. S.</span></span> <span> </span><span class="NLM_article-title">Triazolopyrimidines and Imidazopyridines: Structure–Activity Relationships and in Vivo Efficacy for Trypanosomiasis</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00498</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00498" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVWlu7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=105-110&author=P.+Nagendarauthor=J.+R.+Gillespieauthor=Z.+M.+Herbstauthor=R.+M.+Ranadeauthor=N.+M.+R.+Molaskyauthor=O.+Faghihauthor=R.+M.+Turnerauthor=M.+H.+Gelbauthor=F.+S.+Buckner&title=Triazolopyrimidines+and+Imidazopyridines%3A+Structure%E2%80%93Activity+Relationships+and+in+Vivo+Efficacy+for+Trypanosomiasis&doi=10.1021%2Facsmedchemlett.8b00498"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Triazolopyrimidines and Imidazopyridines: Structure-Activity Relationships and in Vivo Efficacy for Trypanosomiasis</span></div><div class="casAuthors">Nagendar, Pendem; Gillespie, J. Robert; Herbst, Zackary M.; Ranade, Ranae M.; Molasky, Nora M. R.; Faghih, Omeed; Turner, Rachael M.; Gelb, Michael H.; Buckner, Frederick S.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-110</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Better therapeutics are greatly needed to treat patients infected with trypanosomatid parasites such as Trypanosoma cruzi or Trypanosoma brucei.  This report describes 28 new imidazopyridines and triazolopyrimidines with potent and selective antitrypanosomal activity.  Drug-like properties were demonstrated in a no. of in vitro assays.  In vivo efficacy was obsd. for 19 and 20 in acute mouse models of T. cruzi infection.  Compds. 19 and 20 represent potential leads for new anti-Chagas disease drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEdftDgpm_K7Vg90H21EOLACvtfcHk0lg48_JRbqu6UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVWlu7vE&md5=edde33cd58552b8914a962b009d8d185</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00498%26sid%3Dliteratum%253Aachs%26aulast%3DNagendar%26aufirst%3DP.%26aulast%3DGillespie%26aufirst%3DJ.%2BR.%26aulast%3DHerbst%26aufirst%3DZ.%2BM.%26aulast%3DRanade%26aufirst%3DR.%2BM.%26aulast%3DMolasky%26aufirst%3DN.%2BM.%2BR.%26aulast%3DFaghih%26aufirst%3DO.%26aulast%3DTurner%26aufirst%3DR.%2BM.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26atitle%3DTriazolopyrimidines%2520and%2520Imidazopyridines%253A%2520Structure%25E2%2580%2593Activity%2520Relationships%2520and%2520in%2520Vivo%2520Efficacy%2520for%2520Trypanosomiasis%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D105%26epage%3D110%26doi%3D10.1021%2Facsmedchemlett.8b00498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallyburton, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frearson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. W.</span></span> <span> </span><span class="NLM_article-title">Comparison of a high-throughput high-content intracellular <i>Leishmania donovani</i> assay with an axenic amastigote assay</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2913</span>– <span class="NLM_lpage">2922</span>, <span class="refDoi"> DOI: 10.1128/aac.02398-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1128%2FAAC.02398-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=23571538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVartrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=2913-2922&author=M.+De%0ARyckerauthor=I.+Hallyburtonauthor=J.+Thomasauthor=L.+Campbellauthor=S.+Wyllieauthor=D.+Joshiauthor=S.+Cameronauthor=I.+H.+Gilbertauthor=P.+G.+Wyattauthor=J.+A.+Frearsonauthor=A.+H.+Fairlambauthor=D.+W.+Gray&title=Comparison+of+a+high-throughput+high-content+intracellular+Leishmania+donovani+assay+with+an+axenic+amastigote+assay&doi=10.1128%2Faac.02398-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of a high-throughput high-content intracellular Leishmania donovani assay with an axenic amastigote assay</span></div><div class="casAuthors">De Rycker, Manu; Hallyburton, Irene; Thomas, John; Campbell, Lorna; Wyllie, Susan; Joshi, Dhananjay; Cameron, Scott; Gilbert, Ian H.; Wyatt, Paul G.; Frearson, Julie A.; Fairlamb, Alan H.; Gray, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2913-2922</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Visceral leishmaniasis is a neglected tropical disease with significant health impact.  The current treatments are poor, and there is an urgent need to develop new drugs.  Primary screening assays used for drug discovery campaigns have typically used free-living forms of the Leishmania parasite to allow for high-throughput screening.  Such screens do not necessarily reflect the physiol. situation, as the disease-causing stage of the parasite resides inside human host cells.  Assessing the drug sensitivity of intracellular parasites on scale has recently become feasible with the advent of high-content screening methods.  We describe here a 384-well microscopy-based intramacrophage Leishmania donovani assay and compare it to an axenic amastigote system.  A panel of eight ref. compds. was tested in both systems, as well as a human counterscreen cell line, and our findings show that for most clin. used compds. both axenic and intramacrophage assays report very similar results.  A set of 15,659 diverse compds. was also screened using both systems.  This resulted in the identification of seven new antileishmanial compds. and revealed a high false-pos. rate for the axenic assay.  We conclude that the intramacrophage assay is more suited as a primary hit-discovery platform than the current form of axenic assay, and we discuss how modifications to the axenic assay may render it more suitable for hit-discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXnzJTYkYtJrVg90H21EOLACvtfcHk0lg1CYNF8rDBTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVartrvL&md5=9d7d79eea02abc10f3a5c26fac47de27</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1128%2FAAC.02398-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02398-12%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DCampbell%26aufirst%3DL.%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DJoshi%26aufirst%3DD.%26aulast%3DCameron%26aufirst%3DS.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DGray%26aufirst%3DD.%2BW.%26atitle%3DComparison%2520of%2520a%2520high-throughput%2520high-content%2520intracellular%2520Leishmania%2520donovani%2520assay%2520with%2520an%2520axenic%2520amastigote%2520assay%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D2913%26epage%3D2922%26doi%3D10.1128%2Faac.02398-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkley, J.</span></span> <span> </span><span class="NLM_article-title">Regulation of <i>Leishmania</i> populations within host.1. Variable course of <i>Leishmania donovani</i> infections in mice</span>. <i>Clin. Exp. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=606433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A280%3ADyaE1c7gsFynsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1977&pages=119-129&author=D.+J.+Bradleyauthor=J.+Kirkley&title=Regulation+of+Leishmania+populations+within+host.1.+Variable+course+of+Leishmania+donovani+infections+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice</span></div><div class="casAuthors">Bradley D J; Kirkley J</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and experimental immunology</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-29</span>
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    </div><div class="casAbstract">The course of infection with Leishmania donovani was followed in seven strains of laboratory mice with measurement of the liver parasite burdens over 20 weeks.  The acute parasite population growth rate varied greatly between, but not within, strains.  Four strains were relatively resistant with less than an eight-fold increase while the three acutely susceptible strains showed over an eight-fold increase in the first month.  Thereafter, one initially susceptible strain showed a dramatic fall in parasite numbers with histological liver damage while another strain maintained an immense parasite load for up to 2 years involving mononuclear phagocytes throughout the body.  The system provides a model for studying genetic control of resistance to intracellular infection and the range of responses is compared with human leprosy and cutaneous leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQulO71OOh0SLxanA7vODO6fW6udTcc2ebcX-3AjsmQe7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE1c7gsFynsg%253D%253D&md5=ed3061459c68a005a9959edf5a106881</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBradley%26aufirst%3DD.%2BJ.%26aulast%3DKirkley%26aufirst%3DJ.%26atitle%3DRegulation%2520of%2520Leishmania%2520populations%2520within%2520host.1.%2520Variable%2520course%2520of%2520Leishmania%2520donovani%2520infections%2520in%2520mice%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D1977%26volume%3D30%26spage%3D119%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Croft, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snowdon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yardley, V.</span></span> <span> </span><span class="NLM_article-title">The activities of four anticancer alkyllysophospholipids against <i>Leishmania donovani, Trypanosoma cruzi</i> and <i>Trypanosoma brucei</i></span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1041</span>– <span class="NLM_lpage">1047</span>, <span class="refDoi"> DOI: 10.1093/jac/38.6.1041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1093%2Fjac%2F38.6.1041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=9023651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADyaK2sXhtFGitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1996&pages=1041-1047&author=S.+L.+Croftauthor=D.+Snowdonauthor=V.+Yardley&title=The+activities+of+four+anticancer+alkyllysophospholipids+against+Leishmania+donovani%2C+Trypanosoma+cruzi+and+Trypanosoma+brucei&doi=10.1093%2Fjac%2F38.6.1041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei</span></div><div class="casAuthors">Croft, Simon L.; Snowdon, Diane; Yardley, Vanessa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1041-1047</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Saunders</span>)
        </div><div class="casAbstract">The in-vitro activities of four anticancer alkyllysophospholipids, ET-18-OCH3 (edelfosine), hexadecylphosphocholine (miltefosine), ilmofosine and SRI 62-834, were detd. with ED50 values for Leishmania donovani and Trypanosoma cruzi amastigotes between 0.2 and 5.0 μM and for Trypanosoma brucei trypomastigotes between 7.0 and 50.8 μM.  In BALB/c mice miltefosine and ilmofosine were the most active compds. with ED50 values of 2.9 and 14.5 mg/kg × 5 doses against L. donovani and a suppressive effect on T. cruzi infections at 30 mg/kg × 5 doses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlMJL7bxzw5rVg90H21EOLACvtfcHk0lg1CYNF8rDBTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtFGitro%253D&md5=e253981e9c2306b9108cfb71a95395b0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F38.6.1041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F38.6.1041%26sid%3Dliteratum%253Aachs%26aulast%3DCroft%26aufirst%3DS.%2BL.%26aulast%3DSnowdon%26aufirst%3DD.%26aulast%3DYardley%26aufirst%3DV.%26atitle%3DThe%2520activities%2520of%2520four%2520anticancer%2520alkyllysophospholipids%2520against%2520Leishmania%2520donovani%252C%2520Trypanosoma%2520cruzi%2520and%2520Trypanosoma%2520brucei%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D1996%26volume%3D38%26spage%3D1041%26epage%3D1047%26doi%3D10.1093%2Fjac%2F38.6.1041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klein, S.</span></span> <span> </span><span class="NLM_article-title">The use of biorelevant dissolution media to forecast the in vivo performance of a drug</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1208/s12248-010-9203-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1208%2Fs12248-010-9203-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=20458565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovVKns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=397-406&author=S.+Klein&title=The+use+of+biorelevant+dissolution+media+to+forecast+the+in+vivo+performance+of+a+drug&doi=10.1208%2Fs12248-010-9203-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The use of biorelevant dissolution media to forecast the in vivo performance of a drug</span></div><div class="casAuthors">Klein, Sandra</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">397-406</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Simulation of gastrointestinal conditions is essential to adequately predict the in vivo behavior of drug formulations.  To reduce the size and no. of human studies required to identify a drug product with appropriate performance in both the fed and fasted states, it is advantageous to be able to pre-screen formulations in vitro.  The choice of appropriate media for such in vitro tests is crucial to their ability to correctly forecast the food effect in pharmacokinetic studies.  The present paper gives an overview of the development and compn. of biorelevant dissoln. media that can be used for the in vitro simulation of different dosing conditions (fasted and fed states).  In addn., the application of these media to predicting food effects is described in several case examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQrvLqn-uuMrVg90H21EOLACvtfcHk0liZ-sA0UDbsrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovVKns7g%253D&md5=3dc6f6fb7d058c350a82edd78c00b945</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1208%2Fs12248-010-9203-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-010-9203-3%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DS.%26atitle%3DThe%2520use%2520of%2520biorelevant%2520dissolution%2520media%2520to%2520forecast%2520the%2520in%2520vivo%2520performance%2520of%2520a%2520drug%26jtitle%3DAAPS%2520J.%26date%3D2010%26volume%3D12%26spage%3D397%26epage%3D406%26doi%3D10.1208%2Fs12248-010-9203-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higashino, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masaoka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kataoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakuma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, S.</span></span> <span> </span><span class="NLM_article-title">In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs</span>. <i>Mol. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">746</span>– <span class="NLM_lpage">754</span>, <span class="refDoi"> DOI: 10.1021/mp400465p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp400465p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Gju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=746-754&author=H.+Higashinoauthor=T.+Hasegawaauthor=M.+Yamamotoauthor=R.+Matsuiauthor=Y.+Masaokaauthor=M.+Kataokaauthor=S.+Sakumaauthor=S.+Yamashita&title=In+vitro-in+vivo+correlation+of+the+effect+of+supersaturation+on+the+intestinal+absorption+of+BCS+Class+2+drugs&doi=10.1021%2Fmp400465p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro-in Vivo Correlation of the Effect of Supersaturation on the Intestinal Absorption of BCS Class 2 Drugs</span></div><div class="casAuthors">Higashino, Haruki; Hasegawa, Tsubasa; Yamamoto, Mari; Matsui, Rie; Masaoka, Yoshie; Kataoka, Makoto; Sakuma, Shinji; Yamashita, Shinji</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">746-754</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The aim of this study was to establish an in vitro method for evaluating the effect of supersatn. on oral absorption of poorly water-sol. drugs in vivo.  Albendazole, dipyridamole, gefitinib, and ketoconazole were used as model drugs.  Supersatn. of each drug was induced by dilg. its stock soln. by fasted state simulated intestinal fluid (FaSSIF) (solvent-shift method), then dissoln. and pptn. profile of the drug was obsd. in vitro.  The cryst. form of the ppt. was checked by differential scanning calorimetry (DSC).  For comparison, control suspension was prepd. by suspending a drug powder directly into FaSSIF (powder-suspending method).  In vivo intestinal absorption of the drug was obsd. in rats by detd. the plasma concn. after intraduodenal administration of drug suspensions.  For all drugs, suspensions prepd. by solvent-shift method showed significantly higher dissolved concn. in vitro than that prepd. by powder-suspending method, clearly indicated the induction of supersatn.  DSC anal. revealed that cryst. form of the ppt. profoundly affects the extent and the duration of supersatn.  A rat in vivo study confirmed that the supersatn. of these drugs increased the fraction absorbed from the intestine, which corresponded well to the in vitro dissoln. and pptn. profile of drugs except for ketoconazole.  For ketoconazole, an in vivo absorption study was performed in rats pretreated with 1-aminobenzotriazole, a potent inhibitor of CYP mediated metab.  CYP inhibition study suggested that the high luminal concn. of ketoconazole caused by supersatn. satd. the metabolic enzymes and further increased the systemic exposure of the absorbed drug.  The addnl. effects of supersatn. on the absorption of ketoconazole are consistent with previous studies in humans under differing gastric pH conditions.  In conclusion, effects of supersatn. on the intestinal absorption of poorly water-sol. drugs could be predicted from in vitro dissoln. and a pptn. study.  However if supersatn. affects the pharmacokinetic profiles of drugs, such as a first-pass metab., a combination with in vivo study should be required to evaluate its impact on oral bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_N82Ixi3qW7Vg90H21EOLACvtfcHk0liZ-sA0UDbsrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Gju7s%253D&md5=3f9999c80ad38ef958763f9a629be22c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fmp400465p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp400465p%26sid%3Dliteratum%253Aachs%26aulast%3DHigashino%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DMatsui%26aufirst%3DR.%26aulast%3DMasaoka%26aufirst%3DY.%26aulast%3DKataoka%26aufirst%3DM.%26aulast%3DSakuma%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DS.%26atitle%3DIn%2520vitro-in%2520vivo%2520correlation%2520of%2520the%2520effect%2520of%2520supersaturation%2520on%2520the%2520intestinal%2520absorption%2520of%2520BCS%2520Class%25202%2520drugs%26jtitle%3DMol.%2520Pharm.%26date%3D2014%26volume%3D11%26spage%3D746%26epage%3D754%26doi%3D10.1021%2Fmp400465p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ames, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durston, W. E.</span></span> <span> </span><span class="NLM_article-title">An improved bacterial test system for the detection and classification of mutagens and carcinogens</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">782</span>– <span class="NLM_lpage">786</span>, <span class="refDoi"> DOI: 10.1073/pnas.70.3.782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1073%2Fpnas.70.3.782" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=4577135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADyaE3sXktFGnt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1973&pages=782-786&author=B.+N.+Amesauthor=F.+D.+Leeauthor=W.+E.+Durston&title=An+improved+bacterial+test+system+for+the+detection+and+classification+of+mutagens+and+carcinogens&doi=10.1073%2Fpnas.70.3.782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Improved bacterial test system for the detection and classification of mutagens and carcinogens</span></div><div class="casAuthors">Ames, Bruce N.; Lee, Frank D.; Durston, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">782-6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Four strains of Salmonella typhimurium designed for detecting the various types of mutagens and their utility in detecting a wide variety of carcinogens as mutagens were described.  The lipopolysaccharide that normally coats these bacteria was a barrier to penetration of mutagens to the cell membrane.  The set of tester strains was improved by adding a mutation (rfa:  deep rough) that results in a deficient lipopolysaccharide.  The techniques for using these strains for detecting mutagens were presented and the tests were extremely sensitive and convenient.  The specificity of frameshift mutagenesis was clarified.  As adjuncts to the test with the 4 strains, a test that compares mutagenic killing in deep rough strains with and without DNA excision repair, and a test of forward mutagenesis in a deep rough strain lacking excision repair were described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc_-H2XtehILVg90H21EOLACvtfcHk0liZ-sA0UDbsrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXktFGnt7g%253D&md5=8579db7796e200c52a595dfef245bc7c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.70.3.782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.70.3.782%26sid%3Dliteratum%253Aachs%26aulast%3DAmes%26aufirst%3DB.%2BN.%26aulast%3DLee%26aufirst%3DF.%2BD.%26aulast%3DDurston%26aufirst%3DW.%2BE.%26atitle%3DAn%2520improved%2520bacterial%2520test%2520system%2520for%2520the%2520detection%2520and%2520classification%2520of%2520mutagens%2520and%2520carcinogens%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1973%26volume%3D70%26spage%3D782%26epage%3D786%26doi%3D10.1073%2Fpnas.70.3.782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maron, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, B. N.</span></span> <span> </span><span class="NLM_article-title">Revised methods for the Salmonella mutagenicity test</span>. <i>Mutat. Res.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1016/0165-1161(83)90010-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1016%2F0165-1161%2883%2990010-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=6341825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADyaL3sXhvFarsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1983&pages=173-215&author=D.+M.+Maronauthor=B.+N.+Ames&title=Revised+methods+for+the+Salmonella+mutagenicity+test&doi=10.1016%2F0165-1161%2883%2990010-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Revised methods for the Salmonella mutagenicity test</span></div><div class="casAuthors">Maron, Dorothy M.; Ames, Bruce N.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Environmental Mutagenesis and Related Subjects </span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">173-215</span>CODEN:
                <span class="NLM_cas:coden">MEMSE8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A revision of methods for detecting carcinogens and mutagens with the Salmonella mutagenicity test (A. et al., 1975b) is described.  Two new tester strains, a frameshift strain (TA 97) and a strain carrying an ochre mutation on a multicopy plasmid (TA 102), are added to the std. tester set.  TA 97 replaces TA 1537.  TA 1535 and 1538 are removed from the recommended set, but can be retained at the option of the investigator.  TA 98 and 100 are retained.  Other special purpose strains are discussed and minor changes in procedure, (principally in the growth, storage, and preservation of the tester strains) are presented.  Two substitutions are made in diagnostic mutagens to eliminate MNNG and 9-aminoacridine.  Some test modifications are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzIjKbxaVZYrVg90H21EOLACvtfcHk0lhPDZYBGEY5Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhvFarsb4%253D&md5=415285947b98c9ddbbd79bbe000c9dca</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2F0165-1161%2883%2990010-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1161%252883%252990010-9%26sid%3Dliteratum%253Aachs%26aulast%3DMaron%26aufirst%3DD.%2BM.%26aulast%3DAmes%26aufirst%3DB.%2BN.%26atitle%3DRevised%2520methods%2520for%2520the%2520Salmonella%2520mutagenicity%2520test%26jtitle%3DMutat.%2520Res.%26date%3D1983%26volume%3D113%26spage%3D173%26epage%3D215%26doi%3D10.1016%2F0165-1161%2883%2990010-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ames, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, E.</span></span> <span> </span><span class="NLM_article-title">Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test</span>. <i>Mutat. Res.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">363</span>, <span class="refDoi"> DOI: 10.1016/0165-1161(75)90046-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1016%2F0165-1161%2875%2990046-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=768755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADyaE28XmvFyqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1975&pages=347-363&author=B.+N.+Amesauthor=J.+McCannauthor=E.+Yamasaki&title=Methods+for+detecting+carcinogens+and+mutagens+with+the+Salmonella%2Fmammalian-microsome+mutagenicity+test&doi=10.1016%2F0165-1161%2875%2990046-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test</span></div><div class="casAuthors">Ames, Bruce N.; McCann, Joyce; Yamasaki, Edith</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">347-63</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    </div><div class="casAbstract">The general methods for using the Salmonella/microsome test as a mutagenesis screening system are described.  The methods include the std. plate test, the use and storage of bacterial tester strains, prepn. and use of the liver homogenates (S-9), and the methods of inducing rats for elevated microsomal enzyme activity.  The application of this system to screening large nos. of compds. and interpreting the test results are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXRCaWgf4xbbVg90H21EOLACvtfcHk0lhPDZYBGEY5Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XmvFyqtw%253D%253D&md5=93881a3b91fc231635ca1086b945fb5d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2F0165-1161%2875%2990046-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1161%252875%252990046-1%26sid%3Dliteratum%253Aachs%26aulast%3DAmes%26aufirst%3DB.%2BN.%26aulast%3DMcCann%26aufirst%3DJ.%26aulast%3DYamasaki%26aufirst%3DE.%26atitle%3DMethods%2520for%2520detecting%2520carcinogens%2520and%2520mutagens%2520with%2520the%2520Salmonella%252Fmammalian-microsome%2520mutagenicity%2520test%26jtitle%3DMutat.%2520Res.%26date%3D1975%26volume%3D31%26spage%3D347%26epage%3D363%26doi%3D10.1016%2F0165-1161%2875%2990046-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity</span>. <i>Drug Discov. Today</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">648</span>– <span class="NLM_lpage">655</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2010.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1016%2Fj.drudis.2010.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=20570751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVeksb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=648-655&author=A.+P.+Hillauthor=R.+J.+Young&title=Getting+physical+in+drug+discovery%3A+a+contemporary+perspective+on+solubility+and+hydrophobicity&doi=10.1016%2Fj.drudis.2010.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity</span></div><div class="casAuthors">Hill, Alan P.; Young, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">15/16</span>),
    <span class="NLM_cas:pages">648-655</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Suboptimal phys. properties have been identified as a particular shortcoming of compds. in contemporary drug discovery, contributing to high attrition levels.  An anal. of the relationship between hydrophobicity (calcd. and measured) and ∼100 k measured kinetic soly. values has been undertaken.  In line with the General Soly. Equation, ests. of hydrophobicity, particularly ACD c log D pH7.4, give a useful indication of the likely soly. classification of particular mols.  Taking ACD c log D pH7.4 values together with the no. of arom. rings in a given mol. provides enhanced prediction.  The Soly. Forecast Index' (SFI = c log D pH7.4 + #Ar) is proposed as a simple, yet effective, guide to predicting soly.  Moreover, anal. of measured distribution/partition coeff. values highlighted statistically significant shortcomings in the applicability of octanol/water as a model system for hydrophobicity detn. with poorly sol. compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdtQyfNjbFUrVg90H21EOLACvtfcHk0lhPDZYBGEY5Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVeksb3P&md5=7b201081c5586a6ea4b7af00d507d462</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DA.%2BP.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DGetting%2520physical%2520in%2520drug%2520discovery%253A%2520a%2520contemporary%2520perspective%2520on%2520solubility%2520and%2520hydrophobicity%26jtitle%3DDrug%2520Discov.%2520Today%26date%3D2010%26volume%3D15%26spage%3D648%26epage%3D655%26doi%3D10.1016%2Fj.drudis.2010.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscombe, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. P.</span></span> <span> </span><span class="NLM_article-title">Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity</span>. <i>Drug Discov. Today</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">822</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2011.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1016%2Fj.drudis.2011.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=21704184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCru7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=822-830&author=R.+J.+Youngauthor=D.+V.+S.+Greenauthor=C.+N.+Luscombeauthor=A.+P.+Hill&title=Getting+physical+in+drug+discovery+II%3A+the+impact+of+chromatographic+hydrophobicity+measurements+and+aromaticity&doi=10.1016%2Fj.drudis.2011.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity</span></div><div class="casAuthors">Young, Robert J.; Green, Darren V. S.; Luscombe, Christopher N.; Hill, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17/18</span>),
    <span class="NLM_cas:pages">822-830</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here, we review the performance of chromatog. hydrophobicity measurements in a data set of 100 000 GlaxoSmithKline compds., demonstrating the advantages of the method over octanol-water partitioning and highlighting new insights for drug discovery.  The value of chromatog. measurements, vs. other hydrophobicity ests., was supported by improved relationships with soly., permeation, cytochrome P450s, intrinsic clearance, hERG binding and promiscuity.  We also obsd. marked differentiation of the relative influence of intrinsic and effective hydrophobicity.  The summing of hydrophobicity values plus arom. ring count [log D pH7.4 (or log P) + #Ar], indicated a wide relevance for simplistic property forecast indexes' in developability assays, clearly enhanced by chromatog. values; therefore establishing new foundations for enriching property-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmIJyWi-DBW7Vg90H21EOLACvtfcHk0lhPDZYBGEY5Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCru7vF&md5=22788603a45aa77537e8666433473d14</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DGreen%26aufirst%3DD.%2BV.%2BS.%26aulast%3DLuscombe%26aufirst%3DC.%2BN.%26aulast%3DHill%26aufirst%3DA.%2BP.%26atitle%3DGetting%2520physical%2520in%2520drug%2520discovery%2520II%253A%2520the%2520impact%2520of%2520chromatographic%2520hydrophobicity%2520measurements%2520and%2520aromaticity%26jtitle%3DDrug%2520Discov.%2520Today%26date%3D2011%26volume%3D16%26spage%3D822%26epage%3D830%26doi%3D10.1016%2Fj.drudis.2011.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biggart, A.</span>; <span class="NLM_string-name">Liang, F.</span>; <span class="NLM_string-name">Mathison, C. J. N.</span>; <span class="NLM_string-name">Molteni, V.</span>; <span class="NLM_string-name">Nagle, A.</span>; <span class="NLM_string-name">Supek, F.</span>; <span class="NLM_string-name">Yeh, V.</span></span> <span> </span><span class="NLM_article-title">[1,2,4]Triazolo[1,5-A]pyrimidine derivatives as protozoan proteasome inhibitors for the treatment of parasitic diseases such as leishmaniasis</span>. <span class="NLM_patent">WO 2015095477 A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+Biggart&author=F.+Liang&author=C.+J.+N.+Mathison&author=V.+Molteni&author=A.+Nagle&author=F.+Supek&author=V.+Yeh&title=%5B1%2C2%2C4%5DTriazolo%5B1%2C5-A%5Dpyrimidine+derivatives+as+protozoan+proteasome+inhibitors+for+the+treatment+of+parasitic+diseases+such+as+leishmaniasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBiggart%26aufirst%3DA.%26atitle%3D%255B1%252C2%252C4%255DTriazolo%255B1%252C5-A%255Dpyrimidine%2520derivatives%2520as%2520protozoan%2520proteasome%2520inhibitors%2520for%2520the%2520treatment%2520of%2520parasitic%2520diseases%2520such%2520as%2520leishmaniasis%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitaura, K.</span></span> <span> </span><span class="NLM_article-title">Exploring chemistry with the fragment molecular orbital method</span>. <i>Phys. Chem. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">7562</span>– <span class="NLM_lpage">7577</span>, <span class="refDoi"> DOI: 10.1039/c2cp23784a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1039%2Fc2cp23784a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=22410762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvVykurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=7562-7577&author=D.+G.+Fedorovauthor=T.+Nagataauthor=K.+Kitaura&title=Exploring+chemistry+with+the+fragment+molecular+orbital+method&doi=10.1039%2Fc2cp23784a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring chemistry with the fragment molecular orbital method</span></div><div class="casAuthors">Fedorov, Dmitri G.; Nagata, Takeshi; Kitaura, Kazuo</div><div class="citationInfo"><span class="NLM_cas:title">Physical Chemistry Chemical Physics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7562-7577</span>CODEN:
                <span class="NLM_cas:coden">PPCPFQ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9076</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The fragment MO (FMO) method makes possible nearly linear scaling calcns. of large mol. systems, such as water clusters, proteins and DNA.  In particular, FMO has been widely used in biochem. applications involving protein-ligand binding and drug design.  The method has been efficiently parallelized suitable for petascale computing.  Many commonly used wave functions and solvent models have been interfaced with FMO.  We review the historical background of FMO, and summarize its method development and applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_TiaN_HBr9rVg90H21EOLACvtfcHk0lgbgXHYMhZKuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvVykurw%253D&md5=903e3457b1dc5749950ebae5c954960a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2Fc2cp23784a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2cp23784a%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DD.%2BG.%26aulast%3DNagata%26aufirst%3DT.%26aulast%3DKitaura%26aufirst%3DK.%26atitle%3DExploring%2520chemistry%2520with%2520the%2520fragment%2520molecular%2520orbital%2520method%26jtitle%3DPhys.%2520Chem.%2520Chem.%2520Phys.%26date%3D2012%26volume%3D14%26spage%3D7562%26epage%3D7577%26doi%3D10.1039%2Fc2cp23784a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitaura, K.</span></span> <span> </span><span class="NLM_article-title">Pair interaction energy decomposition analysis</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">222</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1002/jcc.20496</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1002%2Fjcc.20496" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=17109433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktVKgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=222-237&author=D.+G.+Fedorovauthor=K.+Kitaura&title=Pair+interaction+energy+decomposition+analysis&doi=10.1002%2Fjcc.20496"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Pair interaction energy decomposition analysis</span></div><div class="casAuthors">Fedorov, Dmitri G.; Kitaura, Kazuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">222-237</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The energy decompn. anal. (EDA) by Kitaura and Morokuma was redeveloped in the framework of the fragment MO method (FMO).  The proposed pair interaction energy decompn. anal. (PIEDA) can treat large mol. clusters and the systems in which fragments are connected by covalent bonds, such as proteins.  The interaction energy in PIEDA is divided into the same contributions as in EDA: the electrostatic, exchange-repulsion, and charge transfer energies, to which the correlation (dispersion) term was added.  The careful comparison to the ab initio EDA interaction energies for water clusters with 2-16 mols. revealed that PIEDA has the error of at most 1.2 kcal/mol (or about 1%).  The anal. was applied to (H2O)1024, the α helix, β turn, and β strand of polyalanine (ALA)10, as well as to the synthetic protein (PDB code 1L2Y) with 20 residues.  The comparative aspects of the polypeptide isomer stability are discussed in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ89I3W8YX1LVg90H21EOLACvtfcHk0lgbgXHYMhZKuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktVKgug%253D%253D&md5=759c711290fe1c44b7c86a28104ccef7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20496%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DD.%2BG.%26aulast%3DKitaura%26aufirst%3DK.%26atitle%3DPair%2520interaction%2520energy%2520decomposition%2520analysis%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2007%26volume%3D28%26spage%3D222%26epage%3D237%26doi%3D10.1002%2Fjcc.20496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brand, S.</span>; <span class="NLM_string-name">Dodd, P. G.</span>; <span class="NLM_string-name">Ko, E.-J.</span>; <span class="NLM_string-name">Marco Martin, M.</span>; <span class="NLM_string-name">Miles, T. J.</span>; <span class="NLM_string-name">Sandberg, L. H.</span>; <span class="NLM_string-name">Thomas, M. G.</span>; <span class="NLM_string-name">Thompson, S.</span></span> <span> </span><span class="NLM_article-title">Compounds</span>. <span class="NLM_patent">WO 2017025416 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=S.+Brand&author=P.+G.+Dodd&author=E.-J.+Ko&author=M.+Marco+Martin&author=T.+J.+Miles&author=L.+H.+Sandberg&author=M.+G.+Thomas&author=S.+Thompson&title=Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrand%26aufirst%3DS.%26atitle%3DCompounds%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luescher, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vo, C.-V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, J. W.</span></span> <span> </span><span class="NLM_article-title">SnAP Reagents for the Synthesis of Piperazines and Morpholines</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1236</span>– <span class="NLM_lpage">1239</span>, <span class="refDoi"> DOI: 10.1021/ol500210z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol500210z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVartb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=1236-1239&author=M.+U.+Luescherauthor=C.-V.+T.+Voauthor=J.+W.+Bode&title=SnAP+Reagents+for+the+Synthesis+of+Piperazines+and+Morpholines&doi=10.1021%2Fol500210z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">SnAP reagents for the synthesis of piperazines and morpholines</span></div><div class="casAuthors">Luescher, Michael U.; Vo, Cam-Van T.; Bode, Jeffrey W.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1236-1239</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Substituted piperazines and morpholines are valuable structural motifs in biol. active compds., but are not easily prepd. by contemporary cross-coupling approaches.  In this report, we introduce SnAP reagents for the transformation of aldehydes into N-unprotected piperazines and morpholines.  This approach offers simple, mild conditions compatible with arom., heteroarom., aliph., and glyoxylic aldehydes and provides mono- and disubstituted N-heterocycles in a single step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDtifHDDeIMrVg90H21EOLACvtfcHk0lgbgXHYMhZKuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVartb0%253D&md5=a6fc1ed4cc7b7d7c859fd992c14d161b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fol500210z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol500210z%26sid%3Dliteratum%253Aachs%26aulast%3DLuescher%26aufirst%3DM.%2BU.%26aulast%3DVo%26aufirst%3DC.-V.%2BT.%26aulast%3DBode%26aufirst%3DJ.%2BW.%26atitle%3DSnAP%2520Reagents%2520for%2520the%2520Synthesis%2520of%2520Piperazines%2520and%2520Morpholines%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D1236%26epage%3D1239%26doi%3D10.1021%2Fol500210z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Law, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ukuser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tape, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbot, E. P. A.</span></span> <span> </span><span class="NLM_article-title">Regioselective Synthesis of 3-Aminoimidazo[1,2-a]pyrimidines with Triflic Anhydride</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3775</span>– <span class="NLM_lpage">3793</span>, <span class="refDoi"> DOI: 10.1055/s-0036-1588425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1055%2Fs-0036-1588425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC2sXps1Gqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2017&pages=3775-3793&author=R.+P.+Lawauthor=S.+Ukuserauthor=D.+T.+Tapeauthor=E.+P.+A.+Talbot&title=Regioselective+Synthesis+of+3-Aminoimidazo%5B1%2C2-a%5Dpyrimidines+with+Triflic+Anhydride&doi=10.1055%2Fs-0036-1588425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Regioselective Synthesis of 3-Aminoimidazo[1,2-a]pyrimidines with Triflic Anhydride</span></div><div class="casAuthors">Law, Robert P.; Ukuser, Sabri; Tape, Daniel T.; Talbot, Eric P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3775-3793</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">1437-210X</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">The regioselective synthesis of 3-aminoimidazo[1,2- a]pyrimidines via triflic anhydride mediated amide activation and intramol. cyclization is reported.  The nature of the added pyridine base allows access to both regioisomers from a simple common precursor [e.g., treatment of pyrimidine amide I with Tf2O and pyridine bases yielded II + III (yield ratios 8:45 % using 2,6-difluoropyridine and 83:9 % using 2-fluoropyridine)].  The method tolerates a range of functional groups and provides access to novel heterocyclic scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5U8cHg7us2LVg90H21EOLACvtfcHk0ljm7vXV0GnpCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXps1Gqs7w%253D&md5=669b29f0bc0bc5e8cd5945cee0486ef7</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1055%2Fs-0036-1588425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0036-1588425%26sid%3Dliteratum%253Aachs%26aulast%3DLaw%26aufirst%3DR.%2BP.%26aulast%3DUkuser%26aufirst%3DS.%26aulast%3DTape%26aufirst%3DD.%2BT.%26aulast%3DTalbot%26aufirst%3DE.%2BP.%2BA.%26atitle%3DRegioselective%2520Synthesis%2520of%25203-Aminoimidazo%255B1%252C2-a%255Dpyrimidines%2520with%2520Triflic%2520Anhydride%26jtitle%3DSynthesis%26date%3D2017%26volume%3D49%26spage%3D3775%26epage%3D3793%26doi%3D10.1055%2Fs-0036-1588425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bode, C.</span>; <span class="NLM_string-name">Boezio, A.</span>; <span class="NLM_string-name">Cheng, A. C.</span>; <span class="NLM_string-name">Choquette, D.</span>; <span class="NLM_string-name">Coats, J. R.</span>; <span class="NLM_string-name">Copeland, K. W.</span>; <span class="NLM_string-name">Huang, H.</span>; <span class="NLM_string-name">La, D.</span>; <span class="NLM_string-name">Lewis, R.</span>; <span class="NLM_string-name">Liao, H.</span>; <span class="NLM_string-name">Potashman, M.</span>; <span class="NLM_string-name">Stellwagen, J.</span>; <span class="NLM_string-name">Yl, S.</span>; <span class="NLM_string-name">Norman, M.</span>; <span class="NLM_string-name">Stec, M.</span>; <span class="NLM_string-name">Peterson, E. A.</span>; <span class="NLM_string-name">Gracefa, R.</span></span> <span> </span><span class="NLM_article-title">Heteroaryl compounds as PIKK inhibitors</span>. U.S. Patent <span class="NLM_patent">US 20,120,190,666 A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=C.+Bode&author=A.+Boezio&author=A.+C.+Cheng&author=D.+Choquette&author=J.+R.+Coats&author=K.+W.+Copeland&author=H.+Huang&author=D.+La&author=R.+Lewis&author=H.+Liao&author=M.+Potashman&author=J.+Stellwagen&author=S.+Yl&author=M.+Norman&author=M.+Stec&author=E.+A.+Peterson&author=R.+Gracefa&title=Heteroaryl+compounds+as+PIKK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBode%26aufirst%3DC.%26atitle%3DHeteroaryl%2520compounds%2520as%2520PIKK%2520inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0032.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0032.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Compounds <b>1</b> (DDD01305143/GSK3494245), <b>2</b> (LXE408), <b>3</b> (initial hit), and <b>4</b> (early lead).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Numbering for the imidazo[1,2-<i>a</i>]pyrimidine scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Tautomerization of scaffold <b>S-11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Summary of the SAR around the core scaffold.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>1</b> bound to the β4 (light blue) and β5 (white) subunits of the <i>L. tarentolae</i> 20S structure. PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QM7">6QM7</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) View of compound <b>1</b> binding in the <i>L. donovani</i> 20S proteasome model β4 and β5 subunits. Shown in stick form are the 12 residues that have a FMO-PIE <−3 kcal/mol; colored red if FMO-PIE <−30 kcal/mol, orange if between −30 and −10 kcal/mol, and yellow if FMO-PIE between −10 and −3 kcal/mol. (B) FMO-PIE decomposition analysis results showing, for each residue within 5 Å, the contribution of the four energy terms: electrostatic (<b>yellow</b> bar), exchange-repulsion (<b>green</b> bar), charge transfer (<b>red</b> bar), and dispersion (<b>blue</b> bar). (C) FMO-PIE generated contribution to compound <b>1</b> binding energy per fragment residues within 5 Å from the ligand.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Molecular ESP maps for some of the studied analogues. Protein surfaces were generated using the APBS plugin for PyMol and colored by calculated charges (red −5 kbT/ec, blue +5 kbT/ec). The ligand surfaces were generated using Jaguar in Schrödinger and colored by the electrostatic potential (red −80 kcal/mol, blue +75 kcal/mol).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. FMO-PIE generated contribution to binding energy in kcal/mol per fragment residues within 5 Å from the ligand calculated for compound <b>1</b> analogues. Red indicates favorable, whereas green indicates unfavorable interaction energies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Superimposition of a 6,5-bi-cyclic system (compound <b>1</b>, shown in green) with a 5,6-bi-cyclic system (compound <b>24</b>, shown in orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>5–13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and Conditions: (a) trimethyl(phenyl)ammonium tribromide, THF, RT, 18 h; (b) MeCN, 60 °C, 4 d, 43% over two steps; (c) SnCl<sub>2</sub>, EtOH, reflux, 2 d, quant.; and (d) pyrrolidine-1-carbonyl chloride, DMAP, pyridine, 40 °C, 2 d, 9–36%.</p></p></figure><figure data-id="sch2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>15</b> and <b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and Conditions: (a) trimethyl(phenyl)ammonium tribromide (1 equiv.), THF, RT, 18 h, 73%; (b) MeCN, 60 °C, 2 d, 43%; (c) trimethyl(phenyl)ammonium tribromide (1 equiv), THF, 60 °C, 18 h, 46%; (d) morpholine and THF, 35 °C, 18 h, then aminoguanidine bicarbonate, acetic acid, MeOH, 60 °C, 18 h, 26%; (e) 2-bromo-1,1-diethoxy-ethane, HBr, water, 90 °C, 30 min, 36%; (f) Br<sub>2</sub>, NaOAc, acetic acid, RT, 1 h, 50%; (g) Pd(PPh<sub>3</sub>)<sub>4</sub>, sodium carbonate, DMF, 80 °C, 18 h, 38%.</p></p></figure><figure data-id="sch3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compound <b>16</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and Conditions: (a) 2-bromopropanedial, AcOH, EtOH, 75 °C, 30 min, 66%; (b) benzeneboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, KOAc, dioxane, 3 h, 64%; (c) Fe, NH<sub>4</sub>Cl, EtOH, water, 75 °C, 2 h; (d) pyrrolidine-1-carbonyl chloride, DMAP, pyridine, DCM, 70 °C, 48 h, 62% over two steps.</p></p></figure><figure data-id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>17</b> and <b>22</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and Conditions: (a) pyrrolidine-1-carbonyl chloride, DMAP, pyridine, DCM, 50 °C, 18 h, 79%; (b) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, CuI, NEt<sub>3</sub>, DMF, 80 °C, 18 h, 46%; (c) KO<i>t</i>Bu, NMP, 75 °C, 18 h, 57%; (d) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, CuI, NEt<sub>3</sub>, MeCN, RT, 6 h; (e) morpholine, 50 °C, 18 h, 12% over two steps.</p></p></figure><figure data-id="sch5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds <b>18</b>, <b>20</b>, <b>21</b>, and <b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and Conditions: (a) (i) Fe, NH<sub>4</sub>Cl, EtOH, water, 75 °C, 2 h. (ii) pyrrolidine-1-carbonyl chloride, DMAP, pyridine, DCM, 50 °C, 18 h, 78%; (b) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, CuI, NEt<sub>3</sub>, DMF, RT, 30 min, 23%; (c) KO<i>t</i>Bu, NMP, 75 °C, 2 h, 86%; (d) morpholine, Pd<sub>2</sub>dba<sub>3</sub>, Xphos, NaO<i>t</i>Bu, DMF, 110 °C, 2 h, 26%; (e) CuI, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>4</sub>, NEt<sub>3</sub>, DMF, 50 °C, 16 h, 69%; (f) morpholine, RuPhos, Pd<sub>2</sub>(dba)<sub>3</sub>, KHMDS, 1,3-dioxane, 90 °C, 15%; (g) CuI, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, NEt<sub>3</sub>, DMF, 80 °C, 2 h, 81%; (h) Silver nitrate, TFA, DCM, RT, 0.5 h, 89%; (i) morpholine, Pd<sub>2</sub>dba<sub>3</sub>, Xphos, NaO<i>t</i>Bu, DMF, 100 °C, 1 h, 33%; (j) LDA, ethyl chloroformate, THF, −78 °C, 2 h, 91%; (k) DBU, MeCN, RT, 18 h, 26%; (l) HBr, 120 °C, 1 h, 26%; (m) (i) iron, NH<sub>4</sub>Cl, EtOH, water, 80 °C, 4 h. (ii) Pyrrolidine-1-carbonyl chloride, DMAP, pyridine, DCM, 50 °C, 18 h, 24% over three steps.</p></p></figure><figure data-id="sch6" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compound <b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NaH, MeI, THF, 0 °C, 5 h, 70%; (b) morpholine, NaO<i>t</i>Bu, Pd<sub>2</sub>(dba)<sub>3</sub>, xantphos, toluene, 80 °C, 18 h, 48%; (c) DMAP, pyridine, DCM, 50 °C, 18 h, 82%; (d) Pd(OAc)<sub>2</sub>, 2-nitrobenzoic acid, Ag<sub>2</sub>O, DMF, 90 °C, 18 h, 2%.</p></p></figure><figure data-id="sch7" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0017.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compound <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>O</i>-(mesitylsulfonyl)hydroxylamine, DCM, MeOH, 0 °C, 10 min; (b) (i) pyrrolidine-1-carbonyl chloride, DMAP, pyridine, DCM, 60 °C, 3 h; (ii) NaOH, water, MeOH, RT, 18 h, 64% over two steps; (c) SOCl<sub>2</sub>, DCM, 50 °C, 1 h; (d) DIPEA, MeCN, 80 °C, 24 h, 13% over two steps.</p></p></figure><figure data-id="sch8" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0018.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Compound <b>25</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) hydrazine hydrate, MeOH, 80 °C, 18 h, 99%; (b) 2-fluoro-5-nitrobenzaldehyde, EtOH, RT, 18 h, 93%; (c) iodobenzene diacetate, DCM, RT, 18 h, 87%; (d) formic acid, reflux, 5 h, 90%; (e) iron, NH<sub>4</sub>Cl, EtOH, THF, water, 75 °C, 18 h, 79%; (f) (i) morpholine, 100 °C, 1 h. (ii) pyrrolidine-1-carbonyl chloride, DMAP, pyridine, 50 °C, 18 h, 29%.</p></p></figure><figure data-id="sch9" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0019.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthesis of Compound <b>29–31</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) HBr, EtOH, 80 °C, 9 h; (b) Br<sub>2</sub>, NaOAc, MeOH, RT, 0.5 h, 34% over two steps; (c) 2-pyridineboronic acid, Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, water, 100 °C, 10 h, 10%; (d) EtOH, reflux, 4 h, 25–59%.</p></p></figure><figure data-id="sch10" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0020.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Synthesis of Compounds <b>32</b> and <b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) paraformaldehyde, morpholine, acetic acid, 50 °C, 18 h; (b) (i) iron, NH<sub>4</sub>Cl, EtOH, water, 80 °C, 18 h; (ii) pyrrolidine-1-carbonyl chloride, DMAP, pyridine, DCM, 50 °C, 18 h, 7% over three steps; (c) POCl<sub>3</sub>, DMF, 80 °C, 20 h; (d) 2-[(tributylstannyl)methoxy]ethanamine (SnAP-M), DCM, then 2,6-lutidine, hexafluoro-2-propanol, Cu(OTf)<sub>2</sub>, 50 °C, 3 h, 50% over two steps; (e) Boc<sub>2</sub>O, MeOH, 50 °C, 3 h, 62%; (f) (i) iron, NH<sub>4</sub>Cl, EtOH, water, 75 °C, 3 h (ii) pyrrolidine-1-carbonyl chloride, DMAP, pyridine, DCM, 50 °C, 20 h, 36%; (g) (i) TFA DCM, RT, 1 h; (ii) paraformaldehyde, acetic acid, THF, RT, 4 h, then sodium triacetoxyborohydride, RT, 24 h, 28%.</p></p></figure><figure data-id="sch11" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0021.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Synthesis of Compounds <b>1</b>, <b>34–38</b>, and <b>41–43</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) EtOH, RT, 12 h, 83%; (b) ZnBr<sub>2</sub>, DCM, reflux, 12 h, 5–46%.</p></p></figure><figure data-id="sch12" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/medium/jm1c00047_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0022.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Synthesis of Compounds <b>39</b>, <b>40</b>, and <b>44–46</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.1c00047/20210506/images/large/jm1c00047_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00047&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) DIPEA, 1,4-dioxane, 120 °C, 18 h, 56%; (b) POCl<sub>3</sub>, 80 °C, 1 h, 67%; (c) (i) Pd/C, H<sub>2</sub>, MeOH, RT, 18 h; (ii) CDI, DIPEA, DCM, 18 h, then pyrrolidine, RT, 4.5 h, 22–46%.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00046" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00046" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alves, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilbe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blesson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monnerat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mowbray, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muthoni
Ouattara, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pécoul, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rijal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rode, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solomos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strub-Wourgaft, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasunna, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zijlstra, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arana, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvar, J.</span></span> <span> </span><span class="NLM_article-title">Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives</span>. <i>Clin. Microbiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">e00048</span>– <span class="NLM_lpage">00018</span>, <span class="refDoi"> DOI: 10.1128/cmr.00048-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1128%2FCMR.00048-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=30158301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVKjtLbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2018&pages=e00048-00018&author=F.+Alvesauthor=G.+Bilbeauthor=S.+Blessonauthor=V.+Goyalauthor=S.+Monneratauthor=C.+Mowbrayauthor=G.+Muthoni%0AOuattaraauthor=B.+P%C3%A9coulauthor=S.+Rijalauthor=J.+Rodeauthor=A.+Solomosauthor=N.+Strub-Wourgaftauthor=M.+Wasunnaauthor=S.+Wellsauthor=E.+E.+Zijlstraauthor=B.+Aranaauthor=J.+Alvar&title=Recent+Development+of+Visceral+Leishmaniasis+Treatments%3A+Successes%2C+Pitfalls%2C+and+Perspectives&doi=10.1128%2Fcmr.00048-18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Recent development of visceral leishmaniasis treatments: successes, pitfalls, and perspectives</span></div><div class="casAuthors">Alves, Fabiana; Bilbe, Graeme; Blesson, Severine; Goyal, Vishal; Monnerat, Severine; Mowbray, Charles; Ouattara, Gina Muthoni; Pecoul, Bernard; Rijal, Suman; Rode, Joelle; Solomos, Alexandra; Strub-Wourgaft, Nathalie; Wasunna, Monique; Wells, Susan; Zijlstra, Eduard E.; Arana, Byron; Alvar, Jorge</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e00048</span>CODEN:
                <span class="NLM_cas:coden">CMIREX</span>;
        ISSN:<span class="NLM_cas:issn">1098-6618</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Research in visceral leishmaniasis in the last decade has been focused on how better to use the existing medicines as monotherapy or in combination.  Systematic research by geog. regions has shown that a universal treatment is far from today's reality.  Substantial progress has been made in the elimination of kala-azar in South Asia, with a clear strategy on first- and second-line therapy options of single-dose liposomal amphotericin B and a combination of paromomycin and miltefosine, resp., among other interventions.  In Eastern Africa, sodium stibogluconate (SSG) and paromomycin in combination offer an advantage compared to the previous SSG monotherapy, although not exempted of limitations, as this therapy requires 17 days of painful double injections and bears the risk of SSG-related cardiotoxicity.  In this region, attempts to improve the combination therapy have been unsuccessful.  However, pharmacokinetic studies have led to a better understanding of underlying mechanisms, like the underexposure of children to miltefosine treatment, and an improved regimen using an allometric dosage.  Given this global scenario of progress and pitfalls, we here review what steps need to be taken with existing medicines and highlight the urgent need for oral drugs.  Furthermore, it should be noted that six candidates belonging to five new chem. classes are reaching phase I, ensuring an optimistic near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDPEfQ3wVInrVg90H21EOLACvtfcHk0lg_G7fyBTi7nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVKjtLbK&md5=2e599e12de044cffa746fc336bbc0c11</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1128%2FCMR.00048-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.00048-18%26sid%3Dliteratum%253Aachs%26aulast%3DAlves%26aufirst%3DF.%26aulast%3DBilbe%26aufirst%3DG.%26aulast%3DBlesson%26aufirst%3DS.%26aulast%3DGoyal%26aufirst%3DV.%26aulast%3DMonnerat%26aufirst%3DS.%26aulast%3DMowbray%26aufirst%3DC.%26aulast%3DMuthoni%2BOuattara%26aufirst%3DG.%26aulast%3DP%25C3%25A9coul%26aufirst%3DB.%26aulast%3DRijal%26aufirst%3DS.%26aulast%3DRode%26aufirst%3DJ.%26aulast%3DSolomos%26aufirst%3DA.%26aulast%3DStrub-Wourgaft%26aufirst%3DN.%26aulast%3DWasunna%26aufirst%3DM.%26aulast%3DWells%26aufirst%3DS.%26aulast%3DZijlstra%26aufirst%3DE.%2BE.%26aulast%3DArana%26aufirst%3DB.%26aulast%3DAlvar%26aufirst%3DJ.%26atitle%3DRecent%2520Development%2520of%2520Visceral%2520Leishmaniasis%2520Treatments%253A%2520Successes%252C%2520Pitfalls%252C%2520and%2520Perspectives%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2018%26volume%3D31%26spage%3De00048%26epage%3D00018%26doi%3D10.1128%2Fcmr.00048-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Field, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, M. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrie, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span> <span> </span><span class="NLM_article-title">Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1038/nrmicro.2016.193</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1038%2Fnrmicro.2016.193" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=28239154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVSms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=217-231&author=M.+C.+Fieldauthor=D.+Hornauthor=A.+H.+Fairlambauthor=M.+A.+J.+Fergusonauthor=D.+W.+Grayauthor=K.+D.+Readauthor=M.+De+Ryckerauthor=L.+S.+Torrieauthor=P.+G.+Wyattauthor=S.+Wyllieauthor=I.+H.+Gilbert&title=Anti-trypanosomatid+drug+discovery%3A+an+ongoing+challenge+and+a+continuing+need&doi=10.1038%2Fnrmicro.2016.193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need</span></div><div class="casAuthors">Field, Mark C.; Horn, David; Fairlamb, Alan H.; Ferguson, Michael A. J.; Gray, David W.; Read, Kevin D.; De Rycker, Manu; Torrie, Leah S.; Wyatt, Paul G.; Wyllie, Susan; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">217-231</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The WHO recognizes human African trypanosomiasis, Chagas disease and the leishmaniases as neglected tropical diseases.  These diseases are caused by parasitic trypanosomatids and range in severity from mild and self-curing to near invariably fatal.  Public health advances have substantially decreased the effect of these diseases in recent decades but alone will not eliminate them.  In this Review, we discuss why new drugs against trypanosomatids are required, approaches that are under investigation to develop new drugs and why the drug discovery pipeline remains essentially unfilled.  In addn., we consider the important challenges to drug discovery strategies and the new technologies that can address them.  The combination of new drugs, new technologies and public health initiatives is essential for the management, and hopefully eventual elimination, of trypanosomatid diseases from the human population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIBpRGL7YaP7Vg90H21EOLACvtfcHk0lg_G7fyBTi7nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVSms7Y%253D&md5=1585d954d6eb695196a6c8921a84e300</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro.2016.193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro.2016.193%26sid%3Dliteratum%253Aachs%26aulast%3DField%26aufirst%3DM.%2BC.%26aulast%3DHorn%26aufirst%3DD.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DGray%26aufirst%3DD.%2BW.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DTorrie%26aufirst%3DL.%2BS.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DAnti-trypanosomatid%2520drug%2520discovery%253A%2520an%2520ongoing%2520challenge%2520and%2520a%2520continuing%2520need%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2017%26volume%3D15%26spage%3D217%26epage%3D231%26doi%3D10.1038%2Fnrmicro.2016.193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baragaña, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duce, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span> <span> </span><span class="NLM_article-title">Challenges and recent progress in drug discovery for tropical diseases</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>559</i></span>,  <span class="NLM_fpage">498</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1038/s41586-018-0327-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1038%2Fs41586-018-0327-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=30046073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtl2jt7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=559&publication_year=2018&pages=498-506&author=M.+De%0ARyckerauthor=B.+Baraga%C3%B1aauthor=S.+L.+Duceauthor=I.+H.+Gilbert&title=Challenges+and+recent+progress+in+drug+discovery+for+tropical+diseases&doi=10.1038%2Fs41586-018-0327-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Challenges and recent progress in drug discovery for tropical diseases</span></div><div class="casAuthors">De Rycker, Manu; Baragana, Beatriz; Duce, Suzanne L.; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">559</span>
        (<span class="NLM_cas:issue">7715</span>),
    <span class="NLM_cas:pages">498-506</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Infectious tropical diseases have a huge effect in terms of mortality and morbidity, and impose a heavy economic burden on affected countries.  These diseases predominantly affect the world's poorest people.  Currently available drugs are inadequate for the majority of these diseases, and there is an urgent need for new treatments.  This Review discusses some of the challenges involved in developing new drugs to treat these diseases and highlights recent progress.  While there have been notable successes, there is still a long way to go.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-L8-tHy6aTbVg90H21EOLACvtfcHk0lhwRRwpILjfzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtl2jt7zP&md5=3bc57ce68776462cf6a053efa276a989</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fs41586-018-0327-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-018-0327-4%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DBaraga%25C3%25B1a%26aufirst%3DB.%26aulast%3DDuce%26aufirst%3DS.%2BL.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DChallenges%2520and%2520recent%2520progress%2520in%2520drug%2520discovery%2520for%2520tropical%2520diseases%26jtitle%3DNature%26date%3D2018%26volume%3D559%26spage%3D498%26epage%3D506%26doi%3D10.1038%2Fs41586-018-0327-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><a href="http://www.who.int/mediacentre/factsheets/fs375/en/" class="extLink">http://www.who.int/mediacentre/factsheets/fs375/en/</a> (accessed March 13, 2021).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.who.int%2Fmediacentre%2Ffactsheets%2Ffs375%2Fen%2F+%28accessed+March+13%2C+2021%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><a href="https://dndi.org/research-development/portfolio/" class="extLink">https://dndi.org/research-development/portfolio/</a>. (accessed March 13, 2021).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fdndi.org%2Fresearch-development%2Fportfolio%2F.+%28accessed+March+13%2C+2021%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gresham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urbaniak, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLean, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccotto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homeyer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pflaumer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boesche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sastry, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berriman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidelli-Disse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiandor, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, M. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span> <span> </span><span class="NLM_article-title">Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>560</i></span>,  <span class="NLM_fpage">192</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.1038/s41586-018-0356-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1038%2Fs41586-018-0356-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=30046105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtl2jt77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=560&publication_year=2018&pages=192-197&author=S.+Wyllieauthor=M.+Thomasauthor=S.+Pattersonauthor=S.+Crouchauthor=M.+De+Ryckerauthor=R.+Loweauthor=S.+Greshamauthor=M.+D.+Urbaniakauthor=T.+D.+Ottoauthor=L.+Stojanovskiauthor=F.+R.+C.+Simeonsauthor=S.+Manthriauthor=L.+M.+MacLeanauthor=F.+Zuccottoauthor=N.+Homeyerauthor=H.+Pflaumerauthor=M.+Boescheauthor=L.+Sastryauthor=P.+Connollyauthor=S.+Albrechtauthor=M.+Berrimanauthor=G.+Drewesauthor=D.+W.+Grayauthor=S.+Ghidelli-Disseauthor=S.+Dixonauthor=J.+M.+Fiandorauthor=P.+G.+Wyattauthor=M.+A.+J.+Fergusonauthor=A.+H.+Fairlambauthor=T.+J.+Milesauthor=K.+D.+Readauthor=I.+H.+Gilbert&title=Cyclin-dependent+kinase+12+is+a+drug+target+for+visceral+leishmaniasis&doi=10.1038%2Fs41586-018-0356-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis</span></div><div class="casAuthors">Wyllie, Susan; Thomas, Michael; Patterson, Stephen; Crouch, Sabrinia; De Rycker, Manu; Lowe, Rhiannon; Gresham, Stephanie; Urbaniak, Michael D.; Otto, Thomas D.; Stojanovski, Laste; Simeons, Frederick R. C.; Manthri, Sujatha; MacLean, Lorna M.; Zuccotto, Fabio; Homeyer, Nadine; Pflaumer, Hannah; Boesche, Markus; Sastry, Lalitha; Connolly, Paul; Albrecht, Sebastian; Berriman, Matt; Drewes, Gerard; Gray, David W.; Ghidelli-Disse, Sonja; Dixon, Susan; Fiandor, Jose M.; Wyatt, Paul G.; Ferguson, Michael A. J.; Fairlamb, Alan H.; Miles, Timothy J.; Read, Kevin D.; Gilbert, Ian H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">560</span>
        (<span class="NLM_cas:issue">7717</span>),
    <span class="NLM_cas:pages">192-197</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Visceral leishmaniasis causes considerable mortality and morbidity in many parts of the world.  There is an urgent need for the development of new, effective treatments for this disease.  Here we describe the development of an anti-leishmanial drug-like chem. series based on a pyrazolopyrimidine scaffold.  The leading compd. from this series (7, DDD853651/GSK3186899) is efficacious in a mouse model of visceral leishmaniasis, has suitable physicochem., pharmacokinetic and toxicol. properties for further development, and has been declared a preclin. candidate.  Detailed mode-of-action studies indicate that compds. from this series act principally by inhibiting the parasite cdc-2-related kinase 12 (CRK12), thus defining a druggable target for visceral leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWvpd9EzGFxLVg90H21EOLACvtfcHk0lhwRRwpILjfzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtl2jt77I&md5=bea43a232049ade6ed9abea3e0510221</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fs41586-018-0356-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41586-018-0356-z%26sid%3Dliteratum%253Aachs%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DCrouch%26aufirst%3DS.%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DLowe%26aufirst%3DR.%26aulast%3DGresham%26aufirst%3DS.%26aulast%3DUrbaniak%26aufirst%3DM.%2BD.%26aulast%3DOtto%26aufirst%3DT.%2BD.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DManthri%26aufirst%3DS.%26aulast%3DMacLean%26aufirst%3DL.%2BM.%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DHomeyer%26aufirst%3DN.%26aulast%3DPflaumer%26aufirst%3DH.%26aulast%3DBoesche%26aufirst%3DM.%26aulast%3DSastry%26aufirst%3DL.%26aulast%3DConnolly%26aufirst%3DP.%26aulast%3DAlbrecht%26aufirst%3DS.%26aulast%3DBerriman%26aufirst%3DM.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DGray%26aufirst%3DD.%2BW.%26aulast%3DGhidelli-Disse%26aufirst%3DS.%26aulast%3DDixon%26aufirst%3DS.%26aulast%3DFiandor%26aufirst%3DJ.%2BM.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DMiles%26aufirst%3DT.%2BJ.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26atitle%3DCyclin-dependent%2520kinase%252012%2520is%2520a%2520drug%2520target%2520for%2520visceral%2520leishmaniasis%26jtitle%3DNature%26date%3D2018%26volume%3D560%26spage%3D192%26epage%3D197%26doi%3D10.1038%2Fs41586-018-0356-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajakane, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Álvarez-Pedraglio, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boesche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantizani-Perez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleghorn, L. A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copley, R. C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouch, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daugan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidelli-Disse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gresham, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hindley, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLean, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miguel-Siles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osuna-Cabello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pena, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quesada-Campos, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reid, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Revill, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruiz-Gomez, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shishikura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinks, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underwood, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiandor, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, T. J.</span></span> <span> </span><span class="NLM_article-title">Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1180</span>– <span class="NLM_lpage">1202</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01218</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01218" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFGhtLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=1180-1202&author=M.+G.+Thomasauthor=M.+De+Ryckerauthor=M.+Ajakaneauthor=S.+Albrechtauthor=A.+I.+%C3%81lvarez-Pedraglioauthor=M.+Boescheauthor=S.+Brandauthor=L.+Campbellauthor=J.+Cantizani-Perezauthor=L.+A.+T.+Cleghornauthor=R.+C.+B.+Copleyauthor=S.+D.+Crouchauthor=A.+Dauganauthor=G.+Drewesauthor=S.+Ferrerauthor=S.+Ghidelli-Disseauthor=S.+Gonzalezauthor=S.+L.+Greshamauthor=A.+P.+Hillauthor=S.+J.+Hindleyauthor=R.+M.+Loweauthor=C.+J.+MacKenzieauthor=L.+MacLeanauthor=S.+Manthriauthor=F.+Martinauthor=J.+Miguel-Silesauthor=V.+L.+Nguyenauthor=S.+Norvalauthor=M.+Osuna-Cabelloauthor=A.+Woodlandauthor=S.+Pattersonauthor=I.+Penaauthor=M.+T.+Quesada-Camposauthor=I.+H.+Reidauthor=C.+Revillauthor=J.+Rileyauthor=J.+R.+Ruiz-Gomezauthor=Y.+Shishikuraauthor=F.+R.+C.+Simeonsauthor=A.+Smithauthor=V.+C.+Smithauthor=D.+Spinksauthor=L.+Stojanovskiauthor=J.+Thomasauthor=S.+Thompsonauthor=T.+Underwoodauthor=D.+W.+Grayauthor=J.+M.+Fiandorauthor=I.+H.+Gilbertauthor=P.+G.+Wyattauthor=K.+D.+Readauthor=T.+J.+Miles&title=Identification+of+GSK3186899%2FDDD853651+as+a+Preclinical+Development+Candidate+for+the+Treatment+of+Visceral+Leishmaniasis&doi=10.1021%2Facs.jmedchem.8b01218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of GSK3186899/DDD853651 as a preclinical development candidate for the treatment of visceral leishmaniasis</span></div><div class="casAuthors">Thomas, Michael G.; De Rycker, Manu; Ajakane, Myriam; Albrecht, Sebastian; Alvarez-Pedraglio, Ana Isabel; Boesche, Markus; Brand, Stephen; Campbell, Lorna; Cantizani-Perez, Juan; Cleghorn, Laura A. T.; Copley, Royston C. B.; Crouch, Sabrinia D.; Daugan, Alain; Drewes, Gerard; Ferrer, Santiago; Ghidelli-Disse, Sonja; Gonzalez, Silvia; Gresham, Stephanie L.; Hill, Alan P.; Hindley, Sean J.; Lowe, Rhiannon M.; MacKenzie, Claire J.; MacLean, Lorna; Manthri, Sujatha; Martin, Franck; Miguel-Siles, Juan; Nguyen, Van Loc; Norval, Suzanne; Osuna-Cabello, Maria; Woodland, Andrew; Patterson, Stephen; Pena, Imanol; Quesada-Campos, Maria Teresa; Reid, Iain H.; Revill, Charlotte; Riley, Jennifer; Ruiz-Gomez, Jose Ramon; Shishikura, Yoko; Simeons, Frederick R. C.; Smith, Alasdair; Smith, Victoria C.; Spinks, Daniel; Stojanovski, Laste; Thomas, John; Thompson, Stephen; Underwood, Tim; Gray, David W.; Fiandor, Jose M.; Gilbert, Ian H.; Wyatt, Paul G.; Read, Kevin D.; Miles, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1180-1202</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The leishmaniases are diseases that affect millions of people across the world, in particular visceral leishmaniasis (VL) which is fatal unless treated.  Current std. of care for VL suffers from multiple issues and there is a limited pipeline of new candidate drugs.  As such, there is a clear unmet medical need to identify new treatments.  This paper describes the optimization of a phenotypic hit against Leishmania donovani, the major causative organism of VL.  The key challenges were to balance soly. and metabolic stability while maintaining potency.  Herein, strategies to address these shortcomings and enhance efficacy are discussed, culminating in the discovery of preclin. development candidate GSK3186899/DDD853651 (1) for VL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3K_YbhzFzXbVg90H21EOLACvtfcHk0ljj3qT7kJ7PeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFGhtLfP&md5=6c0c7ed8d7b5b38b6fe1eb5bbe655bb1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01218%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DM.%2BG.%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DAjakane%26aufirst%3DM.%26aulast%3DAlbrecht%26aufirst%3DS.%26aulast%3D%25C3%2581lvarez-Pedraglio%26aufirst%3DA.%2BI.%26aulast%3DBoesche%26aufirst%3DM.%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DL.%26aulast%3DCantizani-Perez%26aufirst%3DJ.%26aulast%3DCleghorn%26aufirst%3DL.%2BA.%2BT.%26aulast%3DCopley%26aufirst%3DR.%2BC.%2BB.%26aulast%3DCrouch%26aufirst%3DS.%2BD.%26aulast%3DDaugan%26aufirst%3DA.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DGhidelli-Disse%26aufirst%3DS.%26aulast%3DGonzalez%26aufirst%3DS.%26aulast%3DGresham%26aufirst%3DS.%2BL.%26aulast%3DHill%26aufirst%3DA.%2BP.%26aulast%3DHindley%26aufirst%3DS.%2BJ.%26aulast%3DLowe%26aufirst%3DR.%2BM.%26aulast%3DMacKenzie%26aufirst%3DC.%2BJ.%26aulast%3DMacLean%26aufirst%3DL.%26aulast%3DManthri%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DF.%26aulast%3DMiguel-Siles%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DV.%2BL.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DOsuna-Cabello%26aufirst%3DM.%26aulast%3DWoodland%26aufirst%3DA.%26aulast%3DPatterson%26aufirst%3DS.%26aulast%3DPena%26aufirst%3DI.%26aulast%3DQuesada-Campos%26aufirst%3DM.%2BT.%26aulast%3DReid%26aufirst%3DI.%2BH.%26aulast%3DRevill%26aufirst%3DC.%26aulast%3DRiley%26aufirst%3DJ.%26aulast%3DRuiz-Gomez%26aufirst%3DJ.%2BR.%26aulast%3DShishikura%26aufirst%3DY.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DV.%2BC.%26aulast%3DSpinks%26aufirst%3DD.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DThompson%26aufirst%3DS.%26aulast%3DUnderwood%26aufirst%3DT.%26aulast%3DGray%26aufirst%3DD.%2BW.%26aulast%3DFiandor%26aufirst%3DJ.%2BM.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DMiles%26aufirst%3DT.%2BJ.%26atitle%3DIdentification%2520of%2520GSK3186899%252FDDD853651%2520as%2520a%2520Preclinical%2520Development%2520Candidate%2520for%2520the%2520Treatment%2520of%2520Visceral%2520Leishmaniasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D1180%26epage%3D1202%26doi%3D10.1021%2Facs.jmedchem.8b01218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathison, C. J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myburgh, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stinson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federe, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, H. X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venable, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursulaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spraggon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brock, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mottram, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supek, F.</span></span> <span> </span><span class="NLM_article-title">Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>537</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1038/nature19339</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1038%2Fnature19339" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=27501246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVyhtr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=537&publication_year=2016&pages=229-233&author=S.+Khareauthor=A.+S.+Nagleauthor=A.+Biggartauthor=Y.+H.+Laiauthor=F.+Liangauthor=L.+C.+Davisauthor=S.+W.+Barnesauthor=C.+J.+N.+Mathisonauthor=E.+Myburghauthor=M.-Y.+Gaoauthor=J.+R.+Gillespieauthor=X.+Liuauthor=J.+L.+Tanauthor=M.+Stinsonauthor=I.+C.+Riveraauthor=J.+Ballardauthor=V.+Yehauthor=T.+Groesslauthor=G.+Federeauthor=H.+X.+Y.+Kohauthor=J.+D.+Venableauthor=B.+Bursulayaauthor=M.+Shapiroauthor=P.+K.+Mishraauthor=G.+Spraggonauthor=A.+Brockauthor=J.+C.+Mottramauthor=F.+S.+Bucknerauthor=S.+P.+S.+Raoauthor=B.+G.+Wenauthor=J.+R.+Walkerauthor=T.+Tuntlandauthor=V.+Molteniauthor=R.+J.+Glynneauthor=F.+Supek&title=Proteasome+inhibition+for+treatment+of+leishmaniasis%2C+Chagas+disease+and+sleeping+sickness&doi=10.1038%2Fnature19339"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness</span></div><div class="casAuthors">Khare, Shilpi; Nagle, Advait S.; Biggart, Agnes; Lai, Yin H.; Liang, Fang; Davis, Lauren C.; Barnes, S. Whitney; Mathison, Casey J. N.; Myburgh, Elmarie; Gao, Mu-Yun; Gillespie, J. Robert; Liu, Xianzhong; Tan, Jocelyn L.; Stinson, Monique; Rivera, Ianne C.; Ballard, Jaime; Yeh, Vince; Groessl, Todd; Federe, Glenn; Koh, Hazel X. Y.; Venable, John D.; Bursulaya, Badry; Shapiro, Michael; Mishra, Pranab K.; Spraggon, Glen; Brock, Ansgar; Mottram, Jeremy C.; Buckner, Frederick S.; Rao, Srinivasa P. S.; Wen, Ben G.; Walker, John R.; Tuntland, Tove; Molteni, Valentina; Glynne, Richard J.; Supek, Frantisek</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">537</span>
        (<span class="NLM_cas:issue">7619</span>),
    <span class="NLM_cas:pages">229-233</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chagas disease, leishmaniasis and sleeping sickness affect 20 million people worldwide and lead to more than 50,000 deaths annually.  The diseases are caused by infection with the kinetoplastid parasites Trypanosoma cruzi, Leishmania spp. and Trypanosoma brucei spp., resp.  These parasites have similar biol. and genomic sequence, suggesting that all three diseases could be cured with drugs that modulate the activity of a conserved parasite target.  However, no such mol. targets or broad spectrum drugs have been identified to date.  Here we describe a selective inhibitor of the kinetoplastid proteasome (GNF6702) with unprecedented in vivo efficacy, which cleared parasites from mice in all three models of infection.  GNF6702 inhibits the kinetoplastid proteasome through a non-competitive mechanism, does not inhibit the mammalian proteasome or growth of mammalian cells, and is well-tolerated in mice.  Our data provide genetic and chem. validation of the parasite proteasome as a promising therapeutic target for treatment of kinetoplastid infections, and underscore the possibility of developing a single class of drugs for these neglected diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_PXMn1-tj_7Vg90H21EOLACvtfcHk0lgztGkyjK8fmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVyhtr%252FL&md5=a05e7ce0f6b912b3003c5b3f42a005bb</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature19339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19339%26sid%3Dliteratum%253Aachs%26aulast%3DKhare%26aufirst%3DS.%26aulast%3DNagle%26aufirst%3DA.%2BS.%26aulast%3DBiggart%26aufirst%3DA.%26aulast%3DLai%26aufirst%3DY.%2BH.%26aulast%3DLiang%26aufirst%3DF.%26aulast%3DDavis%26aufirst%3DL.%2BC.%26aulast%3DBarnes%26aufirst%3DS.%2BW.%26aulast%3DMathison%26aufirst%3DC.%2BJ.%2BN.%26aulast%3DMyburgh%26aufirst%3DE.%26aulast%3DGao%26aufirst%3DM.-Y.%26aulast%3DGillespie%26aufirst%3DJ.%2BR.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTan%26aufirst%3DJ.%2BL.%26aulast%3DStinson%26aufirst%3DM.%26aulast%3DRivera%26aufirst%3DI.%2BC.%26aulast%3DBallard%26aufirst%3DJ.%26aulast%3DYeh%26aufirst%3DV.%26aulast%3DGroessl%26aufirst%3DT.%26aulast%3DFedere%26aufirst%3DG.%26aulast%3DKoh%26aufirst%3DH.%2BX.%2BY.%26aulast%3DVenable%26aufirst%3DJ.%2BD.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DShapiro%26aufirst%3DM.%26aulast%3DMishra%26aufirst%3DP.%2BK.%26aulast%3DSpraggon%26aufirst%3DG.%26aulast%3DBrock%26aufirst%3DA.%26aulast%3DMottram%26aufirst%3DJ.%2BC.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DRao%26aufirst%3DS.%2BP.%2BS.%26aulast%3DWen%26aufirst%3DB.%2BG.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DMolteni%26aufirst%3DV.%26aulast%3DGlynne%26aufirst%3DR.%2BJ.%26aulast%3DSupek%26aufirst%3DF.%26atitle%3DProteasome%2520inhibition%2520for%2520treatment%2520of%2520leishmaniasis%252C%2520Chagas%2520disease%2520and%2520sleeping%2520sickness%26jtitle%3DNature%26date%3D2016%26volume%3D537%26spage%3D229%26epage%3D233%26doi%3D10.1038%2Fnature19339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Be, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hein, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caridha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciotti, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pybus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreishman-Deitrick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursulaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathison, C. J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerario, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chianelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiricek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eggimann, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luneau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richmond, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudewicz, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, S. P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spraggon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesmann, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, V.</span></span> <span> </span><span class="NLM_article-title">Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">10773</span>– <span class="NLM_lpage">10781</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00499</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00499" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtl2jurzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=10773-10781&author=A.+Nagleauthor=A.+Biggartauthor=C.+Beauthor=H.+Srinivasauthor=A.+Heinauthor=D.+Caridhaauthor=R.+J.+Sciottiauthor=B.+Pybusauthor=M.+Kreishman-Deitrickauthor=B.+Bursulayaauthor=Y.+H.+Laiauthor=M.-Y.+Gaoauthor=F.+Liangauthor=C.+J.+N.+Mathisonauthor=X.+Liuauthor=V.+Yehauthor=J.+Smithauthor=I.+Lerarioauthor=Y.+Xieauthor=D.+Chianelliauthor=M.+Gibneyauthor=A.+Bermanauthor=Y.-L.+Chenauthor=J.+Jiricekauthor=L.+C.+Davisauthor=X.+Liuauthor=J.+Ballardauthor=S.+Khareauthor=F.+K.+Eggimannauthor=A.+Luneauauthor=T.+Groesslauthor=M.+Shapiroauthor=W.+Richmondauthor=K.+Johnsonauthor=P.+J.+Rudewiczauthor=S.+P.+S.+Raoauthor=C.+Thompsonauthor=T.+Tuntlandauthor=G.+Spraggonauthor=R.+J.+Glynneauthor=F.+Supekauthor=C.+Wiesmannauthor=V.+Molteni&title=Discovery+and+Characterization+of+Clinical+Candidate+LXE408+as+a+Kinetoplastid-Selective+Proteasome+Inhibitor+for+the+Treatment+of+Leishmaniases&doi=10.1021%2Facs.jmedchem.0c00499"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases</span></div><div class="casAuthors">Nagle, Advait; Biggart, Agnes; Be, Celine; Srinivas, Honnappa; Hein, Andreas; Caridha, Diana; Sciotti, Richard J.; Pybus, Brandon; Kreishman-Deitrick, Mara; Bursulaya, Badry; Lai, Yin H.; Gao, Mu-Yun; Liang, Fang; Mathison, Casey J. N.; Liu, Xiaodong; Yeh, Vince; Smith, Jeffrey; Lerario, Isabelle; Xie, Yongping; Chianelli, Donatella; Gibney, Michael; Berman, Ashley; Chen, Yen-Liang; Jiricek, Jan; Davis, Lauren C.; Liu, Xianzhong; Ballard, Jaime; Khare, Shilpi; Eggimann, Fabian Kurt; Luneau, Alexandre; Groessl, Todd; Shapiro, Michael; Richmond, Wendy; Johnson, Kevin; Rudewicz, Patrick J.; Rao, Srinivasa P. S.; Thompson, Christopher; Tuntland, Tove; Spraggon, Glen; Glynne, Richard J.; Supek, Frantisek; Wiesmann, Christian; Molteni, Valentina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">10773-10781</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Visceral leishmaniasis is responsible for up to 30,000 deaths every year.  Current treatments have shortcomings that include toxicity and variable efficacy across endemic regions.  Previously, we reported the discovery of GNF6702, a selective inhibitor of the kinetoplastid proteasome, which cleared parasites in murine models of leishmaniasis, Chagas disease, and human African trypanosomiasis.  Here, we describe the discovery and characterization of LXE408(I), a structurally related kinetoplastid-selective proteasome inhibitor currently in Phase 1 human clin. trials.  Furthermore, we present high-resoln. cryo-EM structures of the Leishmania tarentolae proteasome in complex with LXE408, which provides a compelling explanation for the noncompetitive mode of binding of this novel class of inhibitors of the kinetoplastid proteasome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFHqvdoR1fT7Vg90H21EOLACvtfcHk0lgztGkyjK8fmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtl2jurzM&md5=30d8293eed0e94a7bdb75c9d794f52ce</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00499%26sid%3Dliteratum%253Aachs%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DBiggart%26aufirst%3DA.%26aulast%3DBe%26aufirst%3DC.%26aulast%3DSrinivas%26aufirst%3DH.%26aulast%3DHein%26aufirst%3DA.%26aulast%3DCaridha%26aufirst%3DD.%26aulast%3DSciotti%26aufirst%3DR.%2BJ.%26aulast%3DPybus%26aufirst%3DB.%26aulast%3DKreishman-Deitrick%26aufirst%3DM.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DLai%26aufirst%3DY.%2BH.%26aulast%3DGao%26aufirst%3DM.-Y.%26aulast%3DLiang%26aufirst%3DF.%26aulast%3DMathison%26aufirst%3DC.%2BJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DYeh%26aufirst%3DV.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DLerario%26aufirst%3DI.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DChianelli%26aufirst%3DD.%26aulast%3DGibney%26aufirst%3DM.%26aulast%3DBerman%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DY.-L.%26aulast%3DJiricek%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DL.%2BC.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBallard%26aufirst%3DJ.%26aulast%3DKhare%26aufirst%3DS.%26aulast%3DEggimann%26aufirst%3DF.%2BK.%26aulast%3DLuneau%26aufirst%3DA.%26aulast%3DGroessl%26aufirst%3DT.%26aulast%3DShapiro%26aufirst%3DM.%26aulast%3DRichmond%26aufirst%3DW.%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DRudewicz%26aufirst%3DP.%2BJ.%26aulast%3DRao%26aufirst%3DS.%2BP.%2BS.%26aulast%3DThompson%26aufirst%3DC.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DSpraggon%26aufirst%3DG.%26aulast%3DGlynne%26aufirst%3DR.%2BJ.%26aulast%3DSupek%26aufirst%3DF.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DMolteni%26aufirst%3DV.%26atitle%3DDiscovery%2520and%2520Characterization%2520of%2520Clinical%2520Candidate%2520LXE408%2520as%2520a%2520Kinetoplastid-Selective%2520Proteasome%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Leishmaniases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D10773%26epage%3D10781%26doi%3D10.1021%2Facs.jmedchem.0c00499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, C.-w.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pena, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bueren-Calabuig, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantizani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cebrian, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craggs, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goswami, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobrath, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeacock, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, E.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korczynska, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacLean, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manthri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mata-Cantero, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moniz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nühs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osuna-Cabello, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shishikura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinks, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viayna Gaza, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccotto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, M. A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiandor, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miles, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span> <span> </span><span class="NLM_article-title">Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">9318</span>– <span class="NLM_lpage">9323</span>, <span class="refDoi"> DOI: 10.1073/pnas.1820175116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1073%2Fpnas.1820175116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=30962368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC1MXovFGlsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=9318-9323&author=S.+Wyllieauthor=S.+Brandauthor=M.+Thomasauthor=M.+De+Ryckerauthor=C.-w.+Chungauthor=I.+Penaauthor=R.+P.+Binghamauthor=J.+A.+Bueren-Calabuigauthor=J.+Cantizaniauthor=D.+Cebrianauthor=P.+D.+Craggsauthor=L.+Fergusonauthor=P.+Goswamiauthor=J.+Hobrathauthor=J.+Howeauthor=L.+Jeacockauthor=E.-J.+Koauthor=J.+Korczynskaauthor=L.+MacLeanauthor=S.+Manthriauthor=M.+S.+Martinezauthor=L.+Mata-Canteroauthor=S.+Monizauthor=A.+N%C3%BChsauthor=M.+Osuna-Cabelloauthor=E.+Pintoauthor=J.+Rileyauthor=S.+Robinsonauthor=P.+Rowlandauthor=F.+R.+C.+Simeonsauthor=Y.+Shishikuraauthor=D.+Spinksauthor=L.+Stojanovskiauthor=J.+Thomasauthor=S.+Thompsonauthor=E.+Viayna+Gazaauthor=R.+J.+Wallauthor=F.+Zuccottoauthor=D.+Hornauthor=M.+A.+J.+Fergusonauthor=A.+H.+Fairlambauthor=J.+M.+Fiandorauthor=J.+Martinauthor=D.+W.+Grayauthor=T.+J.+Milesauthor=I.+H.+Gilbertauthor=K.+D.+Readauthor=M.+Marcoauthor=P.+G.+Wyatt&title=Preclinical+candidate+for+the+treatment+of+visceral+leishmaniasis+that+acts+through+proteasome+inhibition&doi=10.1073%2Fpnas.1820175116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition</span></div><div class="casAuthors">Wyllie, Susan; Brand, Stephen; Thomas, Michael; De Rycker, Manu; Chung, Chun-wa; Pena, Imanol; Bingham, Ryan P.; Bueren-Calabuig, Juan A.; Cantizani, Juan; Cebrian, David; Craggs, Peter D.; Ferguson, Liam; Goswami, Panchali; Hobrath, Judith; Howe, Jonathan; Jeacock, Laura; Ko, Eun-Jung; Korczynska, Justyna; MacLean, Lorna; Manthri, Sujatha; Martinez, Maria S.; Mata-Cantero, Lydia; Moniz, Sonia; NA1/4hs, Andrea; Osuna-Cabello, Maria; Pinto, Erika; Riley, Jennifer; Robinson, Sharon; Rowland, Paul; Simeons, Frederick R. C.; Shishikura, Yoko; Spinks, Daniel; Stojanovski, Laste; Thomas, John; Thompson, Stephen; Gaza, Elisabet Viayna; Wall, Richard J.; Zuccotto, Fabio; Horn, David; Ferguson, Michael A. J.; Fairlamb, Alan H.; Fiandor, Jose M.; Martin, Julio; Gray, David W.; Miles, Timothy J.; Gilbert, Ian H.; Read, Kevin D.; Marco, Maria; Wyatt, Paul G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">9318-9323</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Visceral leishmaniasis (VL), caused by the protozoan parasites Leishmania donovani and Leishmania infantum, is one of the major parasitic diseases worldwide.  There is an urgent need for new drugs to treat VL, because current therapies are unfit for purpose in a resource-poor setting.  Here, we describe the development of a preclin. drug candidate, GSK3494245/DDD01305143/compd. 8, with potential to treat this neglected tropical disease.  The compd. series was discovered by repurposing hits from a screen against the related parasite Trypanosoma cruzi.  Subsequent optimization of the chem. series resulted in the development of a potent cidal compd. with activity against a range of clin. relevant L. donovani and L. infantum isolates.  Compd. 8 demonstrates promising pharmacokinetic properties and impressive in vivo efficacy in our mouse model of infection comparable with those of the current oral antileishmanial miltefosine.  Detailed mode of action studies confirm that this compd. acts principally by inhibition of the chymotrypsin-like activity catalyzed by the β5 subunit of the L. donovani proteasome.  High-resoln. cryo-EM structures of apo and compd. 8-bound Leishmania tarentolae 20S proteasome reveal a previously undiscovered inhibitor site that lies between the β4 and β5 proteasome subunits.  This induced pocket exploits β4 residues that are divergent between humans and kinetoplastid parasites and is consistent with all of our exptl. and mutagenesis data.  As a result of these comprehensive studies and due to a favorable developability and safety profile, compd. 8 is being advanced toward human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiLTLZPb2MCLVg90H21EOLACvtfcHk0ljioX7s5f7gyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXovFGlsb0%253D&md5=799defb4ef812d64ffe230c78aff3511</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1820175116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1820175116%26sid%3Dliteratum%253Aachs%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DBrand%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DChung%26aufirst%3DC.-w.%26aulast%3DPena%26aufirst%3DI.%26aulast%3DBingham%26aufirst%3DR.%2BP.%26aulast%3DBueren-Calabuig%26aufirst%3DJ.%2BA.%26aulast%3DCantizani%26aufirst%3DJ.%26aulast%3DCebrian%26aufirst%3DD.%26aulast%3DCraggs%26aufirst%3DP.%2BD.%26aulast%3DFerguson%26aufirst%3DL.%26aulast%3DGoswami%26aufirst%3DP.%26aulast%3DHobrath%26aufirst%3DJ.%26aulast%3DHowe%26aufirst%3DJ.%26aulast%3DJeacock%26aufirst%3DL.%26aulast%3DKo%26aufirst%3DE.-J.%26aulast%3DKorczynska%26aufirst%3DJ.%26aulast%3DMacLean%26aufirst%3DL.%26aulast%3DManthri%26aufirst%3DS.%26aulast%3DMartinez%26aufirst%3DM.%2BS.%26aulast%3DMata-Cantero%26aufirst%3DL.%26aulast%3DMoniz%26aufirst%3DS.%26aulast%3DN%25C3%25BChs%26aufirst%3DA.%26aulast%3DOsuna-Cabello%26aufirst%3DM.%26aulast%3DPinto%26aufirst%3DE.%26aulast%3DRiley%26aufirst%3DJ.%26aulast%3DRobinson%26aufirst%3DS.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%2BC.%26aulast%3DShishikura%26aufirst%3DY.%26aulast%3DSpinks%26aufirst%3DD.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DThompson%26aufirst%3DS.%26aulast%3DViayna%2BGaza%26aufirst%3DE.%26aulast%3DWall%26aufirst%3DR.%2BJ.%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DHorn%26aufirst%3DD.%26aulast%3DFerguson%26aufirst%3DM.%2BA.%2BJ.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DFiandor%26aufirst%3DJ.%2BM.%26aulast%3DMartin%26aufirst%3DJ.%26aulast%3DGray%26aufirst%3DD.%2BW.%26aulast%3DMiles%26aufirst%3DT.%2BJ.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DMarco%26aufirst%3DM.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26atitle%3DPreclinical%2520candidate%2520for%2520the%2520treatment%2520of%2520visceral%2520leishmaniasis%2520that%2520acts%2520through%2520proteasome%2520inhibition%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2019%26volume%3D116%26spage%3D9318%26epage%3D9323%26doi%3D10.1073%2Fpnas.1820175116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moawad, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganame, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioset, J.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span> <span> </span><span class="NLM_article-title">Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e1896</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0001896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1371%2Fjournal.pntd.0001896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=23209849" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2012&author=M.+L.+Sykesauthor=J.+B.+Baellauthor=M.+Kaiserauthor=E.+Chatelainauthor=S.+R.+Moawadauthor=D.+Ganameauthor=J.-R.+Iosetauthor=V.+M.+Avery&title=Identification+of+compounds+with+anti-proliferative+activity+against+Trypanosoma+brucei+brucei+strain+427+by+a+whole+cell+viability+based+HTS+campaign&doi=10.1371%2Fjournal.pntd.0001896"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0001896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0001896%26sid%3Dliteratum%253Aachs%26aulast%3DSykes%26aufirst%3DM.%2BL.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DChatelain%26aufirst%3DE.%26aulast%3DMoawad%26aufirst%3DS.%2BR.%26aulast%3DGaname%26aufirst%3DD.%26aulast%3DIoset%26aufirst%3DJ.-R.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26atitle%3DIdentification%2520of%2520compounds%2520with%2520anti-proliferative%2520activity%2520against%2520Trypanosoma%2520brucei%2520brucei%2520strain%2520427%2520by%2520a%2520whole%2520cell%2520viability%2520based%2520HTS%2520campaign%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2012%26volume%3D6%26doi%3D10.1371%2Fjournal.pntd.0001896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smithson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holbrook, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connelly, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiplin Guy, R.</span></span> <span> </span><span class="NLM_article-title">Optimization of the electrophile of chloronitrobenzamide leads active against <i>Trypanosoma brucei</i></span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">4127</span>– <span class="NLM_lpage">4131</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.05.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1016%2Fj.bmcl.2013.05.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=23746473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptVCqur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4127-4131&author=J.+Y.+Hwangauthor=D.+C.+Smithsonauthor=G.+Holbrookauthor=F.+Zhuauthor=M.+C.+Connellyauthor=M.+Kaiserauthor=R.+Brunauthor=R.+Kiplin+Guy&title=Optimization+of+the+electrophile+of+chloronitrobenzamide+leads+active+against+Trypanosoma+brucei&doi=10.1016%2Fj.bmcl.2013.05.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of the electrophile of chloronitrobenzamide leads active against Trypanosoma brucei</span></div><div class="casAuthors">Hwang, Jong Yeon; Smithson, David C.; Holbrook, Gloria; Zhu, Fangyi; Connelly, Michele C.; Kaiser, Marcel; Brun, Reto; Kiplin Guy, R.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4127-4131</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We previously reported the phenylchloronitrobenzamides (PCNBs), a novel class of compds. active against the species of trypanosomes that cause Human African Trypanosomiasis (HAT).  Herein, we explored the potential to adjust the reactivity of the electrophilic chloronitrobenzamide core.  These studies identified compd. 7d that potently inhibited the growth of trypanosomes (EC50 = 120 nM for Trypanosoma b. brucei, 18 nM for Trypanosoma b. rhodesiense, and 38 nM for Trypanosoma b. gambiense) without significant cytotoxicity against mammalian cell lines (EC50 > 25 μM for HepG2, HEK293, Raji, and BJ cell lines) and also had good stability in microsomal models (t1/2 > 4 h in both human and mouse).  Overall these properties indicate the compd. 7d and its analogs are worth further exploration as potential leads for HAT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH59s5PcHo4bVg90H21EOLACvtfcHk0lggOvzOjV6bSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptVCqur8%253D&md5=94a03896f45223eeb0f4ed6f3e5b6800</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.05.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.05.049%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DJ.%2BY.%26aulast%3DSmithson%26aufirst%3DD.%2BC.%26aulast%3DHolbrook%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DF.%26aulast%3DConnelly%26aufirst%3DM.%2BC.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DKiplin%2BGuy%26aufirst%3DR.%26atitle%3DOptimization%2520of%2520the%2520electrophile%2520of%2520chloronitrobenzamide%2520leads%2520active%2520against%2520Trypanosoma%2520brucei%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4127%26epage%3D4131%26doi%3D10.1016%2Fj.bmcl.2013.05.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tatipaka, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norcross, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hulverson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranade, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagendar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Creason, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McQueen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duster, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, M. H.</span></span> <span> </span><span class="NLM_article-title">Substituted 2-phenylimidazopyridines: a new class of drug leads for human African trypanosomiasis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">828</span>– <span class="NLM_lpage">835</span>, <span class="refDoi"> DOI: 10.1021/jm401178t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401178t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFKqtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=828-835&author=H.+B.+Tatipakaauthor=J.+R.+Gillespieauthor=A.+K.+Chatterjeeauthor=N.+R.+Norcrossauthor=M.+A.+Hulversonauthor=R.+M.+Ranadeauthor=P.+Nagendarauthor=S.+A.+Creasonauthor=J.+McQueenauthor=N.+A.+Dusterauthor=A.+Nagleauthor=F.+Supekauthor=V.+Molteniauthor=T.+Wenzlerauthor=R.+Brunauthor=R.+Glynneauthor=F.+S.+Bucknerauthor=M.+H.+Gelb&title=Substituted+2-phenylimidazopyridines%3A+a+new+class+of+drug+leads+for+human+African+trypanosomiasis&doi=10.1021%2Fjm401178t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted 2-Phenylimidazopyridines: A New Class of Drug Leads for Human African Trypanosomiasis</span></div><div class="casAuthors">Tatipaka, Hari Babu; Gillespie, J. Robert; Chatterjee, Arnab K.; Norcross, Neil R.; Hulverson, Matthew A.; Ranade, Ranae M.; Nagendar, Pendem; Creason, Sharon A.; McQueen, Joshua; Duster, Nicole A.; Nagle, Advait; Supek, Frantisek; Molteni, Valentina; Wenzler, Tanja; Brun, Reto; Glynne, Richard; Buckner, Frederick S.; Gelb, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">828-835</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A phenotypic screen of a compd. library for antiparasitic activity on Trypanosoma brucei, the causative agent of human African trypanosomiasis, led to the identification of substituted 2-(3-aminophenyl)-oxazolopyridines as a starting point for hit-to-lead medicinal chem.  A total of 110 analogs were prepd., which led to the identification of I, a substituted 2-(3-aminophenyl)-imidazopyridine.  This compd. showed antiparasitic activity in vitro with an EC50 of 2 nM and displayed reasonable druglike properties when tested in a no. of in vitro assays.  I was orally bioavailable and displayed good plasma and brain exposure in mice.  I cured mice infected with Trypanosoma brucei when dosed orally down to 2.5 mg/kg.  Given its potent antiparasitic properties and its ease of synthesis, I represents a new lead for the development of drugs to treat human African trypanosomiasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKqZdMjPCMsrVg90H21EOLACvtfcHk0lggOvzOjV6bSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFKqtLzK&md5=3ed810c038784126456b0d6d93f099eb</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm401178t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401178t%26sid%3Dliteratum%253Aachs%26aulast%3DTatipaka%26aufirst%3DH.%2BB.%26aulast%3DGillespie%26aufirst%3DJ.%2BR.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DNorcross%26aufirst%3DN.%2BR.%26aulast%3DHulverson%26aufirst%3DM.%2BA.%26aulast%3DRanade%26aufirst%3DR.%2BM.%26aulast%3DNagendar%26aufirst%3DP.%26aulast%3DCreason%26aufirst%3DS.%2BA.%26aulast%3DMcQueen%26aufirst%3DJ.%26aulast%3DDuster%26aufirst%3DN.%2BA.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DSupek%26aufirst%3DF.%26aulast%3DMolteni%26aufirst%3DV.%26aulast%3DWenzler%26aufirst%3DT.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DGlynne%26aufirst%3DR.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26atitle%3DSubstituted%25202-phenylimidazopyridines%253A%2520a%2520new%2520class%2520of%2520drug%2520leads%2520for%2520human%2520African%2520trypanosomiasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D828%26epage%3D835%26doi%3D10.1021%2Fjm401178t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferrins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahmani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sykes, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teston, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almohaywi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyland, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span> <span> </span><span class="NLM_article-title">3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid <i>Trypanosoma brucei</i>, the causative agent for human African trypanosomiasis</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">465</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1016%2Fj.ejmech.2013.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=23831695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Sktb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2013&pages=450-465&author=L.+Ferrinsauthor=R.+Rahmaniauthor=M.+L.+Sykesauthor=A.+J.+Jonesauthor=V.+M.+Averyauthor=E.+Testonauthor=B.+Almohaywiauthor=J.+Yinauthor=J.+Smithauthor=C.+Hylandauthor=K.+L.+Whiteauthor=E.+Ryanauthor=M.+Campbellauthor=S.+A.+Charmanauthor=M.+Kaiserauthor=J.+B.+Baell&title=3-%28Oxazolo%5B4%2C5-b%5Dpyridin-2-yl%29anilides+as+a+novel+class+of+potent+inhibitors+for+the+kinetoplastid+Trypanosoma+brucei%2C+the+causative+agent+for+human+African+trypanosomiasis&doi=10.1016%2Fj.ejmech.2013.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis</span></div><div class="casAuthors">Ferrins, Lori; Rahmani, Raphael; Sykes, Melissa L.; Jones, Amy J.; Avery, Vicky M.; Teston, Eliott; Almohaywi, Basmah; Yin, Jie Xiang; Smith, Jason; Hyland, Chris; White, Karen L.; Ryan, Eileen; Campbell, Michael; Charman, Susan A.; Kaiser, Marcel; Baell, Jonathan B.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">450-465</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A whole organism high-throughput screen of approx. 87,000 compds. against Trypanosoma brucei brucei led to the recent discovery of several novel compd. classes with low micromolar activity against this organism and without appreciable cytotoxicity to mammalian cells.  Herein we report a structure-activity relation (SAR) investigation around one of these hit classes, the 3-(oxazolo[4,5-b]pyridin-2-yl)anilides.  Sharp SAR is revealed, with our most active compd. (I) exhibiting an IC50 of 91 nM against the human pathogenic strain T.b. rhodesiense and being more than 700 times less toxic towards the L6 mammalian cell line.  Physicochem. properties are attractive for many compds. in this series.  For the most potent representatives, we show that soly. and metabolic stability are key parameters to target during future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruFGlHJ2ScL7Vg90H21EOLACvtfcHk0lggOvzOjV6bSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Sktb7L&md5=12ad544172d828822118646b5b95bf6d</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DFerrins%26aufirst%3DL.%26aulast%3DRahmani%26aufirst%3DR.%26aulast%3DSykes%26aufirst%3DM.%2BL.%26aulast%3DJones%26aufirst%3DA.%2BJ.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DTeston%26aufirst%3DE.%26aulast%3DAlmohaywi%26aufirst%3DB.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DHyland%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26atitle%3D3-%2528Oxazolo%255B4%252C5-b%255Dpyridin-2-yl%2529anilides%2520as%2520a%2520novel%2520class%2520of%2520potent%2520inhibitors%2520for%2520the%2520kinetoplastid%2520Trypanosoma%2520brucei%252C%2520the%2520causative%2520agent%2520for%2520human%2520African%2520trypanosomiasis%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D66%26spage%3D450%26epage%3D465%26doi%3D10.1016%2Fj.ejmech.2013.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagendar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillespie, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herbst, Z. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranade, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molasky, N. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faghih, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, F. S.</span></span> <span> </span><span class="NLM_article-title">Triazolopyrimidines and Imidazopyridines: Structure–Activity Relationships and in Vivo Efficacy for Trypanosomiasis</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00498</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00498" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVWlu7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=105-110&author=P.+Nagendarauthor=J.+R.+Gillespieauthor=Z.+M.+Herbstauthor=R.+M.+Ranadeauthor=N.+M.+R.+Molaskyauthor=O.+Faghihauthor=R.+M.+Turnerauthor=M.+H.+Gelbauthor=F.+S.+Buckner&title=Triazolopyrimidines+and+Imidazopyridines%3A+Structure%E2%80%93Activity+Relationships+and+in+Vivo+Efficacy+for+Trypanosomiasis&doi=10.1021%2Facsmedchemlett.8b00498"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Triazolopyrimidines and Imidazopyridines: Structure-Activity Relationships and in Vivo Efficacy for Trypanosomiasis</span></div><div class="casAuthors">Nagendar, Pendem; Gillespie, J. Robert; Herbst, Zackary M.; Ranade, Ranae M.; Molasky, Nora M. R.; Faghih, Omeed; Turner, Rachael M.; Gelb, Michael H.; Buckner, Frederick S.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">105-110</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Better therapeutics are greatly needed to treat patients infected with trypanosomatid parasites such as Trypanosoma cruzi or Trypanosoma brucei.  This report describes 28 new imidazopyridines and triazolopyrimidines with potent and selective antitrypanosomal activity.  Drug-like properties were demonstrated in a no. of in vitro assays.  In vivo efficacy was obsd. for 19 and 20 in acute mouse models of T. cruzi infection.  Compds. 19 and 20 represent potential leads for new anti-Chagas disease drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEdftDgpm_K7Vg90H21EOLACvtfcHk0lhhdwqUGWh_Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVWlu7vE&md5=edde33cd58552b8914a962b009d8d185</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00498%26sid%3Dliteratum%253Aachs%26aulast%3DNagendar%26aufirst%3DP.%26aulast%3DGillespie%26aufirst%3DJ.%2BR.%26aulast%3DHerbst%26aufirst%3DZ.%2BM.%26aulast%3DRanade%26aufirst%3DR.%2BM.%26aulast%3DMolasky%26aufirst%3DN.%2BM.%2BR.%26aulast%3DFaghih%26aufirst%3DO.%26aulast%3DTurner%26aufirst%3DR.%2BM.%26aulast%3DGelb%26aufirst%3DM.%2BH.%26aulast%3DBuckner%26aufirst%3DF.%2BS.%26atitle%3DTriazolopyrimidines%2520and%2520Imidazopyridines%253A%2520Structure%25E2%2580%2593Activity%2520Relationships%2520and%2520in%2520Vivo%2520Efficacy%2520for%2520Trypanosomiasis%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D105%26epage%3D110%26doi%3D10.1021%2Facsmedchemlett.8b00498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Rycker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallyburton, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyllie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyatt, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frearson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fairlamb, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, D. W.</span></span> <span> </span><span class="NLM_article-title">Comparison of a high-throughput high-content intracellular <i>Leishmania donovani</i> assay with an axenic amastigote assay</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2913</span>– <span class="NLM_lpage">2922</span>, <span class="refDoi"> DOI: 10.1128/aac.02398-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1128%2FAAC.02398-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=23571538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVartrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=2913-2922&author=M.+De%0ARyckerauthor=I.+Hallyburtonauthor=J.+Thomasauthor=L.+Campbellauthor=S.+Wyllieauthor=D.+Joshiauthor=S.+Cameronauthor=I.+H.+Gilbertauthor=P.+G.+Wyattauthor=J.+A.+Frearsonauthor=A.+H.+Fairlambauthor=D.+W.+Gray&title=Comparison+of+a+high-throughput+high-content+intracellular+Leishmania+donovani+assay+with+an+axenic+amastigote+assay&doi=10.1128%2Faac.02398-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of a high-throughput high-content intracellular Leishmania donovani assay with an axenic amastigote assay</span></div><div class="casAuthors">De Rycker, Manu; Hallyburton, Irene; Thomas, John; Campbell, Lorna; Wyllie, Susan; Joshi, Dhananjay; Cameron, Scott; Gilbert, Ian H.; Wyatt, Paul G.; Frearson, Julie A.; Fairlamb, Alan H.; Gray, David W.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2913-2922</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Visceral leishmaniasis is a neglected tropical disease with significant health impact.  The current treatments are poor, and there is an urgent need to develop new drugs.  Primary screening assays used for drug discovery campaigns have typically used free-living forms of the Leishmania parasite to allow for high-throughput screening.  Such screens do not necessarily reflect the physiol. situation, as the disease-causing stage of the parasite resides inside human host cells.  Assessing the drug sensitivity of intracellular parasites on scale has recently become feasible with the advent of high-content screening methods.  We describe here a 384-well microscopy-based intramacrophage Leishmania donovani assay and compare it to an axenic amastigote system.  A panel of eight ref. compds. was tested in both systems, as well as a human counterscreen cell line, and our findings show that for most clin. used compds. both axenic and intramacrophage assays report very similar results.  A set of 15,659 diverse compds. was also screened using both systems.  This resulted in the identification of seven new antileishmanial compds. and revealed a high false-pos. rate for the axenic assay.  We conclude that the intramacrophage assay is more suited as a primary hit-discovery platform than the current form of axenic assay, and we discuss how modifications to the axenic assay may render it more suitable for hit-discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXnzJTYkYtJrVg90H21EOLACvtfcHk0lhhdwqUGWh_Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVartrvL&md5=9d7d79eea02abc10f3a5c26fac47de27</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1128%2FAAC.02398-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02398-12%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BRycker%26aufirst%3DM.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DCampbell%26aufirst%3DL.%26aulast%3DWyllie%26aufirst%3DS.%26aulast%3DJoshi%26aufirst%3DD.%26aulast%3DCameron%26aufirst%3DS.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DFrearson%26aufirst%3DJ.%2BA.%26aulast%3DFairlamb%26aufirst%3DA.%2BH.%26aulast%3DGray%26aufirst%3DD.%2BW.%26atitle%3DComparison%2520of%2520a%2520high-throughput%2520high-content%2520intracellular%2520Leishmania%2520donovani%2520assay%2520with%2520an%2520axenic%2520amastigote%2520assay%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D2913%26epage%3D2922%26doi%3D10.1128%2Faac.02398-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirkley, J.</span></span> <span> </span><span class="NLM_article-title">Regulation of <i>Leishmania</i> populations within host.1. Variable course of <i>Leishmania donovani</i> infections in mice</span>. <i>Clin. Exp. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">119</span>– <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=606433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A280%3ADyaE1c7gsFynsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1977&pages=119-129&author=D.+J.+Bradleyauthor=J.+Kirkley&title=Regulation+of+Leishmania+populations+within+host.1.+Variable+course+of+Leishmania+donovani+infections+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice</span></div><div class="casAuthors">Bradley D J; Kirkley J</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and experimental immunology</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-29</span>
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    </div><div class="casAbstract">The course of infection with Leishmania donovani was followed in seven strains of laboratory mice with measurement of the liver parasite burdens over 20 weeks.  The acute parasite population growth rate varied greatly between, but not within, strains.  Four strains were relatively resistant with less than an eight-fold increase while the three acutely susceptible strains showed over an eight-fold increase in the first month.  Thereafter, one initially susceptible strain showed a dramatic fall in parasite numbers with histological liver damage while another strain maintained an immense parasite load for up to 2 years involving mononuclear phagocytes throughout the body.  The system provides a model for studying genetic control of resistance to intracellular infection and the range of responses is compared with human leprosy and cutaneous leishmaniasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQulO71OOh0SLxanA7vODO6fW6udTcc2ebMirlbDmOGZbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE1c7gsFynsg%253D%253D&md5=ed3061459c68a005a9959edf5a106881</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBradley%26aufirst%3DD.%2BJ.%26aulast%3DKirkley%26aufirst%3DJ.%26atitle%3DRegulation%2520of%2520Leishmania%2520populations%2520within%2520host.1.%2520Variable%2520course%2520of%2520Leishmania%2520donovani%2520infections%2520in%2520mice%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D1977%26volume%3D30%26spage%3D119%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Croft, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snowdon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yardley, V.</span></span> <span> </span><span class="NLM_article-title">The activities of four anticancer alkyllysophospholipids against <i>Leishmania donovani, Trypanosoma cruzi</i> and <i>Trypanosoma brucei</i></span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">1041</span>– <span class="NLM_lpage">1047</span>, <span class="refDoi"> DOI: 10.1093/jac/38.6.1041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1093%2Fjac%2F38.6.1041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=9023651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADyaK2sXhtFGitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1996&pages=1041-1047&author=S.+L.+Croftauthor=D.+Snowdonauthor=V.+Yardley&title=The+activities+of+four+anticancer+alkyllysophospholipids+against+Leishmania+donovani%2C+Trypanosoma+cruzi+and+Trypanosoma+brucei&doi=10.1093%2Fjac%2F38.6.1041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei</span></div><div class="casAuthors">Croft, Simon L.; Snowdon, Diane; Yardley, Vanessa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1041-1047</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Saunders</span>)
        </div><div class="casAbstract">The in-vitro activities of four anticancer alkyllysophospholipids, ET-18-OCH3 (edelfosine), hexadecylphosphocholine (miltefosine), ilmofosine and SRI 62-834, were detd. with ED50 values for Leishmania donovani and Trypanosoma cruzi amastigotes between 0.2 and 5.0 μM and for Trypanosoma brucei trypomastigotes between 7.0 and 50.8 μM.  In BALB/c mice miltefosine and ilmofosine were the most active compds. with ED50 values of 2.9 and 14.5 mg/kg × 5 doses against L. donovani and a suppressive effect on T. cruzi infections at 30 mg/kg × 5 doses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlMJL7bxzw5rVg90H21EOLACvtfcHk0lhZiCwvHnbjiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtFGitro%253D&md5=e253981e9c2306b9108cfb71a95395b0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F38.6.1041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F38.6.1041%26sid%3Dliteratum%253Aachs%26aulast%3DCroft%26aufirst%3DS.%2BL.%26aulast%3DSnowdon%26aufirst%3DD.%26aulast%3DYardley%26aufirst%3DV.%26atitle%3DThe%2520activities%2520of%2520four%2520anticancer%2520alkyllysophospholipids%2520against%2520Leishmania%2520donovani%252C%2520Trypanosoma%2520cruzi%2520and%2520Trypanosoma%2520brucei%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D1996%26volume%3D38%26spage%3D1041%26epage%3D1047%26doi%3D10.1093%2Fjac%2F38.6.1041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klein, S.</span></span> <span> </span><span class="NLM_article-title">The use of biorelevant dissolution media to forecast the in vivo performance of a drug</span>. <i>AAPS J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1208/s12248-010-9203-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1208%2Fs12248-010-9203-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=20458565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovVKns7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=397-406&author=S.+Klein&title=The+use+of+biorelevant+dissolution+media+to+forecast+the+in+vivo+performance+of+a+drug&doi=10.1208%2Fs12248-010-9203-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The use of biorelevant dissolution media to forecast the in vivo performance of a drug</span></div><div class="casAuthors">Klein, Sandra</div><div class="citationInfo"><span class="NLM_cas:title">AAPS Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">397-406</span>CODEN:
                <span class="NLM_cas:coden">AJAOB6</span>;
        ISSN:<span class="NLM_cas:issn">1550-7416</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Simulation of gastrointestinal conditions is essential to adequately predict the in vivo behavior of drug formulations.  To reduce the size and no. of human studies required to identify a drug product with appropriate performance in both the fed and fasted states, it is advantageous to be able to pre-screen formulations in vitro.  The choice of appropriate media for such in vitro tests is crucial to their ability to correctly forecast the food effect in pharmacokinetic studies.  The present paper gives an overview of the development and compn. of biorelevant dissoln. media that can be used for the in vitro simulation of different dosing conditions (fasted and fed states).  In addn., the application of these media to predicting food effects is described in several case examples.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQrvLqn-uuMrVg90H21EOLACvtfcHk0lhZiCwvHnbjiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovVKns7g%253D&md5=3dc6f6fb7d058c350a82edd78c00b945</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1208%2Fs12248-010-9203-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1208%252Fs12248-010-9203-3%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DS.%26atitle%3DThe%2520use%2520of%2520biorelevant%2520dissolution%2520media%2520to%2520forecast%2520the%2520in%2520vivo%2520performance%2520of%2520a%2520drug%26jtitle%3DAAPS%2520J.%26date%3D2010%26volume%3D12%26spage%3D397%26epage%3D406%26doi%3D10.1208%2Fs12248-010-9203-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higashino, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masaoka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kataoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakuma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, S.</span></span> <span> </span><span class="NLM_article-title">In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs</span>. <i>Mol. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">746</span>– <span class="NLM_lpage">754</span>, <span class="refDoi"> DOI: 10.1021/mp400465p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp400465p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Gju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=746-754&author=H.+Higashinoauthor=T.+Hasegawaauthor=M.+Yamamotoauthor=R.+Matsuiauthor=Y.+Masaokaauthor=M.+Kataokaauthor=S.+Sakumaauthor=S.+Yamashita&title=In+vitro-in+vivo+correlation+of+the+effect+of+supersaturation+on+the+intestinal+absorption+of+BCS+Class+2+drugs&doi=10.1021%2Fmp400465p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro-in Vivo Correlation of the Effect of Supersaturation on the Intestinal Absorption of BCS Class 2 Drugs</span></div><div class="casAuthors">Higashino, Haruki; Hasegawa, Tsubasa; Yamamoto, Mari; Matsui, Rie; Masaoka, Yoshie; Kataoka, Makoto; Sakuma, Shinji; Yamashita, Shinji</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">746-754</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The aim of this study was to establish an in vitro method for evaluating the effect of supersatn. on oral absorption of poorly water-sol. drugs in vivo.  Albendazole, dipyridamole, gefitinib, and ketoconazole were used as model drugs.  Supersatn. of each drug was induced by dilg. its stock soln. by fasted state simulated intestinal fluid (FaSSIF) (solvent-shift method), then dissoln. and pptn. profile of the drug was obsd. in vitro.  The cryst. form of the ppt. was checked by differential scanning calorimetry (DSC).  For comparison, control suspension was prepd. by suspending a drug powder directly into FaSSIF (powder-suspending method).  In vivo intestinal absorption of the drug was obsd. in rats by detd. the plasma concn. after intraduodenal administration of drug suspensions.  For all drugs, suspensions prepd. by solvent-shift method showed significantly higher dissolved concn. in vitro than that prepd. by powder-suspending method, clearly indicated the induction of supersatn.  DSC anal. revealed that cryst. form of the ppt. profoundly affects the extent and the duration of supersatn.  A rat in vivo study confirmed that the supersatn. of these drugs increased the fraction absorbed from the intestine, which corresponded well to the in vitro dissoln. and pptn. profile of drugs except for ketoconazole.  For ketoconazole, an in vivo absorption study was performed in rats pretreated with 1-aminobenzotriazole, a potent inhibitor of CYP mediated metab.  CYP inhibition study suggested that the high luminal concn. of ketoconazole caused by supersatn. satd. the metabolic enzymes and further increased the systemic exposure of the absorbed drug.  The addnl. effects of supersatn. on the absorption of ketoconazole are consistent with previous studies in humans under differing gastric pH conditions.  In conclusion, effects of supersatn. on the intestinal absorption of poorly water-sol. drugs could be predicted from in vitro dissoln. and a pptn. study.  However if supersatn. affects the pharmacokinetic profiles of drugs, such as a first-pass metab., a combination with in vivo study should be required to evaluate its impact on oral bioavailability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_N82Ixi3qW7Vg90H21EOLACvtfcHk0ljAfmERmhkoSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Gju7s%253D&md5=3f9999c80ad38ef958763f9a629be22c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fmp400465p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp400465p%26sid%3Dliteratum%253Aachs%26aulast%3DHigashino%26aufirst%3DH.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DMatsui%26aufirst%3DR.%26aulast%3DMasaoka%26aufirst%3DY.%26aulast%3DKataoka%26aufirst%3DM.%26aulast%3DSakuma%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DS.%26atitle%3DIn%2520vitro-in%2520vivo%2520correlation%2520of%2520the%2520effect%2520of%2520supersaturation%2520on%2520the%2520intestinal%2520absorption%2520of%2520BCS%2520Class%25202%2520drugs%26jtitle%3DMol.%2520Pharm.%26date%3D2014%26volume%3D11%26spage%3D746%26epage%3D754%26doi%3D10.1021%2Fmp400465p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ames, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, F. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durston, W. E.</span></span> <span> </span><span class="NLM_article-title">An improved bacterial test system for the detection and classification of mutagens and carcinogens</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">782</span>– <span class="NLM_lpage">786</span>, <span class="refDoi"> DOI: 10.1073/pnas.70.3.782</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1073%2Fpnas.70.3.782" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=4577135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADyaE3sXktFGnt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1973&pages=782-786&author=B.+N.+Amesauthor=F.+D.+Leeauthor=W.+E.+Durston&title=An+improved+bacterial+test+system+for+the+detection+and+classification+of+mutagens+and+carcinogens&doi=10.1073%2Fpnas.70.3.782"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Improved bacterial test system for the detection and classification of mutagens and carcinogens</span></div><div class="casAuthors">Ames, Bruce N.; Lee, Frank D.; Durston, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">782-6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Four strains of Salmonella typhimurium designed for detecting the various types of mutagens and their utility in detecting a wide variety of carcinogens as mutagens were described.  The lipopolysaccharide that normally coats these bacteria was a barrier to penetration of mutagens to the cell membrane.  The set of tester strains was improved by adding a mutation (rfa:  deep rough) that results in a deficient lipopolysaccharide.  The techniques for using these strains for detecting mutagens were presented and the tests were extremely sensitive and convenient.  The specificity of frameshift mutagenesis was clarified.  As adjuncts to the test with the 4 strains, a test that compares mutagenic killing in deep rough strains with and without DNA excision repair, and a test of forward mutagenesis in a deep rough strain lacking excision repair were described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc_-H2XtehILVg90H21EOLACvtfcHk0ljAfmERmhkoSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXktFGnt7g%253D&md5=8579db7796e200c52a595dfef245bc7c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.70.3.782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.70.3.782%26sid%3Dliteratum%253Aachs%26aulast%3DAmes%26aufirst%3DB.%2BN.%26aulast%3DLee%26aufirst%3DF.%2BD.%26aulast%3DDurston%26aufirst%3DW.%2BE.%26atitle%3DAn%2520improved%2520bacterial%2520test%2520system%2520for%2520the%2520detection%2520and%2520classification%2520of%2520mutagens%2520and%2520carcinogens%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1973%26volume%3D70%26spage%3D782%26epage%3D786%26doi%3D10.1073%2Fpnas.70.3.782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maron, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, B. N.</span></span> <span> </span><span class="NLM_article-title">Revised methods for the Salmonella mutagenicity test</span>. <i>Mutat. Res.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">173</span>– <span class="NLM_lpage">215</span>, <span class="refDoi"> DOI: 10.1016/0165-1161(83)90010-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1016%2F0165-1161%2883%2990010-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=6341825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADyaL3sXhvFarsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=1983&pages=173-215&author=D.+M.+Maronauthor=B.+N.+Ames&title=Revised+methods+for+the+Salmonella+mutagenicity+test&doi=10.1016%2F0165-1161%2883%2990010-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Revised methods for the Salmonella mutagenicity test</span></div><div class="casAuthors">Maron, Dorothy M.; Ames, Bruce N.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Environmental Mutagenesis and Related Subjects </span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">173-215</span>CODEN:
                <span class="NLM_cas:coden">MEMSE8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A revision of methods for detecting carcinogens and mutagens with the Salmonella mutagenicity test (A. et al., 1975b) is described.  Two new tester strains, a frameshift strain (TA 97) and a strain carrying an ochre mutation on a multicopy plasmid (TA 102), are added to the std. tester set.  TA 97 replaces TA 1537.  TA 1535 and 1538 are removed from the recommended set, but can be retained at the option of the investigator.  TA 98 and 100 are retained.  Other special purpose strains are discussed and minor changes in procedure, (principally in the growth, storage, and preservation of the tester strains) are presented.  Two substitutions are made in diagnostic mutagens to eliminate MNNG and 9-aminoacridine.  Some test modifications are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzIjKbxaVZYrVg90H21EOLACvtfcHk0ljAfmERmhkoSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhvFarsb4%253D&md5=415285947b98c9ddbbd79bbe000c9dca</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2F0165-1161%2883%2990010-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1161%252883%252990010-9%26sid%3Dliteratum%253Aachs%26aulast%3DMaron%26aufirst%3DD.%2BM.%26aulast%3DAmes%26aufirst%3DB.%2BN.%26atitle%3DRevised%2520methods%2520for%2520the%2520Salmonella%2520mutagenicity%2520test%26jtitle%3DMutat.%2520Res.%26date%3D1983%26volume%3D113%26spage%3D173%26epage%3D215%26doi%3D10.1016%2F0165-1161%2883%2990010-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ames, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, E.</span></span> <span> </span><span class="NLM_article-title">Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test</span>. <i>Mutat. Res.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">363</span>, <span class="refDoi"> DOI: 10.1016/0165-1161(75)90046-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1016%2F0165-1161%2875%2990046-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=768755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADyaE28XmvFyqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1975&pages=347-363&author=B.+N.+Amesauthor=J.+McCannauthor=E.+Yamasaki&title=Methods+for+detecting+carcinogens+and+mutagens+with+the+Salmonella%2Fmammalian-microsome+mutagenicity+test&doi=10.1016%2F0165-1161%2875%2990046-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Methods for detecting carcinogens and mutagens with the salmonella/mammalian-microsome mutagenicity test</span></div><div class="casAuthors">Ames, Bruce N.; McCann, Joyce; Yamasaki, Edith</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">347-63</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    </div><div class="casAbstract">The general methods for using the Salmonella/microsome test as a mutagenesis screening system are described.  The methods include the std. plate test, the use and storage of bacterial tester strains, prepn. and use of the liver homogenates (S-9), and the methods of inducing rats for elevated microsomal enzyme activity.  The application of this system to screening large nos. of compds. and interpreting the test results are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXRCaWgf4xbbVg90H21EOLACvtfcHk0ljbkzuamqJGGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XmvFyqtw%253D%253D&md5=93881a3b91fc231635ca1086b945fb5d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2F0165-1161%2875%2990046-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0165-1161%252875%252990046-1%26sid%3Dliteratum%253Aachs%26aulast%3DAmes%26aufirst%3DB.%2BN.%26aulast%3DMcCann%26aufirst%3DJ.%26aulast%3DYamasaki%26aufirst%3DE.%26atitle%3DMethods%2520for%2520detecting%2520carcinogens%2520and%2520mutagens%2520with%2520the%2520Salmonella%252Fmammalian-microsome%2520mutagenicity%2520test%26jtitle%3DMutat.%2520Res.%26date%3D1975%26volume%3D31%26spage%3D347%26epage%3D363%26doi%3D10.1016%2F0165-1161%2875%2990046-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity</span>. <i>Drug Discov. Today</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">648</span>– <span class="NLM_lpage">655</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2010.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1016%2Fj.drudis.2010.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=20570751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVeksb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=648-655&author=A.+P.+Hillauthor=R.+J.+Young&title=Getting+physical+in+drug+discovery%3A+a+contemporary+perspective+on+solubility+and+hydrophobicity&doi=10.1016%2Fj.drudis.2010.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity</span></div><div class="casAuthors">Hill, Alan P.; Young, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">15/16</span>),
    <span class="NLM_cas:pages">648-655</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Suboptimal phys. properties have been identified as a particular shortcoming of compds. in contemporary drug discovery, contributing to high attrition levels.  An anal. of the relationship between hydrophobicity (calcd. and measured) and ∼100 k measured kinetic soly. values has been undertaken.  In line with the General Soly. Equation, ests. of hydrophobicity, particularly ACD c log D pH7.4, give a useful indication of the likely soly. classification of particular mols.  Taking ACD c log D pH7.4 values together with the no. of arom. rings in a given mol. provides enhanced prediction.  The Soly. Forecast Index' (SFI = c log D pH7.4 + #Ar) is proposed as a simple, yet effective, guide to predicting soly.  Moreover, anal. of measured distribution/partition coeff. values highlighted statistically significant shortcomings in the applicability of octanol/water as a model system for hydrophobicity detn. with poorly sol. compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdtQyfNjbFUrVg90H21EOLACvtfcHk0ljbkzuamqJGGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVeksb3P&md5=7b201081c5586a6ea4b7af00d507d462</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DA.%2BP.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DGetting%2520physical%2520in%2520drug%2520discovery%253A%2520a%2520contemporary%2520perspective%2520on%2520solubility%2520and%2520hydrophobicity%26jtitle%3DDrug%2520Discov.%2520Today%26date%3D2010%26volume%3D15%26spage%3D648%26epage%3D655%26doi%3D10.1016%2Fj.drudis.2010.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscombe, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. P.</span></span> <span> </span><span class="NLM_article-title">Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity</span>. <i>Drug Discov. Today</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">822</span>– <span class="NLM_lpage">830</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2011.06.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1016%2Fj.drudis.2011.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=21704184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCru7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=822-830&author=R.+J.+Youngauthor=D.+V.+S.+Greenauthor=C.+N.+Luscombeauthor=A.+P.+Hill&title=Getting+physical+in+drug+discovery+II%3A+the+impact+of+chromatographic+hydrophobicity+measurements+and+aromaticity&doi=10.1016%2Fj.drudis.2011.06.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity</span></div><div class="casAuthors">Young, Robert J.; Green, Darren V. S.; Luscombe, Christopher N.; Hill, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">17/18</span>),
    <span class="NLM_cas:pages">822-830</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Here, we review the performance of chromatog. hydrophobicity measurements in a data set of 100 000 GlaxoSmithKline compds., demonstrating the advantages of the method over octanol-water partitioning and highlighting new insights for drug discovery.  The value of chromatog. measurements, vs. other hydrophobicity ests., was supported by improved relationships with soly., permeation, cytochrome P450s, intrinsic clearance, hERG binding and promiscuity.  We also obsd. marked differentiation of the relative influence of intrinsic and effective hydrophobicity.  The summing of hydrophobicity values plus arom. ring count [log D pH7.4 (or log P) + #Ar], indicated a wide relevance for simplistic property forecast indexes' in developability assays, clearly enhanced by chromatog. values; therefore establishing new foundations for enriching property-based drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmIJyWi-DBW7Vg90H21EOLACvtfcHk0ljbkzuamqJGGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCru7vF&md5=22788603a45aa77537e8666433473d14</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26aulast%3DGreen%26aufirst%3DD.%2BV.%2BS.%26aulast%3DLuscombe%26aufirst%3DC.%2BN.%26aulast%3DHill%26aufirst%3DA.%2BP.%26atitle%3DGetting%2520physical%2520in%2520drug%2520discovery%2520II%253A%2520the%2520impact%2520of%2520chromatographic%2520hydrophobicity%2520measurements%2520and%2520aromaticity%26jtitle%3DDrug%2520Discov.%2520Today%26date%3D2011%26volume%3D16%26spage%3D822%26epage%3D830%26doi%3D10.1016%2Fj.drudis.2011.06.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biggart, A.</span>; <span class="NLM_string-name">Liang, F.</span>; <span class="NLM_string-name">Mathison, C. J. N.</span>; <span class="NLM_string-name">Molteni, V.</span>; <span class="NLM_string-name">Nagle, A.</span>; <span class="NLM_string-name">Supek, F.</span>; <span class="NLM_string-name">Yeh, V.</span></span> <span> </span><span class="NLM_article-title">[1,2,4]Triazolo[1,5-A]pyrimidine derivatives as protozoan proteasome inhibitors for the treatment of parasitic diseases such as leishmaniasis</span>. <span class="NLM_patent">WO 2015095477 A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+Biggart&author=F.+Liang&author=C.+J.+N.+Mathison&author=V.+Molteni&author=A.+Nagle&author=F.+Supek&author=V.+Yeh&title=%5B1%2C2%2C4%5DTriazolo%5B1%2C5-A%5Dpyrimidine+derivatives+as+protozoan+proteasome+inhibitors+for+the+treatment+of+parasitic+diseases+such+as+leishmaniasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBiggart%26aufirst%3DA.%26atitle%3D%255B1%252C2%252C4%255DTriazolo%255B1%252C5-A%255Dpyrimidine%2520derivatives%2520as%2520protozoan%2520proteasome%2520inhibitors%2520for%2520the%2520treatment%2520of%2520parasitic%2520diseases%2520such%2520as%2520leishmaniasis%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitaura, K.</span></span> <span> </span><span class="NLM_article-title">Exploring chemistry with the fragment molecular orbital method</span>. <i>Phys. Chem. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">7562</span>– <span class="NLM_lpage">7577</span>, <span class="refDoi"> DOI: 10.1039/c2cp23784a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1039%2Fc2cp23784a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=22410762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvVykurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=7562-7577&author=D.+G.+Fedorovauthor=T.+Nagataauthor=K.+Kitaura&title=Exploring+chemistry+with+the+fragment+molecular+orbital+method&doi=10.1039%2Fc2cp23784a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring chemistry with the fragment molecular orbital method</span></div><div class="casAuthors">Fedorov, Dmitri G.; Nagata, Takeshi; Kitaura, Kazuo</div><div class="citationInfo"><span class="NLM_cas:title">Physical Chemistry Chemical Physics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7562-7577</span>CODEN:
                <span class="NLM_cas:coden">PPCPFQ</span>;
        ISSN:<span class="NLM_cas:issn">1463-9076</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The fragment MO (FMO) method makes possible nearly linear scaling calcns. of large mol. systems, such as water clusters, proteins and DNA.  In particular, FMO has been widely used in biochem. applications involving protein-ligand binding and drug design.  The method has been efficiently parallelized suitable for petascale computing.  Many commonly used wave functions and solvent models have been interfaced with FMO.  We review the historical background of FMO, and summarize its method development and applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_TiaN_HBr9rVg90H21EOLACvtfcHk0lgRgGJKPqxkqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvVykurw%253D&md5=903e3457b1dc5749950ebae5c954960a</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2Fc2cp23784a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2cp23784a%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DD.%2BG.%26aulast%3DNagata%26aufirst%3DT.%26aulast%3DKitaura%26aufirst%3DK.%26atitle%3DExploring%2520chemistry%2520with%2520the%2520fragment%2520molecular%2520orbital%2520method%26jtitle%3DPhys.%2520Chem.%2520Chem.%2520Phys.%26date%3D2012%26volume%3D14%26spage%3D7562%26epage%3D7577%26doi%3D10.1039%2Fc2cp23784a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitaura, K.</span></span> <span> </span><span class="NLM_article-title">Pair interaction energy decomposition analysis</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">222</span>– <span class="NLM_lpage">237</span>, <span class="refDoi"> DOI: 10.1002/jcc.20496</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1002%2Fjcc.20496" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=17109433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktVKgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=222-237&author=D.+G.+Fedorovauthor=K.+Kitaura&title=Pair+interaction+energy+decomposition+analysis&doi=10.1002%2Fjcc.20496"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Pair interaction energy decomposition analysis</span></div><div class="casAuthors">Fedorov, Dmitri G.; Kitaura, Kazuo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">222-237</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The energy decompn. anal. (EDA) by Kitaura and Morokuma was redeveloped in the framework of the fragment MO method (FMO).  The proposed pair interaction energy decompn. anal. (PIEDA) can treat large mol. clusters and the systems in which fragments are connected by covalent bonds, such as proteins.  The interaction energy in PIEDA is divided into the same contributions as in EDA: the electrostatic, exchange-repulsion, and charge transfer energies, to which the correlation (dispersion) term was added.  The careful comparison to the ab initio EDA interaction energies for water clusters with 2-16 mols. revealed that PIEDA has the error of at most 1.2 kcal/mol (or about 1%).  The anal. was applied to (H2O)1024, the α helix, β turn, and β strand of polyalanine (ALA)10, as well as to the synthetic protein (PDB code 1L2Y) with 20 residues.  The comparative aspects of the polypeptide isomer stability are discussed in detail.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ89I3W8YX1LVg90H21EOLACvtfcHk0lgRgGJKPqxkqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktVKgug%253D%253D&md5=759c711290fe1c44b7c86a28104ccef7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20496%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DD.%2BG.%26aulast%3DKitaura%26aufirst%3DK.%26atitle%3DPair%2520interaction%2520energy%2520decomposition%2520analysis%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2007%26volume%3D28%26spage%3D222%26epage%3D237%26doi%3D10.1002%2Fjcc.20496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brand, S.</span>; <span class="NLM_string-name">Dodd, P. G.</span>; <span class="NLM_string-name">Ko, E.-J.</span>; <span class="NLM_string-name">Marco Martin, M.</span>; <span class="NLM_string-name">Miles, T. J.</span>; <span class="NLM_string-name">Sandberg, L. H.</span>; <span class="NLM_string-name">Thomas, M. G.</span>; <span class="NLM_string-name">Thompson, S.</span></span> <span> </span><span class="NLM_article-title">Compounds</span>. <span class="NLM_patent">WO 2017025416 A1</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=S.+Brand&author=P.+G.+Dodd&author=E.-J.+Ko&author=M.+Marco+Martin&author=T.+J.+Miles&author=L.+H.+Sandberg&author=M.+G.+Thomas&author=S.+Thompson&title=Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrand%26aufirst%3DS.%26atitle%3DCompounds%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luescher, M. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vo, C.-V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, J. W.</span></span> <span> </span><span class="NLM_article-title">SnAP Reagents for the Synthesis of Piperazines and Morpholines</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1236</span>– <span class="NLM_lpage">1239</span>, <span class="refDoi"> DOI: 10.1021/ol500210z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol500210z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVartb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=1236-1239&author=M.+U.+Luescherauthor=C.-V.+T.+Voauthor=J.+W.+Bode&title=SnAP+Reagents+for+the+Synthesis+of+Piperazines+and+Morpholines&doi=10.1021%2Fol500210z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">SnAP reagents for the synthesis of piperazines and morpholines</span></div><div class="casAuthors">Luescher, Michael U.; Vo, Cam-Van T.; Bode, Jeffrey W.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1236-1239</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Substituted piperazines and morpholines are valuable structural motifs in biol. active compds., but are not easily prepd. by contemporary cross-coupling approaches.  In this report, we introduce SnAP reagents for the transformation of aldehydes into N-unprotected piperazines and morpholines.  This approach offers simple, mild conditions compatible with arom., heteroarom., aliph., and glyoxylic aldehydes and provides mono- and disubstituted N-heterocycles in a single step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDtifHDDeIMrVg90H21EOLACvtfcHk0lgRgGJKPqxkqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVartb0%253D&md5=a6fc1ed4cc7b7d7c859fd992c14d161b</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fol500210z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol500210z%26sid%3Dliteratum%253Aachs%26aulast%3DLuescher%26aufirst%3DM.%2BU.%26aulast%3DVo%26aufirst%3DC.-V.%2BT.%26aulast%3DBode%26aufirst%3DJ.%2BW.%26atitle%3DSnAP%2520Reagents%2520for%2520the%2520Synthesis%2520of%2520Piperazines%2520and%2520Morpholines%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D1236%26epage%3D1239%26doi%3D10.1021%2Fol500210z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Law, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ukuser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tape, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbot, E. P. A.</span></span> <span> </span><span class="NLM_article-title">Regioselective Synthesis of 3-Aminoimidazo[1,2-a]pyrimidines with Triflic Anhydride</span>. <i>Synthesis</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3775</span>– <span class="NLM_lpage">3793</span>, <span class="refDoi"> DOI: 10.1055/s-0036-1588425</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=10.1055%2Fs-0036-1588425" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;key=1%3ACAS%3A528%3ADC%252BC2sXps1Gqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2017&pages=3775-3793&author=R.+P.+Lawauthor=S.+Ukuserauthor=D.+T.+Tapeauthor=E.+P.+A.+Talbot&title=Regioselective+Synthesis+of+3-Aminoimidazo%5B1%2C2-a%5Dpyrimidines+with+Triflic+Anhydride&doi=10.1055%2Fs-0036-1588425"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Regioselective Synthesis of 3-Aminoimidazo[1,2-a]pyrimidines with Triflic Anhydride</span></div><div class="casAuthors">Law, Robert P.; Ukuser, Sabri; Tape, Daniel T.; Talbot, Eric P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3775-3793</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">1437-210X</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">The regioselective synthesis of 3-aminoimidazo[1,2- a]pyrimidines via triflic anhydride mediated amide activation and intramol. cyclization is reported.  The nature of the added pyridine base allows access to both regioisomers from a simple common precursor [e.g., treatment of pyrimidine amide I with Tf2O and pyridine bases yielded II + III (yield ratios 8:45 % using 2,6-difluoropyridine and 83:9 % using 2-fluoropyridine)].  The method tolerates a range of functional groups and provides access to novel heterocyclic scaffolds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5U8cHg7us2LVg90H21EOLACvtfcHk0ljdGyHbCFUWKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXps1Gqs7w%253D&md5=669b29f0bc0bc5e8cd5945cee0486ef7</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1055%2Fs-0036-1588425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0036-1588425%26sid%3Dliteratum%253Aachs%26aulast%3DLaw%26aufirst%3DR.%2BP.%26aulast%3DUkuser%26aufirst%3DS.%26aulast%3DTape%26aufirst%3DD.%2BT.%26aulast%3DTalbot%26aufirst%3DE.%2BP.%2BA.%26atitle%3DRegioselective%2520Synthesis%2520of%25203-Aminoimidazo%255B1%252C2-a%255Dpyrimidines%2520with%2520Triflic%2520Anhydride%26jtitle%3DSynthesis%26date%3D2017%26volume%3D49%26spage%3D3775%26epage%3D3793%26doi%3D10.1055%2Fs-0036-1588425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bode, C.</span>; <span class="NLM_string-name">Boezio, A.</span>; <span class="NLM_string-name">Cheng, A. C.</span>; <span class="NLM_string-name">Choquette, D.</span>; <span class="NLM_string-name">Coats, J. R.</span>; <span class="NLM_string-name">Copeland, K. W.</span>; <span class="NLM_string-name">Huang, H.</span>; <span class="NLM_string-name">La, D.</span>; <span class="NLM_string-name">Lewis, R.</span>; <span class="NLM_string-name">Liao, H.</span>; <span class="NLM_string-name">Potashman, M.</span>; <span class="NLM_string-name">Stellwagen, J.</span>; <span class="NLM_string-name">Yl, S.</span>; <span class="NLM_string-name">Norman, M.</span>; <span class="NLM_string-name">Stec, M.</span>; <span class="NLM_string-name">Peterson, E. A.</span>; <span class="NLM_string-name">Gracefa, R.</span></span> <span> </span><span class="NLM_article-title">Heteroaryl compounds as PIKK inhibitors</span>. U.S. Patent <span class="NLM_patent">US 20,120,190,666 A1</span>, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=C.+Bode&author=A.+Boezio&author=A.+C.+Cheng&author=D.+Choquette&author=J.+R.+Coats&author=K.+W.+Copeland&author=H.+Huang&author=D.+La&author=R.+Lewis&author=H.+Liao&author=M.+Potashman&author=J.+Stellwagen&author=S.+Yl&author=M.+Norman&author=M.+Stec&author=E.+A.+Peterson&author=R.+Gracefa&title=Heteroaryl+compounds+as+PIKK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBode%26aufirst%3DC.%26atitle%3DHeteroaryl%2520compounds%2520as%2520PIKK%2520inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QM7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6QM7','PDB','6QM7'); return false;">PDB: 6QM7</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i71"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00047">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_05162"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00047?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00047</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental information, synthesis of intermediates, methods for parasitology and modeling, molecular ESP maps and HPLC traces of key compounds, <i>in vitro</i> and <i>in vivo</i> assays, and <i>in vivo</i> pharmacokinetics (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00047/suppl_file/jm1c00047_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Homology model of <i>L. donovani</i> protease subunits β4 and β5 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00047/suppl_file/jm1c00047_si_002.pdb">PDB</a>)</p></li><li><p class="inline">Molecular formula strings for key compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00047/suppl_file/jm1c00047_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00047/suppl_file/jm1c00047_si_001.pdf">jm1c00047_si_001.pdf (6.77 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00047/suppl_file/jm1c00047_si_002.pdb">jm1c00047_si_002.pdb (748.27 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00047/suppl_file/jm1c00047_si_003.csv">jm1c00047_si_003.csv (3.35 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00047&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00047%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-9%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00047" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991426b98f3d06","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
